itraconazole has been researched along with fluconazole in 1189 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (2.27) | 18.7374 |
| 1990's | 309 (25.99) | 18.2507 |
| 2000's | 425 (35.74) | 29.6817 |
| 2010's | 327 (27.50) | 24.3611 |
| 2020's | 101 (8.49) | 2.80 |
| Authors | Studies |
|---|---|
| Driscoll, MD; Lafite, P; Levy, C; Leys, D; Mast, N; McLean, KJ; Munro, AW; Pikuleva, IA; Rigby, SE | 1 |
| Breckenridge, A | 1 |
| Gedde, S; Head, WS; O'Day, DM; Robinson, RD; Williams, TE | 1 |
| Bodey, GP | 1 |
| Wheat, LJ | 1 |
| Denning, DW; Graybill, JR; Hanson, LH; Pappagianis, D; Rinaldi, MG; Sharkey, PK; Stevens, DA; Tucker, RM | 1 |
| Baran, R | 1 |
| Van Cutsem, J | 1 |
| Viviani, MA | 1 |
| Basugi, N; Eguchi, M; Matsuno, A; Yoshida, S | 1 |
| Carbon, C; Eloy, O; Ghnassia, JC; Joly, V; Yeni, P | 1 |
| Garg, AK; Hamir, Z; Padhye, AA; Sekhon, AS | 2 |
| Lesher, JL | 2 |
| Bava, AJ; Negroni, R | 1 |
| Bender, HG; Laufer, B | 1 |
| Büchner, T; Roos, N | 1 |
| Lode, H; Schaberg, T | 1 |
| Lozano, MC; Martín, E; Parras, P | 1 |
| Adibzadeh, M; Friccius, H; Pawelec, G; Pohla, H; Schenk, A; Siegels-Hübenthal, P | 1 |
| Ehninger, G; Jaschonek, K; Pawelec, G; Rehbein, A; Schaudt, K | 1 |
| Durmaz, B | 1 |
| Lamey, PJ; Lewis, MA; Samaranyake, LP | 1 |
| Ancarani, F; Arzeni, D; Barchiesi, F; Scalise, G | 1 |
| Back, DJ; Tjia, JF | 1 |
| Ehninger, G; Jaschonek, K; Pawelec, G | 1 |
| Graybill, JR; Sharkey, PK | 1 |
| Cauwenbergh, G; Heykants, J; Lavrijsen, K; Meuldermans, W; Van Peer, A; Woestenborghs, R | 1 |
| Shindo, K | 1 |
| Ringel, SM | 1 |
| Hector, RF; Yee, E | 1 |
| Defaveri, J; Graybill, JR; Sun, SH | 1 |
| Bailey, EM; Krakovsky, DJ; Rybak, MJ | 1 |
| Linde, I; Mattie, H; Meynaar, I; Poell, R; Van 't Wout, JW; Van Furth, R | 1 |
| Guinet, R; Marlier, H | 1 |
| Larsen, RA | 2 |
| Perfect, JR; Ritter, W; Wright, KA | 1 |
| Meunier, F | 2 |
| Ballard, SA; Ellis, SW; Kelly, SL; Troke, PF | 2 |
| Mai, GT; McCormack, JG; Seow, WK; Thong, YH; Vuddhakul, V | 1 |
| Dupont, B | 4 |
| Mattie, H; van Furth, R; Van t Wout, JW | 1 |
| Kobayashi, GS; Spitzer, ED | 1 |
| Graybill, JR | 2 |
| Goldberg, DJ; Green, ST; Kennedy, DH; McGuire, W; Nathwani, D | 1 |
| Fransen, J; Janssen, PA; Van Cutsem, J; Van Gerven, F | 1 |
| Warnock, DW | 2 |
| Blancard, A; Goudard, M; Mary, C; Quilici, M; Regli, P | 1 |
| Ehninger, G; Einsele, H; Jaschonek, K; Roth, HJ; Steinhilber, D | 1 |
| Coussement, W; De Coster, R; Lampo, A; Marsboom, R; Van Cauteren, H; Vandenberghe, J; Vanparys, P | 1 |
| Polak, A | 1 |
| Dismukes, WE; Saag, MS | 1 |
| Walsh, TJ | 1 |
| Dismukes, WE | 1 |
| Coulaud, JP; Ngo Van, P | 1 |
| Pizzo, A; Walsh, TJ | 1 |
| Gordon, MA; Lapa, EW; Passero, PG | 1 |
| Beach, DH; Goad, LJ; Holz, GG | 1 |
| Faergemann, J | 1 |
| Hay, RJ | 2 |
| Stevens, DA | 3 |
| Durack, DT; Perfect, JR | 1 |
| Durack, DT; Perfect, JR; Savani, DV | 1 |
| Hopwood, V; Johnson, EM; Kennedy, CT; Smith, KJ; Van Cutsem, J; Vanden Bossche, H; Warnock, DW | 1 |
| Cobo, LM; Durack, DT; Perfect, JR; Savani, DV | 1 |
| Abruzzo, GK; Fromtling, RA; Giltinan, DM; Turnbull, TA | 1 |
| Martinez-Suarez, JV; Rodriguez-Tudela, JL | 2 |
| Arning, M; Aul, C | 1 |
| Fothergill, AW; McGough, DA; Peter, J; Pizzo, PA; Rinaldi, MG; Walsh, TJ | 1 |
| Köse, O | 1 |
| Asgari, M; Back, DJ | 1 |
| Albrecht, M; Laufen, H; Wildfeuer, A; Yeates, RA; Zimmermann, T | 2 |
| Wenig, JA | 1 |
| Just-Nübling, G | 1 |
| Clemons, KV; Homola, ME; Stevens, DA | 1 |
| Baldwin, BC; Corran, A; Kelly, SL; Kwon-Chung, J; Lamb, DC | 1 |
| Hahn, K; Scheven, Ch; Scheven, M; Senf, A | 1 |
| Denning, DW | 1 |
| Hoeprich, PD | 1 |
| Ahearn, DG; Kalya, AV | 1 |
| Angarano, G; Bellisario, A; Congedo, P; Coppola, S; Monno, L; Montagna, MT; Pastore, G | 1 |
| Cross, JT; Hickerson, SL; Yamauchi, T | 1 |
| de Lalla, F; Fabris, P; Franzetti, M; Manfrin, V; Pellizzer, G; Stecca, C; Vaglia, A | 1 |
| Barchiesi, F; Colombo, AL; McGough, DA; Rinaldi, MG | 1 |
| Bhakdi, S; Jahn, B; Martin, E; Stueben, A | 1 |
| Denning, DW; Law, D; Mason, C; Moore, CB; Wardle, HM | 1 |
| Hollis, RJ; Messer, SA; Pfaller, MA | 1 |
| He, X; Kauffman, CA; Revankar, SG; Tiballi, RN; Zarins, LT | 1 |
| Goetz, MB; White, A | 1 |
| Bale, MJ; Buschelman, B; Pfaller, MA; Rhomberg, P | 1 |
| Andreu, A; Arévalo, MP; Arias, A; Rodríguez, C; Sierra, A | 1 |
| Bradley, SF; He, X; Kauffman, CA; Sangeorzan, JA; Tiballi, RN; Zarins, LT | 1 |
| Joly, V | 1 |
| Lazo de la Vega, S; Pfaff, G; Volkow, P; Yeates, RA | 1 |
| Wheat, J | 1 |
| Wingard, JR | 1 |
| Aguirre, C; Arredondo, G; Calvo, R; Martinez-Jorda, R; Suarez, E | 1 |
| Kivistö, KT; Klotz, U; Neuvonen, PJ | 1 |
| Leitner, I; Meingassner, JG; Mieth, H | 1 |
| Barchiesi, F; Colombo, AL; Fothergill, AW; McGough, DA; Rinaldi, MG | 2 |
| Ancarani, F; Arzeni, D; Barchiesi, F; Del Poeta, M; Marinucci, G; Morbiducci, V; Scalise, G | 1 |
| Bartlett, MS; Queener, SF; Richardson, JD; Shaw, MM; Smith, JW | 1 |
| Meyer, RD | 1 |
| Laufen, H; Pfaff, G; Wildfeuer, A; Yeates, RA; Zimmermann, T | 1 |
| Cartledge, J; Fisher, M; Gazzard, BG; Nelson, MR; Rogers, T | 1 |
| DeDoncker, PR; Degreef, HJ | 1 |
| Roberts, DT | 1 |
| Bickers, DR | 1 |
| Alvarez Blanco, A; Alvarez, C; Floristán, F; Hernández, I; Hernández, J; Ponton, J; Sarcía-Ruiz, JC | 1 |
| Girmenia, C; Martino, P | 1 |
| Barbieri, G; Barile, F; Conese, M; D'Amico, G; Guerra, AP; Lo Re, M; Lospalluti, M; Pantaleo, AK | 1 |
| Altés, A; Brunet, S; Domingo-Albós, A; Martínez, C; Martino, R; Nomdedéu, J; Sureda, A | 1 |
| Arendorf, TM; van der Bijl, P | 1 |
| Edwards, JE; Filler, SG; Swerdloff, JN | 1 |
| Drew, RH | 1 |
| Sangueza, OP; Shupack, JL; Stiller, MJ | 1 |
| Acuña, G; Brengues, C; Cuny, G; Labarca, J; Muñoz, S; Oddó, D; Saavedra, H; Sepúlveda, C; Solari, A; Veas, F | 1 |
| Johnson, EM; Warnock, DW; White, DJ | 1 |
| Fetchick, R; Graybill, JR; Sharkey-Mathis, PK; Velez, J | 1 |
| Klauss, V; Lund, OE; Miño de Kaspar, H | 1 |
| Degreef, H | 1 |
| Sugar, AM | 1 |
| Barbaro, G; Di Lorenzo, G | 1 |
| Catalin, J; Durand, A; Lacarelle, B; Rajaonarison, JF; Sampol, E | 1 |
| Abe, M; Hiwada, K; Inoue, Y; Kohno, N; Yamamoto, K; Yokoyama, A | 1 |
| Hajjeh, RA | 1 |
| Arredondo, G; Calvo, R; Marcos, F; Martínez-Jordá, R; Suarez, E | 1 |
| He, X; Kauffman, CA; Tiballi, RN; Zarins, LT | 1 |
| Bastide, JM; Janbon, F; Le Guennec, R; Mallié, M; Pujol, C; Reynes, J | 1 |
| Ahonen, J; Neuvonen, PJ; Olkkola, KT | 1 |
| Johnson, EM; Warnock, DW | 1 |
| Davey, KG; Johnson, EM; Szekely, A; Warnock, DW | 1 |
| Phillips, P | 1 |
| Barbarini, G; Barbaro, G; Di Lorenzo, G | 2 |
| Cunha, BA; Klein, NC | 1 |
| Chen, SC; Gilbert, GL; Gordon, S; O'Donnell, ML | 1 |
| Chanock, SJ; Gonzalez, C; Lyman, CA; Pizzo, PA; Walsh, TJ | 1 |
| Powderly, WG | 3 |
| Kauffman, CA | 2 |
| Bastide, JM; Le Guennec, R; Mallie, M; Reynes, J; Rodriguez, E; Valentin, A | 1 |
| Kume, H; Murase, S | 1 |
| Czaika, V; Hopp, M; Kunzelmann, V; Rossner, D; Schmalreck, A; Sterry, W; Tietz, HJ | 1 |
| Eichel, M; Helm, EB; Just-Nübling, G; Stille, W | 1 |
| Odom, RB | 1 |
| Bolmström, A; Messer, SA; Odds, FC; Pfaller, MA; Rex, JH | 1 |
| Berrouane, YF; Hollis, RJ; Pfaller, MA | 1 |
| Clark, FS; Gow, NA; Hitchcock, CA; Parkinson, T | 1 |
| Cox, GM; Dodge, RK; Perfect, JR; Schell, WA | 1 |
| Alcini, P; Barbarini, G; Barbaro, G; Calderon, W; Di Lorenzo, G; Grisorio, B | 1 |
| Clarke, AM; Craib, K; Mahmood, W; Montaner, JS; Phillips, P; Zemcov, J | 1 |
| Helpianska, L; Hlavacova, E; Krcmery, V; Lacka, J; Oravcova, E; Pichna, P; Sorkovska, D; Studena, M; Studena, V; Sycova, Z | 1 |
| Fujimoto, K; Kubo, K; Sekiguchi, M; Tsushima, K | 1 |
| Love, DN; Malik, R; Medeiros, C; Wigney, DI | 1 |
| Caldarola, G; Cauda, R; Morace, G; Ortona, L; Posteraro, B; Tacconelli, E; Tumbarello, M | 1 |
| Djeu, JY; Greene, JN; Hiemenz, JW; Rosemurgy, AS; Sweeney, JF; Wei, S | 1 |
| Chanock, SJ; Walsh, TJ | 1 |
| Suarez, S | 1 |
| Annen, N; Araki, H; Fujimaki, K; Hayakawa, H; Hori, R; Imaizumi, H; Narita, H; Nishida, N; Shimizu, K; Watanbe, Y; Yamamoto, S; Yotsuji, A | 1 |
| Goto, Y; Hashimoto, A; Nagai, H; Nasu, M; Perparim, K; Tashiro, T | 1 |
| Alonso, J; Iglesias, L; Rodriguez-Peralto, JL; Romero, G; Sanchez-Albisua, B; Vanaclocha, F | 1 |
| Legakis, NJ; Papalambrou, D; Soremi, S; Velegraki, A | 1 |
| Jones, RN; Messer, S; Pfaller, MA | 1 |
| Connolly, P; Le Monte, A; Marichal, P; Vanden Bossche, H; Wheat, J | 1 |
| Bastide, JM; Mallié, M | 1 |
| Moreno, MI; Zaror, L | 1 |
| Goldman, M; Lee, YP | 1 |
| Mirels, LF; Stevens, DA | 1 |
| Fujihara, M; Kyo, T; Mikami, Y; Myoken, Y; Sugata, T | 3 |
| Chin, NX; Della-Latta, P; Weitzman, I | 1 |
| Friedman, HL; Greenblatt, DJ; Karsov, D; Schmider, J; Shader, RI; Vena, R; von Moltke, LL | 1 |
| Barry, AL; Bartlett, MS; Espinel-Ingroff, A; Galgiani, JN; Ghannoum, MA; Lancaster, M; Odds, FC; Pfaller, MA; Rex, JH; Rinaldi, MG; Walsh, TJ | 1 |
| Igari, J; Yamane, N | 1 |
| Cabezudo, E; Duarte-Palomino, R; López-Jiménez, J; Odriozola, J; Sousa, A; Velasco-Martínez, JJ | 1 |
| Colin, S; Dannaoui, E; Pichot, J; Piens, MA | 1 |
| Cuenca, M; Gadea, I; Gegúndez, MI; Soriano, F; Valero, ML; Zapardiel, J | 1 |
| Hollis, RJ; Pfaller, MA; Zhang, J | 1 |
| Gøtzsche, PC; Johansen, HK | 1 |
| Carver, PL; Kauffman, CA | 1 |
| Digranes, A; Lassen, J; Nilsen, K; Sandven, P; Tjade, T | 1 |
| Bárcena, R; Candela, A; de Vicente, E; Fortún, J; Guerrero, A; Honrubia, A; López-San Román, A; Monge, G; Nuño, J; Quereda, C; Sánchez-Sousa, A; Velasco, JJ | 1 |
| Adeyemi-Doro, FA; Chan, RC; Cheng, AF; Cheung, SW; Ng, TK | 1 |
| Seibold, M; Tintelnot, K | 1 |
| Blaschke-Hellmessen, R | 1 |
| Cloud, GA; Dismukes, WE; Graybill, JR; Hamill, RJ; Johnson, PC; Kerkering, T; Moskovitz, BL; Powderly, WG; Saag, MS; Sobel, JD; Tuazon, CU; van der Horst, CM | 1 |
| Darouiche, RO; Laine, L; Mallegol, I; Moskovitz, BL; Wilcox, CM; Wu, J | 1 |
| White, TC | 1 |
| Denning, DW; Kelly, SL; Venkateswarlu, K | 1 |
| Ghannoum, MA | 1 |
| Colebunders, R; Goossens, H; Ieven, M; Odds, FC; Schoofs, A; Wouters, L | 1 |
| Barchiesi, F; Falconi Di Francesco, L; Scalise, G | 1 |
| Piérard, GE | 1 |
| Evans, S; Leake, H; Ustianowski, AP | 1 |
| Del Rosso, JQ | 1 |
| Denning, DW; Law, D; Moore, CB | 1 |
| Castagnola, E; Machetti, M; Viscoli, C | 1 |
| Hecker, D | 1 |
| Cartledge, JD; Gazzard, BG; Midgley, J; Petrou, M; Shanson, D | 1 |
| Yamaguchi, H | 2 |
| Joseph, WS | 1 |
| Kauffman, CA; Spiegel, JE; Tiballi, RN; Zarins, LT | 1 |
| Cartledge, JD; Gazzard, BG; Midgley, J | 1 |
| Klimke, K; Schäfer-Korting, M | 1 |
| Hofmann, H; Metzger, S | 1 |
| Espinel-Ingroff, A | 1 |
| Burgaleta, C | 1 |
| Bouza, E; Muñoz, P | 1 |
| Hernanz Hermosa, JM; Lázaro Ochaita, P | 1 |
| Odds, FC | 1 |
| Berenguer Berenguer, J | 1 |
| Jones, RN; Marco, F; Messer, S; Pfaller, MA | 1 |
| Casali, AK; Hamdan, JS | 1 |
| Aller, AI; Bernal, S; Gutierrez, MJ; Martin-Mazuelos, E; Montero, O; Rodriguez Armijo, A; Romero, MJ | 1 |
| Cogliati, M; Pagano, A; Rigoni, AL; Roverselli, A; Tortorano, AM; Viviani, MA | 1 |
| Kadowaki, K; Komaki, H; Mikami, Y; Tanaka, Y; Thomson, KS; Yazawa, K | 1 |
| Gubbins, PO; Penzak, SR | 1 |
| Andrew, SE; Brooks, DE; Dillavou, CL; Ellis, G; Kubilis, PS | 1 |
| Darouiche, RO | 1 |
| Glasmacher, A; Just-Nübling, G; Molitor, E | 1 |
| Arzeni, D; Barchiesi, F; Compagnucci, P; Di Francesco, LF; Giacometti, A; Scalise, G | 1 |
| Seaton, RA | 1 |
| Gould, IM; Kunova, A; Milne, K; Wood, W | 1 |
| Kaukonen, KM; Neuvonen, PJ; Olkkola, KT | 1 |
| Chapman, SW; Rinaldi, MG; Rogers, PD; Sullivan, DC | 1 |
| Friedlander, SF; Suarez, S | 2 |
| Ghannoum, MA; Hawser, SP; Jessup, CJ; Norris, H | 1 |
| Demitrovicova, A; Kralovicova, K; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Mrazova-Studena, M; Oravcova, E; Spanik, S; Stopkova-Grey, K; Trupl, J | 1 |
| Blumberg, HM; Dibb, JC; Edwards, JE; Houston, A; Jarvis, W; Martin, MA; Messer, SA; Neu, HC; Patterson, JE; Pfaller, MA; Rangel-Frausto, MS; Rinaldi, MG; Roldan, CM; Saiman, L; Wenzel, RP; Wiblin, T | 1 |
| Kauffman, CA; Zarins, LT | 2 |
| Edmond, MB; Jones, RN; Messer, SA; Pfaller, MA; Wenzel, RP | 1 |
| Seebacher, C | 2 |
| Clotet, B; De Beule, K; Frechette, G; Hoepelman, A; Phillips, P; Stingl, G; Tchamouroff, S; Vandercam, B; Weitner, L | 1 |
| Amichai, B; Grunwald, MH | 1 |
| Doern, GV; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA; Sader, HS | 1 |
| Elewski, BE | 1 |
| Arikan, S; Chen, Y; Coffman, S; Heffner, T; Lozano-Chiu, M; Messer, SA; Pfaller, MA; Rennie, R; Rex, JH; Sand, C; Wang, J; Yamane, N | 1 |
| McLachlan, AJ; Tett, SE | 1 |
| Arceneaux, KA; Hosgood, G; Taboada, J | 1 |
| Cantu, RA; Fothergill, AW; Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; McCarthy, DI; Patterson, TF; Revankar, SG; Rinaldi, MG; Sanche, SE | 1 |
| Davey, KG; Holmes, AD; Johnson, EM; Szekely, A; Warnock, DW | 1 |
| Nguyen, MH; Yu, CY | 2 |
| Cooper, CR; Fothergill, AW; McGinnis, MR; Pasarell, L; Rinaldi, MG; Sutton, DA | 1 |
| Johnson, EM; Rogers, TR; Warnock, DW | 1 |
| Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 1 |
| Aitchison, T; Bagg, J; Cross, LJ; Wray, D | 1 |
| Casal, M; Linares, MJ; Muñoz, JF; Rodríguez, FC; Solís, F; Valero, A | 1 |
| Cabrera, E; Cantón, E; Orero, A; Pemán, J; Velert, MM | 1 |
| Brandt, ME; Ghannoum, MA; Hajjeh, RA; Jessup, CJ; Mbidde, EK; Messer, SA; Pfaller, MA; Tumberland, M; Zhang, J | 1 |
| Counihan, M; Durol, AL; Graf, JA; Greenblatt, DJ; Harmatz, JS; Mertzanis, P; Roth-Schechter, B; Shader, RI; von Moltke, LL | 1 |
| Klepser, ME; Lewis, RE; Pfaller, MA | 1 |
| Burattini, MN; Colombo, AL; Costa, PR; Fischmann, O; Kallás, EG; Milan, EP | 1 |
| Araj, GF; Daher, NK; Tabbarah, ZA | 1 |
| Watanabe, K | 1 |
| Hiruma, M; Kawai, M; Maeng, DJ; Ogawa, H; Takimoto, R | 1 |
| Espinel-Ingroff, A; Ghannoum, MA; Killian, S; Knapp, CC; Messer, SA; Norris, HA; Pfaller, M | 1 |
| Aubert, D; Béguinot, I; Pinon, JM; Remy, G; Rouger, C; Toubas, D; Witthuhn, F | 1 |
| Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
| Terrell, CL | 1 |
| Friedlander, SF | 1 |
| Hossain, MA; Kohno, S; Maesaki, S; Marichal, P; Sanglard, D; Vanden Bossche, H | 1 |
| Cloud, GA; Cosmatos, D; Dismukes, WE; Fessel, WJ; Graybill, JR; Hafner, R; Johnson, PC; Moskovitz, BL; Riser, L; Saag, MS; Sobel, JD; Thomas, C; Tuazon, CU; Wiesinger, B | 1 |
| Frieden, IJ; Howard, RM | 1 |
| Tanuma, H | 1 |
| Li, RK; Rinaldi, MG | 1 |
| Aller, AI; Bernal, S; Gutiérrez, MJ; Martín-Mazuelos, E; Martínez, MA; Montero, O; Quindós, G | 1 |
| Arzeni, D; Barchiesi, F; Caselli, F; Falconi Di Francesco, L; Gallo, D; Scalise, G | 1 |
| Ambroise-Thomas, P; Brion, JP; Grillot, R; Lebeau, B; Pavese, P | 1 |
| Nishimoto, K | 1 |
| Desmet, P; Raes-Wuytack, C; Swinne, D; Van Looveren, K | 1 |
| Gupta, AK; Katz, HI; Shear, NH | 1 |
| Amalfitano, G; Concia, E; Kwon-Chung, KJ; Luzzati, R; Mondon, P; Petter, R; Polacheck, I | 1 |
| Cuenca-Estrella, M; Rodríguez-Tudela, JL | 1 |
| Cuenca-Estrella, M; Díaz-Guerra, TM; Mellado, E; Monzón, A; Rodríguez-Tudela, JL | 2 |
| Diekema, DJ; Doern, GV; Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Cuenca-Estrella, M; Monzón, A; Ramos, G; Rodríguez-Tudela, JL | 1 |
| Adachi, A; Horikawa, T; Ichihashi, M; Komura, A; Takashima, T | 1 |
| Montero-Gei, F; Robles, ME; Suchil, P | 1 |
| Carrillo-Muñoz, AJ; Cossum, PA; del Valle, O; Miranda, Y; Quindós, G; Ruesga, MT; Tur, C; Wallace, TL | 1 |
| Arrese, JE; Piérard, GE; Piérard-Franchimont, C | 2 |
| Gupta, AK; Lambert, J | 1 |
| Bellens, D; Borgers, M; Koymans, L; Luyten, W; Marichal, P; Odds, FC; Ramaekers, FCS; Vanden Bossche, H; Verhasselt, P; Willemsens, S | 1 |
| Morgenstern, GR; Prentice, AG; Prentice, HG; Ropner, JE; Schey, SA; Warnock, DW | 1 |
| Brenner-Gati, L; Fessel, WJ; Guarnieri, JA; Kaufman, CA; Klausner, M; Lee, J; Merrill, KW; Moskovitz, BL; Oleka, N; Saag, MS; Thomas, C; Ward, DJ | 1 |
| Huijgens, PC; Jonkhoff, AR; Ossenkoppele, GJ; Prooy, E; Simoons-Smit, AM; van Loenen, AC; van Tinteren, H | 1 |
| Alonso-Vargas, R; Arévalo, P; Bornay-Llinares, FJ; Carrillo-Muñoz, AJ; del Valle, O; Gasser, I; Quindós, G; Ruesga, MT; Santos, P; Tur-Tur, C | 1 |
| Gupta, AK; Shear, NH | 1 |
| Bonner, DP; Fung-Tomc, JC; Huczko, E; Minassian, B; White, TC | 1 |
| Brown, P; Jandourek, A; Vazquez, JA | 1 |
| Martin, MV | 1 |
| Czaika, V; Sterry, W; Tietz, HJ | 1 |
| Azevedo, V; Caligiorne, RB; Carmo, FH; Melillo, PH; Peluso, CP; Resende, MA | 1 |
| Wierzbicka, M | 1 |
| Haustein, UF; Nenoff, P; Oswald, U | 1 |
| Korting, HC; Niewerth, M | 1 |
| Abrahão, TB; Benard, G; del Negro, GM; Gesztesi, JL; Lopes, JD; Santos, MV; Sato, J; Souza, AR | 1 |
| Holzgrabe, U; Inkmann, E | 1 |
| Huijgens, PC; Simoons-Smit, AM; Timmers, GJ; Van Loenen, AC | 1 |
| Katz, HI | 1 |
| Burgess, DS; Hardin, TC; Hastings, RW; Rinaldi, MG; Summers, KK | 1 |
| Clemons, KV; Pappagianis, D; Sobel, RA; Sorensen, KN; Stevens, DA; Williams, PL | 1 |
| Chow, CK; Lawrence, HP; Matear, DW | 1 |
| Ciblak, MA; Clayton, GE; Elie, CM; Li, RK | 1 |
| Hamacher, J; Kurt, AM; Nicod, LP; Spiliopoulos, A | 1 |
| Bernal, S; Chávez, M; Gutiérrez, MJ; Mazuelos, EM; Quindós, G; Serrano, MC; Valverde, A | 1 |
| Hahn, RC; Hamdan, JS | 1 |
| Hartmann, M; Kappe, R; Prariyachatigul, C; Rimek, D; Zimmermann, T | 1 |
| Bradley, MC; Elewski, BE; Ghannoum, MA; Isham, N; Leidich, S | 1 |
| Chakrabarti, A; Dogra, MR; Gupta, A; Gupta, V; Patnaik, B; Ram, J; Ray, P | 1 |
| Böhme, A; Hoelzer, D; Karthaus, M | 1 |
| Doyu, M; Inukai, A; Sobue, G; Watanabe, H | 1 |
| Niki, Y | 1 |
| Anndo, T | 1 |
| Kawana, A | 1 |
| Castelli, A; Laurini, L; Massai, L; Romano, C | 1 |
| Kohler, SM; LeMonte, AM; Schnizlein-Bick, C; Smedema, ML; Washum, KE; Wheat, LJ | 1 |
| Del Rosso, JQ; Gupta, AK | 1 |
| Arzeni, D; Barchiesi, F; Carle, F; Caselli, F; Di Cesare, S; Di Francesco, LF; Fallani, S; Fortuna, M; Giacometti, A; Giannini, D; Mazzei, T; Novelli, A; Scalise, G; Schimizzi, AM | 1 |
| Gallacher, K; Helenius, H; Issakainen, J; Lehtonen, OP; Nikoskelainen, J; Richardson, MD; Salonen, JH | 1 |
| Gupta, AK; Summerbell, RC | 1 |
| Hollis, RJ; Houston, A; Jones, RN; Messer, SA; Pfaller, MA; Yamazumi, T | 1 |
| Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, M; Seibold, M; Willinger, B | 1 |
| Burgess, DS; Hastings, RW | 1 |
| Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O | 1 |
| Rand, S | 1 |
| Smith, EB | 1 |
| Gupta, AK | 1 |
| Catanzaro, A; Cloud, GA; Delgado, KL; Flanigan, C; Galgiani, JN; Johnson, RH; Larsen, RA; Lutz, JE; Mirels, LF; Nassar, F; Rinaldi, MG; Sharkey, PK; Singh, VR; Stevens, DA; Williams, PL | 1 |
| Masci, JR | 1 |
| Drake, L; Gupta, AK; Lambert, J; Shear, N; Yaniv, R | 1 |
| Aller, AI; Bernal, S; Chávez, M; Gutiérrez, MJ; Martín-Mazuelos, E; Recio, FJ | 1 |
| Kibbler, CC; McWhinney, PH; Paterson, PJ; Potter, M; Prentice, HG | 1 |
| Brankovic, L; Hindler, J; Muehlbauer, L; Steele-Moore, L; Wong-Beringera, A | 1 |
| Ellepola, AN; Samaranayake, LP | 2 |
| Meis, JF; Verweij, PE | 1 |
| Buslaeva, GN | 1 |
| Bodey, GP; Chatzinikolaou, I; Hajiioannou, I; Kontoyiannis, DP; Maraki, S; Rolston, KV; Samonis, G | 1 |
| Bassler, M; Rodgers, P | 1 |
| Barchiesi, F; Cogliati, M; Di Francesco, LF; Scalise, G; Tortorano, AM; Viviani, MA | 1 |
| Arredondo, G; Calvo, R; García-Sanchez, J; Martinez-Jordá, R; Suárez, E; Vazquez, JA | 1 |
| Leitner, I; Ryder, NS | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| D'Auria, FD; Simonetti, N; Strippoli, R; Tecca, M | 1 |
| Baddley, JW; Moser, SA; Pappas, PG; Smith, AM | 1 |
| King, S; McGeer, A; Richardson, S; Walmsley, S; Ye, Y | 1 |
| Cheng, B | 1 |
| Barr, D; Smart, T | 1 |
| Brooks, JT; Wheat, LJ | 1 |
| Gregurek-Novak, T; Gupta, AK | 1 |
| Briand, V; Lortholary, O | 1 |
| Baglivo, E; Bagnoud, M; Hengstler, J; Leuenberger, P; Pournaras, CJ; Safran, AB | 1 |
| Bleicher, JJ; Davenport, DS; Kauffman, CA; Malani, PN | 1 |
| Boyle, K; Espinel-Ingroff, A; Sheehan, DJ | 1 |
| Bonito, AJ; Patton, LL; Shugars, DA | 1 |
| Crego, AL; Gómez, J; Lavandera, JL; Marina, ML | 1 |
| Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Groll, AH; Müller, FM; Ritter, J | 1 |
| Kumarasamy, N; Menon, T; Solomon, S; Thyagarajan, SP; Umamaheswari, K | 1 |
| Brizendine, E; Connolly, P; Hafner, R; Smedema, M; Wheat, LJ | 1 |
| Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
| Torres-Rodríguez, JM; Vivas, JR | 1 |
| Bruserud, O | 1 |
| Chen, BK; Friedlander, SF | 1 |
| Brizendine, E; Connolly, P; Haddad, N; Hafner, R; Le Monte, A; Wheat, LJ | 1 |
| Marr, KA | 2 |
| Muller, RJ | 1 |
| Gompakis, N; Kanakoudi-Tsakalidou, F; Kanellopoulou, K; Mpantouraki, M; Roilides, E; Trachana, M | 1 |
| Antoniadou, A; Dosios, T; Giamarellou, H; Petrikkos, G; Sabatakou, H; Skiada, A | 1 |
| Fukuoka, T; Harada, Y; Harasaki, T; Inoue, S; Kamai, Y; Konosu, T; Mori, M; Nakagawa, A; Nakamura, Y; Ohya, S; Oida, S; Seki, S; Seta, Y; Shibayama, T; Somada, A; Uchida, T; Yasuda, H | 1 |
| Nagino, K; Ogawa, M; Shimohira, H; Uchida, K; Yamaguchi, H | 1 |
| Mantovani, L; Virgili, A; Zampino, MR | 1 |
| Arzeni, D; Barchiesi, F; D'Angelo, M; Falconi Di Francesco, L; Giuliana, G; Milici, ME; Pizzo, G; Scalise, G | 1 |
| Calderon, L; Clemons, KV; Martinez, M; Stevens, DA | 1 |
| Harry, JB; Lyons, CN; Song, JL; White, TC | 1 |
| Aller, AI; Bernal, S; Chávez, M; Gutiérrez, MJ; Martín Mazuelos, E; Quindós, G; Serrano, C; Valverde, A | 1 |
| Kantarjiev, TB; Kuzmanov, AH; Zissova, LG | 1 |
| Damle, B; Hess, H; Kaul, S; Knupp, C | 1 |
| Fothergill, AW; Gonzalez, G; Perea, S; Rinaldi, MG; Sutton, DA | 1 |
| Akar, A; Arca, E; Gür, AR; Kurumlu, Z; Taştan, HB | 1 |
| Alcântara, AP; Carvalho, MT; Colombo, AL; Ferreira, MS; Martinez, R; Milan, EP; Queiroz-Telles, F; Sant'Ana, Pde L | 1 |
| Fukuda, T | 1 |
| Hassim, SM; Samsudin, SH; Somchit, N | 1 |
| Bradbury, BD; Jick, SS | 1 |
| Arikan, S; Hasçelik, G | 1 |
| Capilla, J; Fernández-Torres, B; Guarro, J; Ortoneda, M; Pujol, I | 1 |
| Alvarado, D; Díaz, MC; Silva, V | 2 |
| Itoh, S; Kajiwara, M; Kumagai, J; Nagasawa, M; Sugimoto, T; Tomizawa, D | 1 |
| Arthington-Skaggs, BA; Brandt, ME; Ciblak, MA; Frade, JP; Hajjeh, RA; Harrison, LH; Lee-Yang, W; Sofair, AN; Warnock, DW | 1 |
| Baldassarri, R; Biancofiore, G; Bindi, ML; Catalano, G; Filipponi, F; Mosca, F; Romanelli, AM; Vagelli, A | 1 |
| Glad'ko, VV; Tarasenko, GN | 1 |
| Denning, DW; Moore, CB; Mosquera, J; Sharp, A; Warn, PA | 1 |
| Qian, J; Yu, P; Zha, GZ | 1 |
| Beijnen, JH; Bult, A; Koks, CH; Meenhorst, PL | 1 |
| Armstrong, D; Chaturvedi, V; Koll, BS; Larone, DH; Perlin, DS; Safdar, A | 1 |
| Busuttil, RW; Winston, DJ | 1 |
| Adesina, A; Chodosh, J; Hampton, DE | 1 |
| Cuenca-Estrella, M; Mellado, E; Rodríguez-Tudela, JL | 1 |
| Abeck, D; Korting, HC; Möhrenschlager, M; Ring, J; Seidl, HP | 1 |
| Krawczyk, E; Luczak, M; Marchel, H; Rokosz, A; Swoboda-Kopec, E; Wroblewska, MM | 1 |
| Arikan, S; Ergin, C; Ergin, S | 1 |
| Kurowski, R; Ostapchuk, M | 1 |
| Beran, M; Cortes, J; Estey, E; Giles, F; Kantarjian, H; Koller, C; Kontoyiannis, D; Mattiuzzi, GN; Munsell, M; Raad, I; Shen, Y | 1 |
| Cartelle, M; Cuenca-Estrella, M; Durán, MT; Gil, E; Guerrero, A; Molina, F; Rodríguez-Tudela, JL | 1 |
| De Punzio, C; Garutti, P; Genazzani, AR; Mollica, G; Nappi, C; Piccoli, R | 1 |
| Cantón, E; Gobernado, M; López-Ribot, JL; Pemán, J; Viudes, A | 1 |
| Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
| Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Kottom, TJ; Limper, AH; Morales, IJ; Puri, V; Thomas, CF; Vohra, PK | 1 |
| Bruneau, JM; Caer, JP; Fudali, C; Hodgson, J; Labas, V; Lecaque, D; Legrand, R; Maillet, I; Supatto, F; Tagat, E | 1 |
| Kamei, K | 1 |
| Cassone, A; De Bernardis, F; Girolamo, A; Mondello, F; Salvatore, G | 1 |
| Barker, KS; Pearson, MM; Rogers, PD | 1 |
| Matysiak, J; Niewiadomy, A | 1 |
| Qiu, WY; Tseng, SC; Yao, YF; Zhang, B; Zhang, YM; Zhou, P | 1 |
| Blumer, JL; Chandrasekar, PH; Goldman, M; Lazarus, HM; Leitz, GJ; Maziarz, RT; Territo, MC; Winston, DJ | 1 |
| Blin, P; Chevalier, E; Cohen, Y; Dupont, H; Gauzit, R; Hennequin, C; Montravers, P; Palestro, B; Timsit, JF; Veber, B | 1 |
| Anunnatsiri, S; Chetchotisakd, P; Choksawadphinyo, K; Mootsikapun, P | 1 |
| Avery, RK; Bolwell, BJ; Mossad, SB | 1 |
| De Maubeuge, J; Kolivras, A; Lateur, N; Scheers, C; Song, M; Wiame, L | 1 |
| Nikkels, AF; Piérard, GE | 1 |
| Usatine, RP | 1 |
| Hamdan, JS; Moraes, EM; Prímola, NS | 1 |
| Geraldine, P; Kaliamurthy, J; Thomas, PA | 1 |
| del Palacio, A; Garau, M; Pereiro, M | 1 |
| Alvareda, D; Silva, V; Zepeda, G | 1 |
| Barchiesi, F; Bille, J; Chryssanthou, E; Cuenca-Estrella, M; Denning, DW; Donnelly, JP; Dromer, F; Dupont, B; Moore, CB; Rex, JH; Richardson, MD; Rodríguez-Tudela, JL; Sancak, B; Verweij, PE | 1 |
| Fang, K; Sun, QN | 1 |
| Grooters, AM; Taboada, J | 1 |
| Banerjee, U; Casadevall, A; Datta, K; Jain, N; Rattan, A; Sethi, S | 1 |
| Gupta, AK; Ryder, JE | 1 |
| Branchini, ML; Colombo, AL; Kussano, EJ; Nakagawa, Z; Nucci, M; Valdetaro, F | 1 |
| De Hoog, GS; Verweij, PE; Vitale, RG | 1 |
| Erdem, U; Gonlum, A; Saracli, MA; Yildiran, ST | 1 |
| Ikeda, F | 1 |
| Boeckh, M; Corey, L; Crippa, F; Leisenring, W; Marr, KA; McDonald, GB; Slattery, JT | 1 |
| Akula, I; Edlind, T; Jain, P | 1 |
| Banker, DD; Iyer, RS | 1 |
| Balajee, SA; Boeckh, M; Corey, L; Crippa, F; Hoyle, M; Leisenring, W; Marr, KA; Musher, B; Nichols, WG | 1 |
| Al, MA; Bagg, J; Baxter, W; Coleman, D; Jackson, MS; Lewis, MA; McEndrick, S; McHugh, S; Sweeney, MP | 1 |
| Fehér, J; Lengyel, G | 1 |
| Antoniadou, A; Bodey, GP; Han, XY; Kontoyiannis, DP; Lewis, RE; Raad, II; Rolston, KV; Safdar, A; Tarrand, JP; Thornby, J; Torres, HA | 1 |
| Kostecka, M; Krajewska-Kułak, E; Matysiak, J; Niewiadomy, A; Łukaszuk, C | 1 |
| Chávez-Caballero, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Serrano-Martino, Mdel C; Valverde-Conde, A | 1 |
| Kontoyiannis, DP; Lewis, RE; Lionakis, MS; Liu, W; May, GS; Wiederhold, N | 1 |
| Cerqueira, CH; de F L Fernandes, O; Miranda, AT; Passos, XS; Silva, Mdo R; Souza, LK | 1 |
| Ginarte, M; Pereiro, M; Toribio, J | 1 |
| González-Monroy, J; Hernández-Hernández, F; López-Martínez, R; Manzano-Gayosso, P; Méndez-Tovar, LJ | 1 |
| Gangneux, JP; Guiguen, C; Preney, L; Théraud, M | 1 |
| Nabeshima, T; Sekiguchi, K; Sobue, S | 1 |
| McDonald, HR | 1 |
| Escudero, E; Han, XY; Tarrand, JJ | 1 |
| Karpov, OI; Klimko, NN; Kolbin, AS | 1 |
| Joseph Wheat, L | 1 |
| Chakrabarti, A; Kaur, I; Kumar, B; Partap, R | 1 |
| Fernandez-Obregon, AC; Greer, DL; Wignall, FS; Wingfield, AB | 1 |
| Maertens, JA | 1 |
| Bucci, B; Castagnola, E; Machetti, M; Viscoli, C | 1 |
| Boyle, GJ; Gandhi, S; Kurland, G; Law, YM; Mahnke, CB; Michaels, M; Miller, SA; Pigula, FA; Sutton, RM; Venkataramanan, R; Webber, SA | 1 |
| Reinel, D | 1 |
| Battagliotti, C; Galíndez, J; Greca, A; Kilstein, J; Negro-Marquínez, L; Pietrobon, D | 1 |
| Abe, N; Aihara, M; Fukuda, S; Iwasaki, M; Komatsu, M; Matsuo, S; Nagasaka, Y; Shimakawa, K | 1 |
| Costa, M; de Araújo, RS; Miranda, AT; Passos, XS; Paula, CR; Silva, Mdo R | 1 |
| Chan, YC; Friedlander, SF | 1 |
| Gupta, AK; Johnson, AM; Ryder, JE | 1 |
| Cornely, OA; Karthaus, M; Ullmann, AJ | 1 |
| Higgins, KM; Powers, JH | 1 |
| Mossad, SB | 1 |
| Chen, J; Li, R; Wan, Z | 1 |
| Al Hedaithy, SS; Fotedar, R | 1 |
| Borovsky, M; Liptajova, D; Sojakova, M; Subik, J | 1 |
| Kovachev, S; Nacheva, A; Stoev, S; Vacheva-Dobrevski, R; Vasilev, N | 1 |
| Akova, M; Aoun, M; Cohen, J; De Bock, R; de Pauw, BE; Egyed, M; Ellis, M; Herbrecht, R; Krcmery, V; Kullberg, BJ; Marinus, A; Oude Lashof, AM; Siffnerová, H; Sylvester, R | 1 |
| Nolard, N; Swinne, D; Van der Flaes, M; Watelle, M | 1 |
| García Agudo, L; Garcia Martos, P; Marín, P; Montes de Oca, M; Puerto, JL; Ruiz Aragón, J; Saldarreaga, A | 1 |
| Marrazzo, J | 1 |
| Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE | 1 |
| Jones, AL; Pai, MP | 1 |
| Chakrabarti, A; M, J; Mondal, RK; Singhi, SC | 1 |
| Kanakura, Y; Winston, DJ | 1 |
| Menichetti, F | 1 |
| Spence, D | 4 |
| Antal, Z; Dóczi, I; Dósa, E; Kredics, L; Nagy, E; Varga, J | 1 |
| Carrillo-Muñoz, AJ; Casals, J; del Valle, O; Guardià, C; Guglietta, A; Palacín, C; Quindós, G; Rodríguez, V | 1 |
| Hasiah, AH; Noordin, MM; Norshahida, AR; Somchit, N; Sulaiman, MR; Zuraini, A | 1 |
| Goto, Y; Haga, T; Hasegawa, T; Kosuge, J; Shinjo, T; Takatori, K; Tateyama, S; Uchida, K; Yamaguchi, R; Yoshida, Y | 1 |
| Garg, G; Gupta, ML; Kanga, AK; Mahajan, VK; Sharma, NL; Sharma, RC | 1 |
| Chimishkian, KL; Minenko, SV; Ptushkin, VV; Sokolova, EN; Zhukov, NV | 1 |
| Halsey, ES; Hospenthal, DR; Rasnake, MS | 1 |
| Friedlander, SF; Roberts, BJ | 1 |
| Yasuda, MA | 1 |
| Nolard, N; Swinne, D; Watelle, M | 1 |
| Arikan, S; Hascelik, G; Sancak, B | 1 |
| Batra, R; Gupta, AK; Kohli, Y | 1 |
| Ayangil, D; Cankaya, S; Ferahbaş, A; Koc, AN; Silici, S | 1 |
| Suh, MK | 1 |
| Afonso, E; Candido, RC; Ferreira, JC; Krakhecke, AG | 1 |
| Gugel, A; Laverdiere, M; Leisenring, W; Marr, KA | 1 |
| Gander, R; Hoang, MP; Hussey, SM; Southern, P | 1 |
| Steinbach, WJ | 1 |
| Ai'e, X; Xiujiao, X | 1 |
| Chang, LW; Kennedy, GE; Phipps, WT; Rutherford, GW | 1 |
| Giusiano, G; Gómez, V; Mangiaterra, M; Rojas, F | 1 |
| Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE | 1 |
| Cetinkaya, Z; Kiraz, N | 1 |
| Cárdenes, CD; Carrillo-Muñoz, AJ; Carrillo-Orive, B; Casals, JB; Del Valle, O; Ezkurra, PA; Quindós, G; Rodríguez, V | 1 |
| Abdel-Salam, HA | 1 |
| Costa-de-Oliveira, S; Mårdh, PA; Pina-Vaz, C; Ricardo, E; Rodrigues, AG | 1 |
| Glasmacher, A; Prentice, AG | 1 |
| Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE | 1 |
| Bagg, J; Brailsford, S; Davies, AN; Jackson, MS; Sweeney, MP | 1 |
| Alía-Aponte, C; Baró-Tomás, T; Jiménez-Cabello, T; Lázera, MS; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Bishara, J; Peled, N; Samra, Z; Yardeni, M | 1 |
| Falagas, ME; Michalopoulos, A; Vardakas, KZ | 1 |
| Niwa, T; Shiraga, T; Takagi, A | 1 |
| Amsden, JR; Gubbins, PO | 1 |
| Colombo, GL; Morlotti, L; Serra, G | 1 |
| Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
| Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G | 1 |
| Hector, RF | 1 |
| Andreesen, R; Bertz, H; Bodenstein, H; Boewer, C; Cornely, O; Dölken, G; Glasmacher, A; Hänel, M; Junghanss, C; Pasold, R; Ullmann, AJ; Wandt, H; Wedding, U; Wolf, HH | 1 |
| Ortiz-Ibarra, J; Reyna-Figueroa, J; Villagrana-Zesati, R | 1 |
| Díaz, MC; Giusiano, G; Gómez, V; Mangiaterra, M; Rojas, F; Saito, VG | 1 |
| Aggarwal, P; Capoor, MR; Deb, M; Nair, D; Srivastava, L; Verma, PK | 1 |
| Kul'ko, AB; Mitrokhin, SD; Moroz, AM | 1 |
| Gasnier, O; Lortholary, O; Malvy, D; Mienniel, B; Receveur, MC; Rivière, JP; Roussin, C | 1 |
| Djulbegovic, B; Glasmacher, A; Prentice, AG | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 2 |
| Budak, F; Ozcan, SK; Susever, S; Willke, A; Yucesoy, G | 1 |
| Franks, JN; Welihozkiy, A | 1 |
| Crawford, F; Ferrari, J | 2 |
| Das, H; Deb, M; Khanal, B; Kumar, S; Panda, A | 1 |
| Gribskov, JL; Kirby, KA; Marr, KA; Panackal, AA; Rinaldi, M; Staab, JF | 1 |
| Zhao, M; Zhou, ZT | 1 |
| Dambrauskiene, A; Skrodeniene, E; Vitkauskiene, A | 1 |
| Hiruma, M | 1 |
| da Costa, SC; de Resende, MA; Lyon, JP; Munhoz, MF; Totti, VM | 1 |
| Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F | 1 |
| Akria, L; Benyamini, N; Dally, N; Dann, EJ; Fineman, R; Gorelik, A; Haddad, N; Oren, I; Rowe, JM; Sprecher, H; Tamir, A; Zuckerman, T | 1 |
| Ahmad Bustamam, A; Hasiah, AH; Israf, DA; Khairi, HM; Somchit, N; Sulaiman, MR; Wong, CW; Zuraini, A | 1 |
| Hamimah, H; Ng, KP; Rohani, MY; Tanty Haryanty, T; Tay, ST | 1 |
| Barger, AM; Gilor, C; Graves, TK; O'Dell-Anderson, K | 1 |
| Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K | 1 |
| Arcaya, NM; Beltrán-Luengo, H; Mesa, LM; Milagros Calvo, B; Pineda, MR | 1 |
| Candido, RC; Ferreira, JC; Pedroso, RS | 1 |
| Tietz, HJ | 1 |
| Blignaut, E; Botes, ME; Nieman, HL | 1 |
| Díaz, MC; Garcia Saito, V; Giusiano, G; Gómez, V; Mangiaterra, M; Rojas, F | 1 |
| Nishiyama, Y; Uchida, K; Yamaguchi, H | 1 |
| Rott, T; Rylander, R; Tercelj, M | 1 |
| Abe, S; Uchida, K; Yamaguchi, H | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| Bagg, J; Chalmers, EA; Gibson, BE; Kennedy, HF; Shankland, GS; Williams, CL | 1 |
| Alvarez, MS; Silverberg, NB | 1 |
| Barros, ME; Hamdan, JS; Santos, Dde A | 1 |
| Krockenberger, MB; Malik, R; Martin, P; O'Brien, CR; Wigney, DI | 1 |
| Jayasinghe, M; Röcken, M; Schaller, M; Schmidt, S; Walker, B | 1 |
| Clemons, KV; Kamberi, P; Sobel, RA; Stevens, DA; Striebel, JM; Waldvogel, A; Williams, PL | 1 |
| Hashinaga, K; Hiramatsu, K; Ishii, H; Kadota, J; Kishi, K; Kushima, H; Ohama, M; Tokimatsu, I; Umeki, K | 1 |
| Nakagawa, Y | 1 |
| Canton, E; Espinel-Ingroff, A; Gibbs, D; Wang, A | 1 |
| Costa, CR; de Araujo, CR; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Miranda, KC; Passos, XS | 1 |
| Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D | 1 |
| Hutzler, JM; Locuson, CW; Tracy, TS | 1 |
| Angulo-Gonzalez, D; Cornely, OA; Goh, YT; Hardalo, C; Helfgott, D; Holowiecki, J; Maertens, J; Perfect, J; Petrini, M; Stockelberg, D; Suresh, R; Ullmann, AJ; Walsh, TJ; Winston, DJ | 1 |
| De Pauw, BE; Donnelly, JP | 1 |
| Chung, PC; Hsiao, CH; Huang, SC; Hwang, YS; Lin, HC; Ngan, KW; Tsai, YJ | 1 |
| Colombo, AL; Costa, SF; da Matta, VL; de Souza Carvalho Melhem, M; dos Anjos Martins, M; Duboc de Almeida, GM; Levin, AS; Moretti, ML; Nucci, M; Rodero, L; Souza Dias, MB | 1 |
| Brocks, DR; El-Kadi, AO; Korashy, HM; Shayeganpour, A | 1 |
| Aoyama, Y; Ito, Y; Kanamaru, A; Kiguchi, T; Masaoka, T; Matsuda, M; Matsuura, Y; Mugitani, A; Ohyashiki, K; Sakamoto, E; Takeuchi, M; Tamura, K; Urabe, A; Wakita, H; Yoshida, I | 1 |
| Caputi, AP; Cricelli, C; Galatti, L; Greco, A; Mazzaglia, G; Nicoletti, G; Schito, GC; Sessa, E; Spina, E | 1 |
| da Silva Barros, ME; de Assis Santos, D; Soares Hamdan, J | 1 |
| Araújo, CR; Costa, CR; e Souza, LK; Fernandes, Ode F; Nascimento, ES; Passos, XS; Sales, WS; Silva, Mdo R | 1 |
| Williams, PL | 1 |
| Barros, MEDS; Hamdan, JS; Santos, DA | 1 |
| Easley, C; Kauffman, CA; Kirkpatrick, P; Malani, AN | 1 |
| Ahmad, S; Al-Kazemi, N; Al-Sweih, NA; Chandy, R; Joseph, L; Khan, S; Khan, ZU | 1 |
| Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
| Bonifaz, A; Fierro, L; Paredes, V | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Aller, AI; Castro, C; Claro, R; Colom, MF; Martín-Mazuelos, E; Serrano, C | 1 |
| Chen, S; Li, J; Li, S; Liu, Z; Tu, Y; Wu, Y | 1 |
| Gupta, A; Mao, Q; Unadkat, JD | 1 |
| Bellmann, R; Weiler, S | 1 |
| van Dissel, JT; van Nieuwkoop, C | 1 |
| de Assis Santos, D; Figueiredo, VT; Hamdan, JS; Resende, MA | 1 |
| Guilhermetti, E; Shinobu, CS; Svidzinski, TI; Takahachi, G | 1 |
| Creutzig, U; Groll, AH; Kaiser, J; Klingebiel, T; Lehrnbecher, T; Ritter, J; Schwabe, D; Varwig, D | 1 |
| Arikan, S; Hüseyin, A; Sancak, B | 1 |
| Arslan, H; Azap, O; Can, F; Demirbileki, M; Timurkaynak, F | 1 |
| Korting, HC; Schmid-Wendtner, MH | 1 |
| Can, F; Demirbilek, M; Sarifakioglu, E; Seçkin, D | 1 |
| Chan, AK; Chang, CH; Kurth, T; Orav, JE; Young-Xu, Y | 1 |
| Ali, S; Forgie, SE; Graham, TA | 1 |
| Abouelfath, A; Depont, F; Dupon, M; Dutronc, H; Galpérine, T; Giauque, E; Hébert, G; Moore, N; Ragnaud, JM; Valentino, R; Vargas, F | 1 |
| Chen, SC; Sorrell, TC | 1 |
| Brocks, DR; El-Kadi, AO; Korashy, HM | 1 |
| Bergus, G; González, U; Jacobson, J; Martínez-Monzón, C; Seaton, T | 1 |
| Pantazidou, A; Tebruegge, M | 1 |
| Chang, CL; Kim, MN; Kim, SH; Lee, HS; Lee, JS; Lee, K; Lee, WG; Ryang, DW; Shin, BM; Shin, JH; Shin, MG; Suh, SP; Uh, Y | 1 |
| Holmes, AR; Iguchi, Y; Ikeda, F; Maki, K; Matsumoto, S; Mutoh, S; Tawara, S; Watabe, E | 1 |
| Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW | 1 |
| Falagas, ME; Iavazzo, C; Pitsouni, E | 1 |
| Jin, H; Li, S; Liu, M; Shi, W; Xie, L | 1 |
| Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P | 1 |
| Chang-Xing, L; Jiang-Qiang, S; Qiu-Xia, C; Shun-Fang, L; Wen, L; Wen-Ming, H | 1 |
| Christopherson, H; Daenen, S; de Jong-van den Berg, LT; de Vries, R; Glasmacher, A; Howells, S; Postma, MJ; Prentice, A; Tolley, K | 1 |
| Hernández-Hernández, F; López-Martínez, R; Manzano-Gayosso, P; Méndez-Tovar, LJ; Millan-Chiu, B; Mondragón-González, R; Velásquez-Hernández, V | 1 |
| Abrahamsen, TG; Gaustad, P; Warris, A; Winn, RM | 1 |
| Chen, SP; Shu, YG; Xu, YJ; Zhu, Y | 1 |
| Araiza, J; Arias, P; Bonifaz, A; Macias, B; Paredes-Farrera, F; Ponce, RM | 1 |
| Cai, CJ; Chen, GH; Guo, Y; Li, MR; Lu, MQ; Yang, Y; Yi, HM; Yi, SH | 1 |
| Gupta, R; Thami, GP | 1 |
| Almyroudis, NG; Gonzalez, AV; Segal, BH; Ullmann, AJ | 1 |
| Carrillo-Muñoz, AJ; Eraso, E; Espinel-Ingroff, A; Quindós, G; Ruesga, M; Villar-Vidal, M | 1 |
| Arechavala, A; Corti, M; Negroni, R; Palmieri, O; Semorile, K; Trione, N | 1 |
| Andes, D; Smith, J | 1 |
| Balci, DD; Cetin, M | 1 |
| Balbinot, A; Catavitello, C; Celentano, C; D'Antonio, D; D'Antonio, F; Di Bonaventura, G; Febbo, F; Liberati, M; Manna, A; Piccolomini, R; Savini, V; Talia, M | 1 |
| Ishida, S; Matsui, H; Nishimura, Y; Okano, Y; Oyama, TB; Oyama, TM; Oyama, Y; Sakanashi, Y; Yokota, S | 1 |
| Karthaus, M | 1 |
| Ayala, J; Elizondo, M; González, GM | 1 |
| Menon, T; Umamaheswari, K | 1 |
| Dolande, M; Panizo, MM; Reviákina, V; Selgrad, S | 1 |
| Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A | 1 |
| Jeong, SH; Jung, SI; Kim, EC; Kim, MN; Kim, SH; Lee, HS; Lee, JS; Lee, K; Lee, MK; Lee, WG; Park, KH; Ryang, DW; Shin, JH; Shin, MG; Suh, SP; Uh, Y | 1 |
| Li, L; Li, R; Luo, S; Sun, X; Wang, Z | 1 |
| Hollenbach, E | 1 |
| Jansen, JP; Janssen, JJ; Lugtenburg, E; O'Sullivan, AK; Rijnders, B; Span, LF; Stam, WB | 1 |
| Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L | 1 |
| Candido, RC; da Costa, KR; Ferreira, JC; Komesu, MC | 1 |
| Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P | 1 |
| Aktas, E; Cizmeci, Z; Durmaz, R; Gulcan, H; Kuzucu, C; Otlu, B | 1 |
| Anderson, R; Steel, HC; Tintinger, GR | 1 |
| Kagoshima, Y; Konosu, T; Oida, S; Somada, A; Uchida, T | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Touw, DJ; Verweij, PE | 1 |
| Collins, CD; Ellis, JJ; Kaul, DR | 1 |
| Adem, A; Al-Marzouqi, AH; Elwy, HM; Shehadi, I | 1 |
| Maesaki, S; Tarumoto, N | 1 |
| Fujii, Y; Inase, N; Yoshizawa, Y | 1 |
| dos Santos Lazéra, M; Guarro, J; Pastor, FJ; Pujol, I | 1 |
| Cisalpino, PS; da Costa César, G; de Carvalho, IR; dos Anjos Martins, M; Kohler, LM; Santos, DA; Soares, BM | 1 |
| Harris, BP; Koerner, IL | 1 |
| Fatuzzo, F; Iacobello, C; La Rosa, R; Larocca, L; Montineri, A; Nigro, L | 1 |
| Cheng, A; Lou, H; Sun, L; Sun, S; Wu, X; Zhang, Y | 1 |
| Ono, F; Yasumoto, S | 1 |
| Islam, N; Islam, T; Kamal, M; Muhammad, N; Shafiquzzaman, M | 1 |
| Alexopoulos, EC; Antonopoulou, S; Aoun, M; Baka, S; Grigoriou, O; Kalambokas, T; Kouskouni, E; Logothetis, E; Papadias, K; Velegraki, A; Zannos, A | 1 |
| Rahkhoodaee, F; Raymond, M; Tsao, S | 1 |
| Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R | 1 |
| Celik, AD; Kantarcioglu, S; Mert, A; Ozaras, R; Ozturk, R; Tabak, F | 1 |
| Ambudkar, SV; Gaur, M; Prasad, R; Puri, N; Sharma, M; Shukla, S | 1 |
| Billack, B; Lau-Cam, C; Santoro, M | 1 |
| Balachandran, C; De, A; Mehta, V; Monga, P | 1 |
| Bulut, Y; Günday, E; Güven, M; Yenişehirli, G | 1 |
| Ambudkar, SV; Manoharlal, R; Prasad, R; Prasad, T; Puri, N; Sharma, M; Shukla, S | 1 |
| Furman-Kuklińska, K; Myśliwiec, M; Naumnik, B | 1 |
| Budihardja, D; Freund, V; Mayser, P | 1 |
| Chen, E; Leitz, GJ; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Rex, JH; Rodriguez, JR | 1 |
| Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL | 1 |
| Carrasco-Portugal, Mdel C; Flores-Murrieta, FJ; Landa, C | 1 |
| Borges Sá, M; Garnacho Montero, J | 1 |
| Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
| Accoceberry, I; Bernadou, JM; Breilh, D; Gordien, JB; Pigneux, A; Rouault, A; Saux, MC; Tabrizi, R; Vigouroux, S | 1 |
| Balbinot, A; Bianco, A; Catavitello, C; D'Antonio, D; D'Antonio, F; Savini, V | 1 |
| Alp, S; Arikan, S; Hasçelik, G; Sancak, B | 1 |
| Braga-Silva, LA; Carvalho, SM; Fracalanzza, SE; Mesquita, DG; Ribeiro, MD; Santos, AL | 1 |
| Anasetti, C; Field, T; Gergis, U; Greene, J; Huang, Y; Kharfan-Dabaja, M; Markey, K; Perkins, J; Schell, MJ; Wetzstein, G | 1 |
| Cao, Y; Che, X; Ji, H; Miao, Z; Sheng, C; Wang, W; Yao, J; Zhang, W | 1 |
| Brown, SJ | 1 |
| Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
| Black, TA; Chau, AS; Cornely, OA; Mann, PA; McNicholas, PM; Mendrick, C; Patel, R; Patino, H; Ullmann, AJ | 1 |
| Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B | 1 |
| Ouyang, J; Shao, X; Wang, J; Xu, J; Yang, Y; Zhan, P; Zhou, R | 1 |
| Bhat, RM; Sequeira, F; Srinivas, M; Sukumar, D; Swethadri, GK | 1 |
| de Souza, W; Lemgruber, L; Martins-Duarte, ES; Vommaro, RC | 1 |
| Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ | 1 |
| Baudraz-Rosselet, F; Bontems, O; Lurati, M; Monod, M; Ruffieux, C | 1 |
| Asanuma, S; Fujii, S; Hirano, T; Imai, K; Kasai, M; Kiyama, Y; Kobayashi, N; Kosugi, M; Matsuoka, S; Nakata, M; Noguchi, S; Ogasawara, M; Ota, S; Wada, A | 1 |
| Dag, I; Kasifoglu, N; Kiraz, N; Kiremitci, A; Oz, Y; Yamac, M | 1 |
| Fleischhacker, M; Moran, G; Pasligh, J; Ruhnke, M | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Gomez-Lopez, A; Lass-Floerl, C; Rodriguez-Tudela, JL | 1 |
| Besse, B; Hennequin, C; Le Pape, P; Loge, C; Morio, F | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| Millikan, LE | 1 |
| Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA | 1 |
| Brilhante, RS; Cordeiro, RA; Maia, DC; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Soares, GD | 1 |
| Bai, FY; Ge, SH; Li, J; Li, RY; Wan, Z; Xu, J | 1 |
| Murayama, N; Nakamoto, M; Niwa, T; Shimizu, M; Yamazaki, H | 1 |
| Addidle, M; Grimwade, K; Kasuga, T; Pynn, J; Skellern, P | 1 |
| Lazzaro, C | 1 |
| Kelly, DE; Kelly, SL; Lamb, DC; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG | 1 |
| Heeres, J; Lewi, P; Meerpoel, L | 1 |
| Kelly, DE; Kelly, SL; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG | 1 |
| Belda, S; Cremades, R; Lopez, P; Rodriguez, JC; Royo, G; Ruiz-Garcia, M; Soler, L | 1 |
| Krzyściak, P; Macura, AB | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M | 1 |
| Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, NJ; Warrilow, AG | 1 |
| Chen, MC; Li, HT; Li, Z; Liu, JH; Luo, DQ | 1 |
| Day, JN; Hong Chau, TT; Kim Cuc, NT; Le, T; Manh Sieu, TP; Shikuma, CM; Si Lam, P | 1 |
| Calahorra, M; Lozano, C; Peña, A; Sánchez, NS | 1 |
| Dranitsaris, G; Khoury, H | 1 |
| Diamond, G; Felsenstein, S; Hua, J; Markowitz, K; Scott, RW; Yamarthy, R | 1 |
| Ko, KS; Lee, JY; Peck, KR; Song, JH | 1 |
| Ando, T; Ikushima, S; Masunaga, A; Morimoto, K; Oritsu, M; Takemura, T | 1 |
| Clemans, JM; Deitz, KL; Legendre, AM; Riedesel, EA; Yaeger, MJ | 1 |
| de Souza, W; Ishida, K; Rodrigues, JC; Rozental, S; Urbina, JA; Visbal, G | 1 |
| Campbell, BC; Chan, KL; Faria, NC; Gonçalves, LA; Kim, JH; Martins, Mde L | 1 |
| Coleman, DC; Costigan, C; Fleming, P; Healy, CM; McGovern, E; McManus, BA; Moran, GP; Nunn, J; Sullivan, DJ | 1 |
| De Carolis, E; Fadda, G; Maffei, A; Mattei, R; Posteraro, B; Posteraro, P; Sanguinetti, M; Torre, A; Trivella, F | 1 |
| Nweze, EI; Ogbonnaya, UL | 1 |
| Batista, MR; Bertoni, TA; Consolaro, ME; Cortez, DA; Damke, E; Donati, L; Ferreira, IC; Svidzinski, TI; Tsuzuki, JK | 1 |
| Alves, SH; Azevedo, MI; Botton, SA; Dutra, V; Jesus, FP; Lautert, C; Machado, ML; Mahl, DL; Santurio, JM; Zanette, RA | 1 |
| Davis, JD; Harper, AL | 1 |
| Brilhante, RS; Caetano, EP; Castelo-Branco, Dde S; Cordeiro, Rde A; de Lima, RA; Fechine, MA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Mourão, CI; Ribeiro, JF; Rocha de Castro E Silva, K; Rocha, FA; Rocha, MF; Sidrim, JJ | 1 |
| Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
| Hai, W; Jianghan, C; Julin, G; Nan, X; Wanqing, L; Xiaojun, W; Yuanjie, Z | 1 |
| Izumikawa, K; Kakeya, H; Kobayashi, T; Kohno, S; Miyazaki, T; Ohno, H; Tashiro, T; Yamamoto, Y; Yanagihara, K | 1 |
| Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K | 1 |
| Hua, H; Xu, Y; Yan, Z; Young, AL | 1 |
| Kamegaya, C; Kido, N; Makimura, K; Omiya, T; Shibata, E; Shindo, I; Yamamoto, Y | 1 |
| Boonmee, D; Chaiwarith, R; Fakthongyoo, A; Praparattanapan, J; Sirisanthana, T; Supparatpinyo, K | 1 |
| Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C | 1 |
| Byekova, Y; Elewski, B; Hughey, L | 1 |
| Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D | 1 |
| Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M | 1 |
| Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J | 1 |
| Calışkan, E; Calışkan, S; Cınar, S; Corakçı, A; Keçeli Özcan, S | 1 |
| Backman, JT; Karonen, T; Laitila, J; Neuvonen, PJ; Niemi, M | 1 |
| Lass-Flörl, C | 1 |
| Chang, YC; Dolan, MA; Garraffo, HM; Ghannoum, MA; Kwon-Chung, KJ; Sionov, E | 1 |
| Abe, S; Cannon, RD; Harding, DR; Hayama, K; Holmes, AR; Ishibashi, H; Ishijima, SA; Monk, BC; Niimi, K; Ono, Y; Tansho, S | 1 |
| Langston, AA; O'Sullivan, AK; Pandya, A; Papadopoulos, G; Perfect, JR; Thompson, D; Weinstein, MC | 1 |
| Aydin, M; Güzel, AB; Ilkit, M; Kalkanci, A; Khalil, II; Kuştimur, S | 1 |
| Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
| Chakrabarti, A; Jatana, M; Rudramurthy, SM; Singh, R | 1 |
| Carreras, E; de la Cámara, R; Grau, S; Jarque, I | 1 |
| Chen, TC; Chen, YC; Chen, YH; Lu, PL | 1 |
| Brilhante, RS; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DS; Cordeiro, RA; Fechine, MA; Lima, RA; Mesquita, JR; Monteiro, AJ; Pereira, JF; Rocha, MF; Sidrim, JJ | 1 |
| Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Giffoni Leite, JJ; Lima, DT; Monteiro, AJ; Paiva, MA; Rocha, MF; Sidrim, JJ; Teixeira, CE | 1 |
| Chander, J; Gulati, N; Kaistha, N; Singla, N | 1 |
| Harkin, KR; Jackson, T; KuKanich, KS; Reinhart, JM | 1 |
| Hu, C; Li, S; Sun, X; Zhang, H; Zhang, X; Zhang, Y; Zhang, Z | 1 |
| Alexis, A; Bhanusali, D; Coley, M; Silverberg, JI; Silverberg, NB | 1 |
| Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F | 1 |
| Guerra, CR; Ishida, K; Nucci, M; Rozental, S | 1 |
| Frazho, JK; Randell, SC; Walker, JT | 1 |
| Chang, W; Cheng, A; Li, Y; Liu, Y; Lou, H; Zhang, L | 1 |
| Macura, AB; Skóra, M | 1 |
| Baez, AA; Bonfietti, LX; Castro e Silva, DM; Martins, MA; Melhem, MS; Pukinskas, SR; Purisco, SU; Szeszs, MW | 1 |
| Kalaivani, R; Kumar, M; Kumaraguru, AK; Manikandan, S; Singh, M | 1 |
| Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
| Aller, AI; Canton, E; Castañón-Olivares, LR; Chowdhary, A; Cordoba, S; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Govender, N; Hagen, F; Illnait-Zaragozi, MT; Johnson, E; Kidd, S; Lass-Flörl, C; Lockhart, SR; Martins, MA; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Schell, WA; St-Germain, G; Trilles, L; Turnidge, J | 1 |
| Ananiev, J; Cardoso, JC; Ginter-Hanselmayer, G; Guarneri, C; Gulubova, M; Hristova, R; Kanazawa, N; Martino, G; Nenoff, P; Nocheva, D; Penev, PK; Taneva, T; Tchernev, G; Zisova, LG | 1 |
| Álvarez, MI; Castro, LÁ; Martínez, E | 1 |
| Murakami, H; Tashiro, M; Tateda, K; Yamaguchi, K; Yoshizawa, S | 1 |
| Hunt, S; Papadopoulos, G; Prasad, M | 1 |
| Klause, S; Meyer, W; Pye, GW; Stadler, CK; Sykes, JE; Wynne, J | 1 |
| Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG | 1 |
| Datau, EA | 1 |
| Ando, K; Fukushima, T; Hata, T; Honda, S; Imaizumi, Y; Imanishi, D; Itonaga, H; Matsuo, E; Miyazaki, Y; Moriuchi, Y; Onimaru, Y; Sato, S; Sawayama, Y; Taguchi, J; Tsushima, H; Yamasaki, R; Yoshida, S | 1 |
| Gärtner, P; Knoth, H; Petry, T | 1 |
| Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
| Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C | 1 |
| Helou, J; Maatouk, I; Moutran, R; Obeid, G | 1 |
| Athanasakis, K; Kyriopoulos, J; Petrakis, I | 1 |
| Arsić Arsenijević, V; Barać, A; Crnčević Radović, L; Pekmezović, M; Trpković, A | 1 |
| Chowdhary, A; Kathuria, S; Khan, N; Kumar, DA; Meis, JF; Muralidhar, S; Prakash, A; Randhawa, HS; Sharma, C; Singh, PK; Wankhede, S | 1 |
| Arnan, M; Clopés, A; de Sevilla, AF; Duarte, RF; Muñoz, C; Patiño, B; Peralta, T; Sánchez-Ortega, I | 1 |
| Ding, YG; Fang, H | 1 |
| Bielecki, J; Hryncewicz-Gwóźdź, A; Jagielski, T; Kalinowska, K; Plomer-Niezgoda, E | 1 |
| Hauben, M; Hung, EY | 1 |
| Maurya, V; Mishra, J; Srivastava, A; Venkatesh, V | 1 |
| Akhtar, S; Masood, S; Rizvi, DA; Tabassum, S | 1 |
| Arikan-Akdagli, S; Canton, E; Hazirolan, G; Sahin, S | 1 |
| Monod, M; Pot, SA; Spiess, BM; Unger, L; Voelter-Ratson, K | 1 |
| Culakova, H; Dzugasova, V; Gbelska, Y; Perzelova, J; Subik, J | 1 |
| Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C | 1 |
| Chander, J; Gombar, S; Sidhu, SK; Singla, N | 1 |
| Jorge, JH; Machado, AL; Mima, EG; Pavarina, AC; Sanitá, PV; Vergani, CE | 1 |
| Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA | 1 |
| Chen, H; Chen, M; Liao, W; Pan, W; Zhou, J | 1 |
| Li, S; Liu, J; Sun, X; Wang, K; Xie, B; Yu, X; Zhang, H; Zhou, F | 1 |
| de Sá, DC; Lamas, AP; Tosti, A | 1 |
| Arakawa, S; Fujisawa, M; Hayama, B; Iwata, K; Jikimoto, T; Ohji, G; Osawa, K; Shigemura, K; Yoshida, H | 1 |
| Chacko, A; Dutta, AK; Esakimuthu, S; Sahni, RD; Sajith, KG | 1 |
| Glavin, FL; Kaye, FJ; Lourdes, LS; Mitchell, CL; Schain, DC | 1 |
| Fukui, A; Ishida, Y; Kamata, N; Naruse, T; Nishi, H; Ohta, K; Takechi, M | 1 |
| Fujisaki, J; Hamada, T; Hirabayashi, D; Kamikawa, Y; Mori, Y; Nagayama, T; Sakamoto, R; Sugihara, K | 1 |
| Luo, Z; Shi, D | 1 |
| Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J | 1 |
| Molter, CM; Papendick, R; Zuba, JR | 1 |
| Åkerborg, Ö; Björkholm, M; Höglund, M; Lundberg, J | 1 |
| Jiang, L; Li, R; Liang, H; Liu, W; Liu, Z; Peng, Y; Qin, Q; Tao, R; Yong, X; Zhang, L | 1 |
| Brillowska-Dabrowska, A; Dzierzanowska-Fangrat, K; Gucwa, K; Milewski, S; Naumiuk, L; Romanowska, E; Szweda, P; Wojciechowska-Koszko, I | 1 |
| Cao, C; Li, X; Liang, H; Mo, D; Sun, C; Wei, L | 1 |
| Charlier, C; Jullien, V; Lecuit, M; Lortholary, O; Pilmis, B; Sobel, J | 1 |
| Huang, X; Li, D; Mylonakis, E; Xi, L | 1 |
| Fan, S; Li, J; Liu, X; Shan, Y; Zhu, Y | 1 |
| Colón, B; Flowers, SA; Rogers, PD; Schuler, MA; Whaley, SG | 1 |
| Cheung, BP; Samaranayake, LP; Samaranayake, YH; Yau, JY; Yeung, KW | 1 |
| Fukatsu, S; Habu, Y; Kimura, Y; Matsubara, K; Ozaki, J; Sato, E; Shida, A; Yamamoto, H; Yano, I | 1 |
| Marcella, SW; Sung, AH; Xie, Y | 1 |
| Li, J; Liu, B; Pan, A; Zhang, L; Zhou, S | 1 |
| Raspor, P; Tomičić, Z; Zupan, J | 1 |
| Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Eikemeier, M; Handgretinger, R; Hartmann, U; Müller, I; Schulz, A; Schwarze, CP | 1 |
| Ahmed, FU; Garg, A; Gupta, A; Mahapatra, AK; Naik, V; Sarkar, C; Sharma, B | 1 |
| Chen, J; Du, L; Gu, J; Liao, W; Yang, Y; Zhu, Y | 1 |
| Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R | 1 |
| Martin Lopez, JE | 1 |
| Alencar, LP; Bandeira, TJ; Brilhante, RS; Castelo-Branco, DS; Cordeiro, Rde A; de Oliveira, JS; Monteiro, AJ; Moreira, JL; Rocha, MF; Sidrim, JJ; Teixeira, CE | 1 |
| He, C; Kang, M; Lei, Y; Xiao, YL; Xie, Y; Zhang, CY | 1 |
| Banerjee, T; Kumar, D; Pratap, CB; Tilak, R | 1 |
| Fong, PH; Lee, VH; Seneviratne, CJ; Wong, SS | 1 |
| Kelly, DE; Kelly, SL; Lamb, DC; Nes, WD; Parker, JE; Rolley, NJ; Smith, SN; Warrilow, AG | 1 |
| Chen, X; Hu, Y; Wang, B; Yang, L; Yu, L | 1 |
| Arzeni, D; Barchiesi, F; Castelli, P; Cirioni, O; Conte, I; Giacometti, A; Kamysz, E; Kamysz, W; Morciano, A; Offidani, AM; Orsetti, E; Scalise, A; Silvestri, C; Simonetti, O; Staffolani, S | 1 |
| Bulanda, M; Jagielski, T; Skóra, M | 1 |
| Chen, X; Jin, C; Li, S; Liu, H; Sun, X; Wang, K; Zhang, Z | 1 |
| Buruiana, AM; Mihali, CV; Popescu, C | 1 |
| Back, H; Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kang, S; Kim, HJ; Kim, SH; Kim, YJ; Lee, DG; Lee, EK; Lee, HJ; Min, WS; Park, SH; Yoo, JH | 1 |
| Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF | 1 |
| Pajaziti, L; Vasili, E | 1 |
| Bandeira, Tde J; Brilhante, RS; Castelo-Branco, Dde S; Cordeiro, Rde A; de Alencar, LP; de Oliveira, JS; Monteiro, AJ; Moreira, JL; Ribeiro, JF; Riello, GB; Rocha, MF; Rodrigues, PH; Sidrim, JJ | 1 |
| Chan, TS; Gill, H; Hwang, YY; Kwong, YL; Marcella, SW | 1 |
| Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF | 1 |
| Albert, ND; Bellanger, AP; Kontoyiannis, DP; Lewis, RE; Walsh, TJ | 1 |
| Coste, AT; Sanglard, D | 1 |
| Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ | 1 |
| Ramírez Soto, MC | 1 |
| Fosso, MY; Garneau-Tsodikova, S; Shrestha, SK | 1 |
| Alencar, LP; Bandeira, TJPG; Brilhante, RSN; Cordeiro, RA; Evangelista, AJJ; Franco, JDS; Marques, FJF; Melo, CVS; Oliveira, JS; Rocha, MFG; Serpa, R; Sidrim, JJC | 1 |
| Adjapong, G; Bartlett, M; Garrill, A; Hale, M | 1 |
| Casadevall, A; Chatterjee, S; Fernandes, C; Gonçalves, T; Nakouzi-Naranjo, A; Prados-Rosales, R; Silva, BM; Stark, RE; Zuzarte, M | 1 |
| Berk, E; Demir, G; Koc, AN; Mutlu Sariguzel, F; Sav, H | 1 |
| Bharath, K; Kar, R; Kumaravel, S; Rajesh, NG; Singh, R | 1 |
| Alencar, LP; Bandeira, SP; Bandeira, TJ; Brandine, GS; Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Guedes, GM; Melo, LM; Moreira, JL; Paiva, MA; Pereira-Neto, WA; Ponte, YB; Rocha, MF; Sales, JA; Sidrim, JJ | 1 |
| Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
| Feng, B; Shen, JL; Tang, XF; Xu, HQ; Xu, SX | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ | 1 |
| Alves, GS; Bentes, Ados S; de Souza, JV; Freire, AK; Jackisch-Matsuura, AB; Matsuura, T; Pinheiro, JF; Wanke, B | 1 |
| Alem, N; Karabıçak, N | 1 |
| Rosen, T; Stein Gold, LF | 1 |
| Liu, ZH; Zhang, X | 1 |
| Busso-Lopes, AF; Kamei, K; Lyra, L; Mikami, Y; Moretti, ML; Peron, IH; Reichert-Lima, F; Schreiber, AZ; Taguchi, H | 1 |
| Chakrabarti, A; Ghosh, A; Honnavar, P; Pamidi, U; Rastogi, V; Rudramurthy, SM | 1 |
| Chandra, P; Colburn, D; Dresser, MJ; Graham, RA; Hop, CE; Malhi, V; Williams, SJ | 1 |
| Garvey, EP; Hoekstra, WJ; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Schotzinger, RJ; Warrilow, AG | 1 |
| Bennett, C; Chen, X; González, U; Hua, X; Jiang, X; Lin, X; Xue, S; Yang, M; Zhang, M | 1 |
| Han, RB; Hao, XK; Ma, YY; Su, MQ; Wen, J; Xin, YJ; Yang, L; Zhang, R | 1 |
| Bai, HH; Dong, HY; Liu, ZH; Wang, FJ; Wu, WX; Zhang, D | 1 |
| Fischer, G; Lee, A; Nguyen, Y | 1 |
| Matos, T; Raspor, P; Tomičić, Z; Zupan, J | 1 |
| Khosravi, AR; Sharifzadeh, A; Shokri, H | 1 |
| Holman, TR; Hughes, DD; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Rolley, NJ; Smyrniotis, CJ; Thoss, V; Warrilow, AG | 1 |
| Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
| Benjamin Lash, D; Heidari, A; Jolliff, J; Munoz, A | 1 |
| Barrueta, JA; Bow, EJ; Charbonneau, C; Cordonnier, C; Cornely, OA; Cragin, L; De Salas-Cansado, M; Garcia-Vidal, C; Jarque, I; Marks, DI; Pagliuca, A; Peral, C; Shaul, AJ; Slavin, M; Solano, C; Sorensen, S; Vanness, DJ | 1 |
| Berta, G; Bona, E; Cantamessa, S; Gamalero, E; Massa, N; Novello, G; Pavan, M; Rocchetti, A | 1 |
| Cassano, R; Mellace, S; Trombino, S | 1 |
| García-Romero, MT; Solís-Arias, MP | 1 |
| Alegre, LR; Carrillo-Muñoz, AJ; Cattana, ME; Córdoba, SB; de Los Ángeles Sosa, M; Fernández, MS; Giusiano, GE; Rojas, FD; Zalazar, LC | 1 |
| Han, X; Hu, Y; Huang, S; Liu, K; Lu, Y; Mao, Z; Wu, Z; Zhou, X | 1 |
| Audisio, E; Aversa, F; Bruno, B; Busca, A; Candoni, A; Delia, M; Monaco, F; Mordini, N; Pagano, L; Passera, R; Vacca, A | 1 |
| Balta, I; Oz, A; Oz, Y; Qoraan, I | 1 |
| Amirrajab, N; Badali, H; Gohar, AA; Moazeni, M; Nabili, M; Shokohi, T | 1 |
| Hsueh, PR; Wang, H; Xu, YC | 1 |
| Basu, SS; Jarolim, P; Mason, DS; Petrides, A | 1 |
| Dymond, AW; Huang, Y; Lisbon, E; Mariani, G; Martin, P; Mathews, D; Severin, P; So, K | 1 |
| Hasegawa, A; Kamata, H; Kano, R; Kimura, S; Lim, SY; Ooya, K; Yanai, T | 1 |
| Cen, W; Feng, W; Lv, Y; Ma, Y; Qiao, Z; Wang, Y; Xi, Z; Yang, J | 1 |
| Gao, J; Gao, N; Li, C; Wu, Y; Ying, C | 1 |
| Alencar, LP; Bittencourt, PV; Brilhante, RSN; de Aguiar Cordeiro, R; de Aquino Pereira-Neto, W; de Melo Guedes, GM; de Oliveira, JS; de Souza Collares Castelo-Branco, D; Nogueira-Filho, EF; Pinheiro, M; Rocha, MFG; Sidrim, JJC | 1 |
| Li, Y; Yu, L | 1 |
| Garvey, EP; Hoekstra, WJ; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Schotzinger, RJ; Warrilow, AGS; Wiederhold, NP | 1 |
| Başaran, S; Bingöl, Z; Çağatay, A; Eraksoy, H; Karabıçak, N; Kılıçaslan, Z; Özsüt, H; Şafak, S; Sarıbuğa, A; Şimşek Yavuz, S; Sutton, DA; Wiederhold, NP | 1 |
| Corrêa, C; Fuentefria, AM; Goldani, LZ; Heidrich, D; Rosa, PD; Scroferneker, ML; Vettorato, G | 1 |
| Blaich, C; Gehlen, D; Liss, B; Müller, C; Prozeller, D; Streichert, T; Wiesen, MHJ | 1 |
| Bamba, S; Guiguemde, RT; Guiguemde, T; Kone, S; Ouedraogo-Traore, R; Sangare, I; Sawadogo, M; Traore, LK; Yacouba, A; Zida, A | 1 |
| Aragón, B; Cámara, R; Gozalbo, I; Grau, S; Jurado, M; Sanz, J | 1 |
| Almeida-Paes, R; Barbedo, LS; de Oliveira, JCA; Dos Santos, ALS; Figueiredo-Carvalho, MHG; Ramos, LS; Zancopé-Oliveira, RM | 1 |
| Aydin, F; Cebeci Güler, N; Tosun, I | 1 |
| Siew, HH | 1 |
| Daali, Y; Desmeules, JA; Marsousi, N; Rudaz, S | 1 |
| Chetri, PB; Mordvinov, VA; Pakharukova, MY; Shukla, R; Sonkar, A; Tripathi, T | 1 |
| Arendrup, MC; Astvad, KMT; Dzajic, E; Gertsen, JB; Hare, RK; Johansen, HK; Knudsen, JD; Kristensen, L; Lemming, L; Nielsen, L; Olesen, B; Pedersen, M; Rosenvinge, FS; Røder, BL; Schønheyder, HC; Søndergaard, TS; Østergård, C | 1 |
| Aluri, J; Boyd, P; Chang, MK; Ferry, J; Lai, WG; Nomoto, M; Rege, B; Schuck, E; Siu, YA; Yasuda, S; Zamora, CA | 1 |
| Chang, M; Chang, YC; Khanal Lamichhane, A; Kwon-Chung, KJ; Sionov, E | 1 |
| Carreira, A; Ferreira, J; Ferreira, JB; Ferreira, RB; Filipe, P; Monteiro, S; Pereira, I | 1 |
| Chandra, A; Gupta, MK; Prakash, P; Tilak, R | 1 |
| Dawgul, MA; Grzywacz, D; Kamysz, W; Liberek, B; Myszka, H | 1 |
| Kooshki, P; Mahmoudabadi, AZ; Rezaei-Matehkolaei, A | 1 |
| Chakrabarti, A; Dogra, S; Mushtaq, K; Narang, T; Paul, RA; Rudramurthy, SM; Shankarnarayan, SA; Shaw, D | 1 |
| Brilhante, RSN; Castelo-Branco, DSCM; Cordeiro, RA; Guedes, GMM; Rocha, MFG; Sidrim, JJC; Silva, MLQD | 1 |
| Bartoszewicz, M; Król, J; Nawrot, U | 1 |
| Hadian, A; Mohamadnia, A; Mortezaee, V; Rezaie, S; Seyedmousavi, S; Sharifynia, S | 1 |
| Ashrafi-Khozani, M; Falahati, M; Farahyar, S; Heidarie-Kohan, F; Majdabadi, N; Mohammadnejad, S; Rahimi-Moghaddam, P; Razavi, T | 1 |
| Qiao, M; Qiu, HY; Sun, AN; Tang, L; Tang, XW; Wu, DP; Yang, XF; Zhang, L | 1 |
| Berta, G; Bona, E; Cantamessa, S; Gamalero, E; Martinotti, S; Massa, N; Novello, G; Pavan, M; Ranzato, E; Rocchetti, A | 1 |
| Friedlander, SF; Gupta, AK; Mays, RR; Piguet, V; Piraccini, BM; Shear, NH; Tosti, A; Versteeg, SG | 1 |
| Aguiar, L; Araújo, GDS; Brilhante, RSN; Castelo-Branco, DSCM; Cordeiro, RA; España, JDA; Guedes, GMM; Oliveira, JS; Paiva, MAN; Pereira-Neto, WA; Pinheiro, AQ; Rocha, MFG; Rocha, MGD; Sales, JA; Sidrim, JJC | 1 |
| Bonamigo, RR; Fay, VDS; Gonçalves, SMB; Gregianini, TS; Rodrigues, DMG | 1 |
| Alves, SH; de Jesus, FPK; Farias, JB; Ferreiro, L; Loreto, ES; Santurio, JM; Schlemmer, KB | 1 |
| Lipner, SR; Scher, RK | 1 |
| Coutinho, P; de Jesús Valle, MJ; Ribeiro, MP; Sánchez Navarro, A | 1 |
| Falahati, M; Farahyar, S; Hadighi, R; Kalantari, S; Khedri, S; Khoshmirsafa, M; Roudbary, M; Santos, ALS | 1 |
| Araújo, C; Goulart, LS; Lima, JS; Olinda, RA; Souza, WWR; Vieira, CA | 1 |
| Keniya, MV; Monk, BC; Ruma, YN; Tyndall, JDA | 1 |
| Keniya, MV; Monk, BC; Sabherwal, M; Sagatova, AA; Tyndall, JDA; Wilson, RK; Woods, MA | 1 |
| Awotiwon, AA; Eshun-Wilson, I; Johnson, S; Meintjes, G; Rutherford, GW | 1 |
| Chen, J; Chen, Y; Fan, W; Han, L; Liu, J; Qi, L; Wang, Z; Xia, X; Zhang, L; Zhao, J | 1 |
| Benhamou, RI; Fridman, M; Herzog, IM; Jaber, QZ; Roichman, Y | 1 |
| Castillo-Martínez, NA; Cornejo-Bravo, JM; Gaitán-Cepeda, LA; Mouriño-Pérez, RR | 1 |
| Barbullushi, A; Dervishi, O; Fida, M; Gjylametaj, N; Kellici, S; Saraceno, R; Vasili, E | 1 |
| Milanezi, ACM; VAN DER Sand, ST; Witusk, JPD | 1 |
| Chen, L; Li, M; Li, N; Qi, F; Wang, N; Zhu, L | 1 |
| Lewis, JS; Nix, DE; Patterson, TF; Thompson, GR | 1 |
| Flowers, SA; Kelly, DE; Kelly, SL; Nishimoto, AT; Parker, JE; Price, CL; Rogers, PD; Warrilow, AG | 1 |
| Bauer, TM; Faessel, H; Faller, DV; Harvey, RD; Lockhart, AC; Nemunaitis, J; Sedarati, F; Venkatakrishnan, K; Zhou, X | 1 |
| Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
| Faria-Ramos, I; Lisboa, C; Miranda, I; Pedrosa, AF; Ricardo, E; Rodrigues, AG; Silva, R; Teixeira-Santos, R | 1 |
| Chan, JFW; Chan, KF; Cheung, M; Fung, KSC; Lai, CKC; Lau, ECL; Lau, SKP; Lee, CY; Li, X; Ng, RHY; Ngan, AHY; Tang, JYM; Tsang, CC; Woo, PCY | 1 |
| Chen, M; Chen, R; Chen, Y; Hu, G; Huang, C; Sun, W; Wang, Z; Zhang, X | 1 |
| Bertout, S; Boyom, FF; Kenfack, IF; Kouanfack, C; Lachaud, L; Nana, AK; Ngouana, TK; Tadjou, L; Toghueo, RMK | 1 |
| Altintop, YA; Atalay, MA; Ergul, AB; Koc, AN | 1 |
| Araújo Paulo de Medeiros, M; de Assis Bezerra Neto, F; Magalhães Pinto, L; Maranhão Chaves, G; Zuza Alves, DL | 1 |
| Mandras, N; Roana, J; Scalas, D; Tullio, V | 1 |
| Fang, Y; Gao, L; Jia, L; Kosgey, JC; Xiong, J; Yang, J; Yu, P; Zhang, F | 1 |
| Braga, SS | 1 |
| Dastgheib, L; Ghasemi, N; Jowkar, F; Nouraei, H; Pakshir, K; Zomorodian, K | 1 |
| Li, R; Sun, L; Wan, Z; Yu, J | 1 |
| López Luis, BA; Ramírez-Montelongo, SM; Salazar-Leal, JI | 1 |
| De Meulder, M; de Zwart, L; Hellemans, P; Jiao, J; Li, LY; Mamidi, RNVS; Ouellet, D; Poggesi, I; Rasschaert, F; Snoeys, J | 1 |
| Liu, D; Wu, L; Zhang, C; Zhang, L | 1 |
| Bamimore, MA; Foley, KA; Gupta, AK; Piguet, V; Shear, NH; Stec, N | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
| Atanasova, L; Bogáts, G; Büchner, R; Cai, F; Chenthamara, K; Dóczi, I; Druzhinina, IS; Hatvani, L; Homa, M; Kocsubé, S; Kredics, L; Manikandan, P; Mlinaric-Missoni, E; Narendran, V; Revathi, R; Vágvölgyi, C | 1 |
| Ding, XL; Liu, LN; Miao, LY; Tian, JX; Xue, L; Yan, HH; Zhang, JJ; Zhang, WJ; Zhang, WW | 1 |
| Cai, T; Chen, Z; Liao, Y; Qiu, X; Zhu, Y | 1 |
| Aneke, CI; Cafarchia, C; Otranto, D; Rhimi, W | 2 |
| AlFouzan, W; Anastasiadis, E; Dhar, R; El Chaar, M; Ghaddar, A; Ghaddar, N; Halimeh, R; Yusef, H | 1 |
| Brilhante, RSN; Caetano, ÉP; Castelo-Branco, DSCM; Cordeiro, RA; Guedes, GMM; Paiva, MAN; Rocha, MFG; Sidrim, JJC; Teixeira, CEC | 1 |
| Fujita, H; Fujiwara, SI; Fukuda, T; Gotoh, M; Iino, M; Jo, Y; Kanda, Y; Kimura, SI; Matsumura, I; Nakamura, S; Okamoto, A; Oyake, T; Saburi, Y; Sakaida, E; Shiratori, S; Takamatsu, Y; Tamura, K; Yamaguchi, H; Yamanouchi, J | 1 |
| Borman, AM; Fraser, M; Johnson, EM; Muller, J; Palmer, MD; Patterson, Z; Szekely, A; Walsh-Quantick, J | 1 |
| Barroso, FD; Cavalcanti, BC; da Silva, AR; da Silva, CR; da Silva, LJ; de Andrade Neto, JB; de Mesquita, JRL; de Moraes, MO; de Sá Carneiro, I; de Sousa Campos, R; do Amaral Valente Sá, LG; Nobre Júnior, HV; Queiroz, HA; S Aires do Nascimento, FB; Sampaio, LS | 1 |
| Abe, M; Anzawa, K; Futatsuya, T; Hoshino, Y; Mochizuki, T; Shoji, A | 1 |
| Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M | 1 |
| Gupta, AK; Piguet, V; Piraccini, BM; Shear, NH; Stec, N; Summerbell, RC; Tosti, A | 1 |
| Hine, P; Murray, M | 1 |
| Kraft, L; Ribeiro, VST; Telles, JP; Tuon, FF | 1 |
| Lin, G; Xie, S; Xu, RA; Ye, L; Ye, X | 1 |
| Cardozo Bonfim Carbone, D; Diniz, PF; Freitas Fernandes, F; Fuzo, CA; Rodrigues Chang, M; Santos Pereira Cardoso Trindade, C; Silva, JS; Silva, MC | 1 |
| Anchan, VN; Chandra, U; Singh, S; Tilak, R; Verma, P | 1 |
| Chen, D; Chen, Z; Wang, Q; Ye, XY | 1 |
| Chen, R; Cui, Y; Li, S; Shi, Y; Song, Y; Yao, L; Zhao, L; Zhen, Y | 1 |
| Chavez-Alvarez, S; Ocampo-Candiani, J; Reyna-Rodríguez, IL | 1 |
| Arendrup, MC; Friberg, N; Guinea, J; Kahlmeter, G; Mares, M; Meletiadis, J | 1 |
| Tratrat, C | 1 |
| Li, WJ; Liu, JY; Meng, LN; Shi, C; Wang, Y; Wei, B; Xiang, MJ; Zhao, Y | 1 |
| Elewski, B | 1 |
| Cortés, JA; Nocua-Báez, LC; Robles, R; Tarazona-Guaranga, L; Uribe-Jerez, P | 1 |
| Mathachan, SR; Sardana, K | 1 |
| Fan, B; Ke, A; Le, K; Prakash, C; Yang, H | 1 |
| Borges, MCM; Cavalcante, LMMB; Libório, MP; Morais, JLDS; Motoyama, PVP; Távora, LGF | 1 |
| Gharaghani, M; Taghipour, S; Zarei Mahmoudabadi, A | 1 |
| Aman, AT; Ambara, A; Annisa, L; Darma, S; Nuryastuti, T; Wibawa, T | 1 |
| Shen, Q; Sheng, L; Zhou, J | 1 |
| Gao, L; Song, F; Wan, Y; Wang, J; Wang, L; Zhang, L; Zhang, X | 1 |
| Cabral, H; da Rosa-Garzon, NG; de Biagi Junior, CAO; de Freitas, MCC; Pedezzi, R | 1 |
| An, N; Fan, Y; Feng, J; Wang, D; Yang, X; Yang, Y | 1 |
| Cohen, SR; Dumont, N; Fiumara, K; Gao, DX; Kahn, JS; Rosmarin, D; Song, S | 1 |
| Damaskou, V; Fokoloros, C; Makris, M; Papadavid, E; Syrmali, A; Tsakiraki, Z | 1 |
| Brüggemann, RJ; Bury, D; Muilwijk, EW; Tissing, WJE; Wolfs, TFW | 1 |
| Fatahinia, M; Kiasat, N; Mahmoudabadi, AZ; Moslem, M | 1 |
| Ito, T; Kamata, H; Kano, R; Miyake, R | 1 |
| Bajalan, Z; Hemmat, N; Javadi, A; Mohammadi, F | 1 |
| Cohen-Rabbie, S; Freshwater, T; Jain, L; Schalkwijk, S; Tomkinson, H; Vishwanathan, K; Wild, M; Xu, S; Zhou, D; Zhou, L | 1 |
| Cohen, BA; Le, TK | 1 |
| Hollingworth, SA; McGuire, TM; Van Driel, ML; Wang, Y | 1 |
| Araújo, RPC; Deegan, KR; Fonseca, MS; Machado, BAS; Meyer, R; Portela, RW; Sokolonski, AR; Umsza-Guez, MA | 1 |
| Billaud, EM; Dannaoui, E; Derobertmasure, A; Kably, B; Launay, M; Lefeuvre, S | 1 |
| Ali, FA; Mohammed, AK; Salh, KK | 1 |
| Chen, L; Chen, W; Li, L | 1 |
| Paaopanchon, C; Pesee, S; Phantumvanit, P; Roytrakul, S; Samaranayake, L | 1 |
| Do, TBT; Ha, TNT; Le, CC; Ngo, TMC; Nguyen, PV; Santona, A; Ton Nu, PA; Tran Thi, G; Vo, MT | 1 |
| Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
| Lu, F; Wang, B; Wang, Y; Xu, Y; Zhang, L; Zhang, M | 1 |
| Alegre, L; Giusiano, G; Latorre, W; Mussin, J; Rojas, FD; Sosa, MLÁ | 1 |
| Čonková, E; Harčárová, M; Marcinčáková, D; Proškovcová, M; Váczi, P | 1 |
| Cooper, EA; Gupta, AK; Hall, DC; Summerbell, RC; Venkataraman, M | 1 |
| Cao, W; Lan, C; Liu, Y; Qin, S; Qin, Z; Zhang, P; Zhang, Z | 1 |
| Babaei, M; Daie Ghazvini, R; Erami, M; Fattahi, M; Getso, MI; Hashemi, SJ; Khodavaisy, S; Mehri, N; Momen-Heravi, M; Parviz, S; Raiesi, O | 1 |
| Buapeth, KO; Chaisut, M; Chanchayanon, B; Indoung, S; Jantrakajorn, S; Morteh, R | 1 |
| Cui, F; Kan, S; Li, X; Liu, W; Pang, Q | 1 |
| Alexander, AB; Gai, JJ; Highland, MA; Horgan, MD; Innis, C; Liguori, BL; Norton, TM; Ossiboff, RJ; Pesavento, PA; Stacy, BA; Wellehan, JFX | 1 |
| An, R; Chen, Y; Cui, F; Cui, M; Fan, S; Kan, S; Li, D; Li, P; Li, X; Liang, X; Liao, Q; Liu, W; Lv, G; Mei, H; Pang, Q; Qiao, Q; Song, N; Xiong, Z; Zhang, M; Zheng, H | 1 |
| Ahmed, NH; Gupta, N; Naik, R; Sidhu, N; Tandon, R; Vanathi, M | 1 |
| Aguiar, ALR; da Silva, BN; de Aguiar Cordeiro, R; de Andrade, ARC; de Lima-Neto, RG; Lima, XTV; Maia, DCSC; Moura, SGB; Pereira, LMG; Portela, FVM; Reis, AT; Rocha, MFG; Sidrim, JJC | 1 |
| Alanio, A; Bailly, E; Bellanger, AP; Bonhomme, J; Botterel, F; Bouchara, JP; Bougnoux, ME; Bourgeois, N; Brun, S; Cassagne, C; Cassaing, S; Chouaki, T; Costa, D; Dalle, F; Dannaoui, E; Debourgogne, A; Delhaes, L; Desbois-Nogard, N; Dupont, D; Durieux, MF; Fekkar, A; Gangneux, JP; Hasseine, L; Houzé, S; Huguenin, A; Lachaud, L; Le Gal, S; Letscher-Bru, V; Mahinc, C; Maubon, D; Mercier, V; Morio, F; Nourrisson, C; Perraud-Cateau, E; Sasso, M; Sendid, B; Yéra, H | 1 |
| Beers, JL; Edginton, AN; Jackson, KD; Yeung, CHT | 1 |
| Gómez-López, A; Martín-Gómez, MT; Salavert Lletí, M | 1 |
| Amin Shahidi, M; Badiee, P; Ghasemi, F; Hashemi, J; Jafarian, H; Mohammadi, R; Najafzadeh, MJ; Shokohi, T | 1 |
| Benedict, K; Dulski, TM; Gold, JAW; Lipner, SR | 1 |
| Anversa, L; Arnoni, MV; Auler, M; Bonfietti, LX; de Camargo, BB; Dias, ALT; Garces, HG; Gimenes, VMF; Lara, BR; Leite Junior, DP; Melhem, MSC; Monari, GPM; Moreira, D; Oliveira, L; Paula, CR; Ramos, RTB; Richini-Pereira, VB; Ruiz, LDS; Silva, NC; Silveira, M | 1 |
| Chun, P; Je, NK; Youm, S | 1 |
| Haramaki, Y; Imatoh, T; Matsumoto, T; Migita, K | 1 |
| Beraquet, CAG; Giordano, ALPL; Lyra, L; Pontes, L; Schreiber, AZ | 1 |
| Akbar, N; Hussain, K; Khalid, M; Khan, NA; Shah, MR; Siddiqui, R | 1 |
| Elgammal, Y; Salama, EA; Seleem, MN | 2 |
| Černáková, L; Dos Santos, ALS; Falahatinejad, M; Mohammadi, SR; Nikoomanesh, F; Rafiee, M; Rodrigues, CF; Roudbary, M | 1 |
| Charkhchian, M; Mirzadeh, M; Mohammadi, F | 1 |
| Abastabar, M; Badiee, P; Haghani, I; Mohammadi, R; Morovati, H; Noorbakhsh, M; Sharifi, M | 1 |
| Caeiro, JP; Cornely, OA; Riera, F; Salmanton-García, J | 1 |
| Čonková, E; Malinovská, Z; Váczi, P | 1 |
| Abdorahimi, M; Ahmadikia, K; Badali, H; Gharehbolagh, SA; Khodavaisy, S; Mahmoudi, S; Meis, JF; Rezaie, S | 1 |
| Ishizuka, H; Kuroda, K; Maekawa, Y; Matsuki, S; Shimizu, T; Tachibana, M; Tsutsumi, J | 1 |
| Celis-Ramírez, AM; Contreras, A; Ehemann, K | 1 |
| Algueró, M; Bartroli, J; Boncompte, E; Forn, J; García-Rafanell, J; Turmo, E; Vericat, ML | 1 |
| Algueró, M; Bartroli, J; Boncompte, E; Conte, L; Forn, J; García-Rafanell, J; Merlos, M; Ramis, J; Turmo, E; Vericat, ML | 2 |
| Kukla, MJ; Liu, L; Marichal, P; Odds, F; Saha, AK; Simoneaux, RL | 1 |
| Casciano, CN; Clement, RP; Johnson, WW; Lew, K; Wang, EJ | 1 |
| Fukuoka, T; Harasaki, T; Honda, T; Kaneko, S; Kawamoto, I; Konosu, T; Shibuya, S; Uchida, T | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Drummond, AJ; Khalaf, AI; McGroarty, I; Pringle, B; Skellern, GG; Suckling, CJ; Waigh, RD | 1 |
| Arora, SK; Jain, S; Jana, GH; Sinha, N | 1 |
| Angiolella, L; Artico, M; Botta, M; Caporuscio, F; Corelli, F; Costi, R; Di Santo, R; Forte, M; Palamara, AT; Tafi, A | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ji, H; Jiang, Q; Lü, J; Miao, Z; Sheng, C; Song, Y; Xu, H; Yao, J; Zhang, M; Zhang, W; Zhou, Y; Zhu, J | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P | 1 |
| Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
| Aurbach, U; Cornely, O; Seifert, H; Stefanik, D | 1 |
| Cheng, S; Clancy, CJ; Clapp, W; Nguyen, KT; Nguyen, MH | 1 |
| Cao, YB; Jiang, YY; Sun, QY; Wu, QY; Xu, JM; Zhang, DZ; Zhang, J; Zhang, WN; Zhao, HQ | 1 |
| Duflos, M; Le Baut, G; Le Borgne, M; Le Pape, P; Lebouvier, N; Na, YM; Pagniez, F | 1 |
| Herrmann, JV; Miltenberger, R; Müller, FM; Salvenmoser, S; Staudigel, A; Tredup, A | 1 |
| Cao, Y; Chen, J; Ji, H; Jiang, Y; Li, Y; Liang, R; Lü, J; Tang, H; Yao, B; Zheng, C; Zhou, Y; Zhu, J | 1 |
| Casadevall, A; Gácser, A; Martinez, LR; Nosanchuk, JD; Ntiamoah, P | 1 |
| Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA | 1 |
| Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
| Guo, Q; Li, Y; Ma, L; Shi, C; Sun, S; Yu, J | 1 |
| Fritsche, TR; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL | 1 |
| Boekhout, T; Curfs-Breuker, I; Fernández, CM; Illnait-Zaragozi, MT; Martínez, GF; Meis, JF | 1 |
| Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
| Crepin, D; Giraud, F; Le Borgne, M; Le Pape, P; Logé, C; Pagniez, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chu, CC; Hsueh, PR; Ruan, SY | 1 |
| Jiang, Y; Jin, Y; Li, P; Liu, P; Sun, P; Sun, Q; Wu, Q; Xie, W; Yang, X; Zhang, D; Zhang, Y; Zhu, S | 1 |
| Artico, M; Botta, M; Caporuscio, F; Cirilli, R; D'Auria, FD; De Melo, NR; Kelly, SL; La Regina, G; La Torre, F; Lamb, DC; Nencioni, L; Olla, S; Palamara, AT; Piscitelli, F; Silvestri, R; Tafi, A | 1 |
| Coleman, DC; Dudley, E; Kelly, DE; Kelly, SL; Lamb, DC; Melo, NR; Moran, GP; Smith, SN; Sullivan, DJ; Warrilow, AG | 1 |
| Kelly, DE; Kelly, SL; Manning, NJ; Merkamm, M; Parker, JE; Pompon, D | 1 |
| Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS | 1 |
| Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
| Jackson, CJ; Kelly, DE; Kelly, SL; Lamb, DC; Marczylo, TH; Parker, JE; Warrilow, AG | 1 |
| Giraud, F; Guillon, R; Le Borgne, M; Le Pape, P; Logé, C; Pagniez, F; Picot, C | 2 |
| Chai, X; Dan, Z; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Yu, S; Zhang, J | 1 |
| Arendrup, MC; Bruun, B; Buzina, W; Garcia-Effron, G; Jensen, HE; Lass-Flörl, C; Lundin, C; Mortensen, KL; Perlin, DS; Reiter, N | 1 |
| Dimopoulos, G; Falagas, ME; Velegraki, A | 1 |
| Chai, X; Dan, Z; Hu, H; Wu, Q; Yu, S; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Kagoshima, Y; Konosu, T; Uchida, T | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Cao, Y; Che, X; Dong, G; Ji, H; Miao, Z; Sheng, C; Wang, W; Xu, Y; Yao, J; Zhang, W | 1 |
| Botta, M; Castagnolo, D; Cona, A; D'Arezzo, S; Doria, D; Fadda, G; Fracasso, ME; Manetti, F; Posteraro, B; Raffi, F; Rajamäki, S; Sanguinetti, M; Visca, P; Zizzari, AT | 1 |
| Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE | 1 |
| Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA | 1 |
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Coste, A; Ischer, F; Jacobsen, MD; MacCallum, DM; Odds, FC; Sanglard, D | 1 |
| Inamine, T; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Miyazaki, Y; Nagayoshi, Y; Saijo, T; Seki, M; Yamamoto, Y; Yamauchi, S; Yanagihara, K | 1 |
| Cao, Y; Che, X; Dong, G; Ji, H; Miao, Z; Sheng, C; Wang, S; Wang, W; Xu, Y; Yao, J; Zhang, W | 1 |
| Bauer, T; Cornely, OA; Farowski, F; Hartmann, P; Müller, C; Rüping, MJ; Steinbach, A; Vehreschild, JJ | 1 |
| Bartley, R; Biswas, C; Chen, SC; Djordjevic, JT; Ellis, DH; Jolliffe, KA; Obando, D; Pantarat, N; Sorrell, TC; Widmer, F | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Warrilow, AG; Weig, M | 1 |
| Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Basset, C; Beauchêne, J; Eparvier, V; Espíndola, LS; Rodrigues, AM; Silva, MR; Stien, D; Theodoro, PN | 1 |
| Afeltra, J; Moglioni, AG; Moltrasio, GY; Sarmiento, GP; Vitale, RG | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zou, Y | 3 |
| Cao, Y; Chai, X; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Xu, J; Yu, S; Zhang, D; Zhang, J; Zou, Y | 1 |
| Juvonen, RO; Koskiranta, J; Ollakka, R; Rahnasto-Rilla, M; Raunio, H; Ritvanen, A; Salminen, KA; Tani, N; Wittekindt, C | 1 |
| Chimov, A; Dimitrov, V; Dobrikov, GM; Momekov, G; Stoilova-Disheva, M; Tzvetkova, P; Valcheva, V | 1 |
| Chai, X; Hu, H; Liao, J; Wu, Q; Xu, M; Yu, S; Zhao, Q; Zou, Y | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Dong, G; Jin, G; Liu, Y; Miao, Z; Sheng, C; Wang, S; Wang, W; Yao, J; Zhang, W; Zhang, Y; Zhu, L; Zhuang, C | 1 |
| Hu, Y; Shen, F; Wang, K; Wang, L; Yang, W; Zhu, J | 1 |
| Chothe, AS; Dudhe, PB; Gadhwe, S; Kathiravan, MK; Mukta, MS; Salake, AB; Watode, RP | 1 |
| Akalin, G; Bertout, S; Demirci, F; Fulcrand, P; Maillard, LT; Martinez, J; Masurier, N; Quinonéro, O; Turan-Zitouni, G | 1 |
| Eparvier, V; Nirma, C; Stien, D | 2 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Ahmad, A; Khan, AU; Rauf, A; Rehan, M; Subbarao, N; Varshney, H | 1 |
| Chai, X; Ding, H; Li, L; Wang, B; Wu, Q; Yu, S; Zou, Y | 1 |
| Araújo, AJ; Costa-Lotufo, LV; de Assis, PA; de Paula, JE; Espindola, LS; Grougnet, R; Kritsanida, M; Michel, S; Theodoro, PN | 1 |
| Chai, X; Hu, H; Huang, T; Li, R; Li, X; Wu, M; Wu, Q; Yu, S; Zhao, Q; Zou, Y | 1 |
| Cai, T; Cao, X; Cao, Y; Chu, W; Hu, W; Sun, Z; Wang, R; Yang, Y | 1 |
| Afsarian, MH; Babazadeh-Qazijahani, M; Badali, H; Emami, S; Irannejad, H | 1 |
| Gerwick, WH; Kurtán, T; Liu, B; Mándi, A; Sun, P; Tang, H; Wang, ZW; Xu, DX; Zhang, W | 1 |
| Besson, T; Chosson, E; Duflos, M; Guillon, R; Hédou, D; Le Pape, P; Logé, C; Pagniez, F; Picot, C; Tonnerre, A | 1 |
| Dong, G; Gu, J; Jiang, Y; Jiang, Z; Liu, N; Liu, Y; Miao, Z; Sheng, C; Wang, C; Wang, S; Wang, Y; Yao, J; Zhang, W | 1 |
| Garvey, EP; Hoekstra, WJ; Moore, WR; Rafferty, SW; Schotzinger, RJ; Yates, CM | 1 |
| Guo, M; Li, C; Li, YR; Liu, JC; Piao, HR; Sun, LP; Zhang, TY; Zheng, CJ | 1 |
| Fosso, MY; Garneau-Tsodikova, S; Green, KD; Shrestha, SK | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chandrika, NT; Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
| Cheng, M; Hao, C; Liu, C; Sun, B; Xie, H; Zhang, X; Zhao, D; Zhao, L; Zhao, S | 1 |
| Chandrasekaran, B; Cherukupalli, S; Hampannavar, GA; Karpoormath, R; Palakollu, VN; Thapliyal, N | 1 |
| Cheng, M; Hao, C; Liu, C; Su, X; Sun, B; Wei, P; Zhang, X; Zhao, D; Zhao, L; Zhao, S | 1 |
| Garneau-Tsodikova, S; Garzan, A; Shrestha, SK | 1 |
| Emami, S; Keighobadi, M; Tavangar, P | 1 |
| Cheng, M; Hao, C; Liu, C; Su, X; Wei, P; Wu, M; Zhang, X; Zhao, D; Zhao, L; Zhao, S | 1 |
| Jiang, Y; Jiang, Z; Li, J; Liu, N; Sheng, C; Tu, J; Wang, Y; Zhang, W; Zhong, H | 1 |
| Adamus, K; Gizińska, M; Koronkiewicz, M; Mikulak, E; Staniszewska, M; Łukowska-Chojnacka, E | 1 |
| Borelli, BM; de Oliveira Fernandes, P; de Oliveira, RB; Gonçalves de Souza, I; Johann, S; Lino, CI; Maltarollo, VG; Maria de Souza Fagundes, E; Ramos, JP; Santos Teixeira, IN; Silvério Matos, TT | 1 |
| Cheng, M; Hao, C; Jiang, X; Su, X; Wei, P; Wu, M; Zhang, X; Zhao, D; Zhao, L; Zhao, S | 1 |
| AlFindee, MN; Chang, CT; Subedi, YP; Takemoto, JY | 1 |
| Piao, HR; Sun, LP; Wu, J; Zhang, TY; Zheng, CJ | 1 |
| Emami, S; Ghobadi, E; Hashemi, SM; Saednia, S | 1 |
| Wang, SQ; Wang, YF; Xu, Z | 1 |
| Chen, Y; Cheng, M; Su, X; Sun, N; Sun, Y; Tian, L; Wang, X; Zhao, D; Zhao, L; Zhao, S | 1 |
| Benhamou, RI; Dorot, O; Elias, R; Fridman, M; Jaber, QZ; Oved, K; Pichinuk, E; Zada, SL | 1 |
| Cheng, M; Su, X; Sun, B; Wei, P; Wu, M; Zhang, X; Zhao, D; Zhao, L; Zhao, S | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Abutaleb, NS; Hagras, M; Kotb, A; Mayhoub, AS; Salama, EA; Sayed, AM; Seleem, MN | 1 |
| Gazzola, S; Guillon, R; Le Pape, P; Logé, C; Montoir, D; Ourliac-Garnier, I; Pagniez, F; Picot, C; Planchat, A; Soklou, KE; Tonnerre, A | 1 |
| Han, G; Li, C; Li, Z; Liu, N; Sheng, C; Tu, J | 1 |
| Geissler, WM; Madeira, M; Martin, IJ; Miller, RR; Raab, CE; Wood, HB | 1 |
| Agafonova, NA; Borisevich, SS; Burgart, YV; Chupakhin, ON; Evstigneeva, NP; Gerasimova, NA; Krasnykh, OP; Kungurov, NV; Kushch, SO; Makhaeva, GF; Maslova, VV; Rudakova, EV; Saloutin, VI; Shchegolkov, EV; Solodnikov, SY; Triandafilova, GA; Ulitko, MV; Zilberberg, NV | 1 |
| Chen, X; Li, C; Liu, N; Sheng, C; Tu, J; Xu, D; Zhu, T | 1 |
| Han, H; Qi, XR; Shen, L; Tang, HF; Xu, QZ; Yang, WS; Yi, YH; Yuan, CH | 1 |
| Cheng, M; Su, X; Sun, N; Sun, Y; Tian, L; Yin, W; Zhang, C; Zhao, D; Zhao, L; Zhao, S; Zheng, Y | 2 |
| Cheng, M; Cui, H; Jiang, H; Li, S; Liu, L; Su, X; Sun, Y; Wu, T; Yin, W; Zhang, Y; Zhao, D; Zhao, L; Zheng, Y | 1 |
| Cheng, M; Cui, H; Jiang, H; Liu, L; Su, X; Sun, Y; Wu, T; Yin, W; Zhang, Y; Zhao, D; Zhao, L | 1 |
| Guengerich, FP; Hargrove, TY; Lepesheva, GI; Nes, WD; Rachakonda, G; Villalta, F; Wawrzak, Z | 1 |
| Emami, S; Ghobadi, E; Saednia, S | 1 |
| Cheng, M; Cui, H; Gao, Z; Jiang, H; Liu, L; Qin, Q; Su, X; Sun, Y; Wu, T; Yin, W; Zhang, Y; Zhao, D; Zhao, L | 1 |
| Cai, J; Fu, T; Hu, CH; Liao, G; Peng, Y; Wang, M; Zhang, X; Zhu, X | 1 |
238 review(s) available for itraconazole and fluconazole
| Article | Year |
|---|---|
Clinical significance of interactions with antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Fluconazole; Humans; Itraconazole; Ketoconazole | 1992 |
Azole antifungal agents.
Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses | 1992 |
Histoplasmosis in Indianapolis.
Topics: Amphotericin B; Disease Outbreaks; Fluconazole; Histoplasmosis; Humans; Indiana; Itraconazole; Ketoconazole | 1992 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Opportunistic Infections | 1992 |
[Current developments in antimycotic therapy in gynecology and obstetrics].
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Female; Fluconazole; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious | 1992 |
Antifungal treatment strategy in leukemia patients.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Mycoses; Tomography, X-Ray Computed | 1992 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1992 |
[Importance of the new triazoles in antifungal therapy].
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1991 |
Diagnosis and treatment of oral candidosis.
Topics: Antifungal Agents; Candidiasis, Oral; Chronic Disease; Fluconazole; HIV Infections; Humans; Immune Tolerance; Itraconazole; Ketoconazole; Opportunistic Infections | 1991 |
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunodiffusion; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses | 1991 |
Fungal infections and their management.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine; Triazoles | 1990 |
Pharmacokinetics of oral antifungals and their clinical implications.
Topics: Absorption; Administration, Oral; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Tissue Distribution | 1990 |
Fluconazole and itraconazole for vulvo-vaginal candidosis.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole | 1990 |
New antifungal agents for the systemic mycoses.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Molecular Structure; Mycoses | 1990 |
The triazole antifungal agents: a review of itraconazole and fluconazole.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Cryptococcus neoformans; Fluconazole; Half-Life; Humans; Itraconazole; Ketoconazole; Metabolic Clearance Rate | 1990 |
Azoles and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Meningitis; Mycoses; Opportunistic Infections | 1990 |
[Systemic mycotic infections].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1990 |
Testing of organisms for susceptibility to triazoles: is it justified?
Topics: Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles | 1989 |
New antifungal agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Azoles; Echinocandins; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Mycoses; Peptides; Peptides, Cyclic; Triazoles | 1989 |
Itraconazole and fluconazole: new drugs for deep fungal infection.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1989 |
Toxicological profile and safety evaluation of antifungal azole derivatives.
Topics: Abnormalities, Drug-Induced; Animals; Antifungal Agents; Endocrine Glands; Fluconazole; Humans; Itraconazole; Ketoconazole; Liver | 1989 |
Azole antifungal agents: emphasis on new triazoles.
Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Triazoles | 1988 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
Azole antifungal drugs: old and new.
Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles | 1988 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1988 |
New oral treatments for dermatophytosis.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Fluconazole; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Triazoles | 1988 |
[Prophylaxis against mycoses in neutropenic patients].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Fluconazole; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Itraconazole; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections | 1994 |
The systemic treatment of onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1995 |
[Therapy of systemic candidiasis].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Burns; Candidiasis; Fluconazole; Humans; Incidence; Itraconazole; Neoplasms; Opportunistic Infections; Postoperative Complications; Transplantation | 1994 |
[Therapy of candidiasis and cryptococcosis in AIDS].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Itraconazole; Ketoconazole | 1994 |
Can we prevent azole resistance in fungi?
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole | 1995 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine | 1995 |
Antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Child; Child, Preschool; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1995 |
[Role of chemoprophylaxis in the prevention of invasive aspergillosis].
Topics: Aerosols; Amphotericin B; Aspergillosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Male | 1994 |
Histoplasmosis: recognition and treatment.
Topics: Amphotericin B; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Serologic Tests | 1994 |
Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Neoplasms; Polyenes | 1994 |
Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences.
Topics: Cytochrome P-450 Enzyme System; Drug Interactions; Fluconazole; Heart; Humans; Itraconazole; Ketoconazole; Prodrugs; Terfenadine | 1994 |
[Choice and use of the new antifungal agents].
Topics: Fluconazole; Humans; Itraconazole; Mycoses | 1994 |
The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Fluconazole; Fungemia; Humans; Itraconazole; London; Meningitis, Cryptococcal; Recurrence; Retrospective Studies; Survival Analysis | 1994 |
Current therapy of dermatophytosis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Morpholines; Time Factors; Tolnaftate | 1994 |
Management of systemic manifestations of fungal disease in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Coccidioidomycosis; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Histoplasmosis; Humans; Itraconazole; Meningitis, Cryptococcal | 1994 |
Oral therapeutic agents in fungal nail disease.
Topics: Administration, Oral; Allylamine; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors; Treatment Outcome | 1994 |
Antifungal therapy: potential interactions with other classes of drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Diagnosis and treatment of invasive fungal infections in cancer patients.
Topics: Amphotericin B; Aspergillosis; Fluconazole; Humans; Itraconazole; Lung Diseases, Fungal; Mycoses; Neoplasms; Serologic Tests; Tomography, X-Ray Computed; Ultrasonography | 1993 |
Itraconazole and fluconazole in oropharyngeal candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; Pharyngeal Diseases | 1993 |
Pharmacotherapy of disseminated histoplasmosis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; United States | 1993 |
Systemic drugs in the treatment of dermatophytoses.
Topics: Antifungal Agents; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Molecular Structure | 1993 |
Onychomycosis. Agents of choice.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Candidiasis, Cutaneous; Fluconazole; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1993 |
[New antifungal agents in the treatment of superficial dermatomycoses].
Topics: Administration, Topical; Antifungal Agents; Azoles; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Tolnaftate | 1993 |
Fluconazole and itraconazole: current status and prospects for antifungal therapy.
Topics: Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Humans; Itraconazole; Mycoses | 1993 |
Disseminated histoplasmosis in persons infected with human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Fluconazole; Histoplasmosis; Humans; Incidence; Itraconazole; Risk Factors; United States | 1995 |
New antifungal drugs for pulmonary mycoses.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1996 |
Invasive fungal infections in children: recent advances in diagnosis and treatment.
Topics: Amphotericin B; Aspergillosis; Candidiasis; Child; Coccidioidomycosis; Cytokines; Diagnosis, Differential; Fluconazole; Histoplasmosis; Humans; Itraconazole; Mucormycosis; Mycoses; Prognosis | 1996 |
Recent advances in the management of cryptococcal meningitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Combined Modality Therapy; Fluconazole; Humans; Intracranial Pressure; Itraconazole; Meningitis, Cryptococcal | 1996 |
Role of azoles in antifungal therapy.
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Mycoses; Opportunistic Infections | 1996 |
[Antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole | 1995 |
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Fluconazole; Flucytosine; Humans; Imidazoles; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Transplantation Conditioning; Triazoles | 1996 |
New antifungal therapy for children.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Child; Dermatomycoses; Drug Interactions; Fluconazole; Hair Diseases; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
The role of azole antifungal agents for systemic antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Drug Costs; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole | 1997 |
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing
Topics: Animals; Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Mice; Microbial Sensitivity Tests | 1997 |
Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic | 1997 |
Use of azoles for systemic antifungal therapy.
Topics: Antifungal Agents; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1997 |
Susceptibility testing of fungi and correlation with clinical outcome.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Predictive Value of Tests; Treatment Outcome | 1997 |
Antifungal treatment in patients with cancer.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Mycoses; Neoplasms | 1997 |
Current trends in onychomycosis therapy: a literature review.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
[Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Miconazole; Microbial Sensitivity Tests; Quality Control; Saccharomyces cerevisiae | 1997 |
Oral treatment options for onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Interactions; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Clinical relevance of antifungal resistance.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cryptococcosis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses | 1997 |
[Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antifungal Agents; Clinical Trials as Topic; Cryptococcosis; Fluconazole; Flucytosine; Humans; Immunotherapy; Itraconazole; Meningitis, Cryptococcal; Mice; Multicenter Studies as Topic; Vaccination | 1995 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topic; Cryptococcosis; Double-Blind Method; Fluconazole; Humans; Itraconazole; Ketoconazole; Mucormycosis; Mycoses; Neutropenia; Nystatin; Primary Prevention; Recurrence; Retrospective Studies | 1995 |
[Prevention and treatment of fungal infections in solid-organ transplant recipients].
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Heart Transplantation; Humans; Itraconazole; Ketoconazole; Kidney Transplantation; Liver Transplantation; Lung Transplantation; Multicenter Studies as Topic; Mycoses; Pancreas Transplantation; Risk Factors; Transplantation | 1995 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles | 1995 |
[Antifungal agent resistance of yeasts of clinical significance].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Yeasts | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Topic; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Hematologic Diseases; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney; Mycoses; Thrombophlebitis | 1995 |
Preventing and treating azole-resistant oropharyngeal candidiasis in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Triazoles | 1998 |
Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues.
Topics: Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Oropharynx; Pharyngeal Diseases | 1998 |
[Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Fluconazole; Flucytosine; Hematologic Diseases; Humans; Itraconazole; Mycoses | 1998 |
The management of cryptococcal meningitis in Papua New Guinea.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Cause of Death; Drug Combinations; Drug Monitoring; Fluconazole; Flucytosine; Humans; Hydrocortisone; Immunocompetence; Intracranial Hypertension; Intracranial Pressure; Itraconazole; Meningitis, Cryptococcal; Multicenter Studies as Topic; Papua New Guinea | 1996 |
Antifungal therapy in children: an update.
Topics: Antifungal Agents; Child; Dermatomycoses; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine | 1998 |
[Diagnosis, differential diagnosis and therapy of onychomycosis].
Topics: Administration, Topical; Antifungal Agents; Diagnosis, Differential; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
Adverse drug reactions of the new oral antifungal agents--terbinafine, fluconazole, and itraconazole.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine | 1998 |
Onychomycosis: pathogenesis, diagnosis, and management.
Topics: Adult; Antifungal Agents; Child; Diagnosis, Differential; Female; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Nails; Naphthalenes; Onychomycosis; Terbinafine | 1998 |
Pediatric antifungal therapy.
Topics: Antifungal Agents; Child; Dermatomycoses; Drug Interactions; Female; Fluconazole; Griseofulvin; Humans; Itraconazole; Male; Naphthalenes; Terbinafine | 1998 |
Therapy of Candida infections: susceptibility testing, resistance, and therapeutic options.
Topics: Antifungal Agents; Candida; Candidiasis; Disease Susceptibility; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests | 1998 |
[Advances in the treatment of severe refractory infections. 4) Deep fungal infection].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Miconazole; Mycoses | 1998 |
Antifungal agents. Part II. The azoles.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Drug Interactions; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Ketoconazole | 1999 |
The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis.
Topics: Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis | 1999 |
Dermatophyte infections in children.
Topics: Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microsporum; Naphthalenes; Terbinafine; Tinea; Trichophyton | 1999 |
Current topics in diagnosis and treatment of tinea unguium in Japan.
Topics: Administration, Oral; Aged; Antifungal Agents; Diagnosis, Differential; Female; Fluconazole; Griseofulvin; Humans; Itraconazole; Japan; Male; Onychomycosis | 1999 |
Oral therapy of common superficial fungal infections of the skin.
Topics: Administration, Oral; Antifungal Agents; Drug Administration Schedule; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea | 1999 |
[Antifungal drugs for pediatric use].
Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Naphthalenes; Terbinafine | 1999 |
Drug interactions with itraconazole, fluconazole, and terbinafine and their management.
Topics: Animals; Antifungal Agents; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Risk Assessment; Terbinafine | 1999 |
Facing up to the diagnostic uncertainty and management of onychomycoses.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1999 |
Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
Topics: Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; United States | 1999 |
The new oral antifungal agents for onychomycosis of the toenails.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1999 |
The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Itraconazole | 1999 |
[Progress and new perspective treatments of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Forecasting; Humans; Itraconazole; Mycoses; Systemic Inflammatory Response Syndrome | 1999 |
Drug interactions of the newer oral antifungal agents.
Topics: Administration, Oral; Antifungal Agents; Contraindications; Drug Interactions; Fluconazole; Humans; Intestinal Absorption; Itraconazole; Naphthalenes; Terbinafine | 1999 |
Antifungal prophylaxis in neutropenic patients with hematologic malignancies.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Neutropenia | 2000 |
[CNS cryptococcosis with idiopathic CD4+ T lymphocytopenia].
Topics: Adult; Antifungal Agents; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Male; Meningitis, Cryptococcal; T-Lymphocytopenia, Idiopathic CD4-Positive; Treatment Outcome | 2000 |
An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Tinea capitis.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Scalp; Terbinafine; Tinea Capitis | 2000 |
Current approach to the acute management of cryptococcal infections.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; CD4 Lymphocyte Count; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV; HIV Infections; Humans; Itraconazole; Lung Diseases, Fungal; Meningitis, Cryptococcal; Randomized Controlled Trials as Topic | 2000 |
Overview: The treatment of dermatophytosis.
Topics: Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine | 2000 |
The treatment of dermatophytosis: safety considerations.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine | 2000 |
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Ciclopirox; Costs and Cost Analysis; Drug Costs; Economics, Pharmaceutical; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Models, Economic; Naphthalenes; Onychomycosis; Pyridones; Randomized Controlled Trials as Topic; Terbinafine; United States | 2000 |
Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Clotrimazole; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Nystatin; Virulence | 2000 |
Current management of fungal infections.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Dermatomycoses; Fluconazole; Humans; Intestinal Absorption; Itraconazole; Onychomycosis | 2001 |
Treating onychomycosis.
Topics: Adult; Antifungal Agents; Child; Clinical Trials as Topic; Combined Modality Therapy; Diagnosis, Differential; Drug Costs; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Patient Education as Topic; Recurrence; Teaching Materials; Terbinafine; Treatment Failure | 2001 |
[Choice and use of antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Mycoses; Time Factors | 2001 |
Disseminated Dactylaria constricta infection in a renal transplant recipient.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Fatal Outcome; Female; Fluconazole; Humans; Itraconazole; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Radiography | 2001 |
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 2001 |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Clotrimazole; Databases as Topic; Fluconazole; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; Nystatin; Oropharynx; Pharyngeal Diseases; Randomized Controlled Trials as Topic; Research Design; Statistics as Topic; Treatment Outcome | 2001 |
[Prevention of fungal infections in children and adolescents with cancer].
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Child; Child, Preschool; Cohort Studies; Double-Blind Method; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Infant, Newborn; Itraconazole; Mycoses; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic; Respiratory Therapy; Risk Factors; Time Factors | 2001 |
Tinea capitis update: a continuing conflict with an old adversary.
Topics: Antifungal Agents; Child; Child, Preschool; Drug Interactions; Drug Resistance, Fungal; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis; United States | 2001 |
A plea to bridge the gap between antifungals and the management of onychomycosis.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2001 |
Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Neutropenia; Opportunistic Infections; Risk Factors | 2001 |
A brief review of antifungal therapy for deep fungal infection.
Topics: Amphotericin B; Antifungal Agents; Drug Compounding; Fluconazole; Humans; Injections, Intravenous; Itraconazole; Mycoses | 2001 |
Fungal skin infections in organ transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Incidence; Itraconazole; Organ Transplantation; Risk Factors | 2002 |
Antifungal prophylaxis in hematopoietic stem cell transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole | 2001 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Solutions | 2002 |
[Clinical relevance of mechanisms of antifungal drug resistance in filamentous fungi].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Resistance, Fungal; Drug Resistance, Multiple; Echinocandins; Fluconazole; Fungi; Incidence; Itraconazole; Lipopeptides; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Polyenes; Spain; Terbinafine | 2002 |
[Tinea capitis. Therapeutic options in the post-griseofulvin era].
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Interactions; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis; Treatment Outcome | 2002 |
Overview of histoplasmosis.
Topics: Amphotericin B; Antifungal Agents; Diagnosis, Differential; Fluconazole; Histoplasmosis; Humans; Itraconazole | 2002 |
[Correlation between in vitro susceptibility to antifungal drugs and the clinical evolution of patients with candidiasis and cryptococcosis].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cryptococcosis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests | 2002 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
[Present status and future prospects of azole antifungal agents in Japan].
Topics: Antifungal Agents; Azoles; Cyclodextrins; Drug Design; Fluconazole; Forecasting; Itraconazole; Japan; Miconazole; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
[Antifungal drug].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Design; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fluorouracil; Fungi; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Polyenes; Pyrimidines | 2003 |
Framing the future of antifungals in atopic dermatitis.
Topics: Antifungal Agents; Dermatitis, Atopic; Fluconazole; Forecasting; Humans; Itraconazole; Ketoconazole; Treatment Outcome | 2003 |
Update on antifungal therapy.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Cat Diseases; Cats; Dog Diseases; Dogs; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 2003 |
The use of oral antifungal agents to treat onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Interactions; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2003 |
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Liver; Mycoses | 2003 |
Infections by the yeast Kodomaea (Pichia) ohmeri: two cases and literature review.
Topics: Adolescent; Aged; Antifungal Agents; Disease Progression; Fatal Outcome; Fluconazole; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Itraconazole; Male; Pichia; Risk Assessment; Severity of Illness Index | 2004 |
[Side effects of systemic antimycotics].
Topics: Amphotericin B; Antifungal Agents; Chills; Fever; Fluconazole; Humans; Itraconazole; Meta-Analysis as Topic; Mycoses; Nausea; Vomiting; Water-Electrolyte Imbalance | 2003 |
History of the development of azole derivatives.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole | 2004 |
Antifungal prophylaxis with azole derivatives.
Topics: Antifungal Agents; Azoles; Bacteremia; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Mycoses | 2004 |
[Disseminated histoplasmosis and AIDS in an Argentine hospital: clinical manifestations, diagnosis and treatment].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Female; Fever; Fluconazole; Hepatomegaly; Histoplasmosis; Humans; Itraconazole; Male; Recurrence; Respiration Disorders; Splenomegaly; Weight Loss | 2004 |
New treatments for tinea capitis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Microsporum; Naphthalenes; Terbinafine; Tinea Capitis; Trichophyton | 2004 |
Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Terbinafine; Treatment Outcome | 2004 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Nystatin; Sexual Partners | 2003 |
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Nystatin; Secondary Prevention; Sexual Partners | 2003 |
Coccidioidomycosis of the male reproductive tract.
Topics: Aged; Antifungal Agents; Coccidioides; Coccidioidomycosis; Complement Fixation Tests; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Prostatic Diseases; Testicular Diseases | 2005 |
Tinea capitis: a treatment update.
Topics: Antifungal Agents; Child; Dose-Response Relationship, Drug; Fluconazole; Griseofulvin; Humans; Itraconazole; Microsporum; Naphthalenes; Pediatrics; Terbinafine; Tinea Capitis; Treatment Outcome; Trichophyton | 2005 |
Pharmacological management of paracoccidioidomycosis.
Topics: Amphotericin B; Central Nervous System Fungal Infections; Drug Resistance; Fluconazole; Follow-Up Studies; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Pyrimidines; Sulfonamides; Triazoles; Voriconazole | 2005 |
Phaeohyphomycosis in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Dermatomycoses; Exophiala; Female; Fluconazole; Humans; Hyphae; Itraconazole; Ketoconazole; Male; Middle Aged; Subcutaneous Tissue | 2005 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Nystatin; Secondary Prevention | 2004 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Randomized Controlled Trials as Topic | 2005 |
Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Mycoses; Neutropenia; Stem Cell Transplantation | 2005 |
Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
Topics: Antifungal Agents; Chi-Square Distribution; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Opportunistic Infections; Randomized Controlled Trials as Topic; Survival Analysis | 2005 |
[Drug-drug interaction of antifungal drugs].
Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Drug-drug interactions of antifungal agents and implications for patient care.
Topics: Acidosis, Renal Tubular; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Caspofungin; Clinical Trials as Topic; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Echinocandins; Enzyme Inhibitors; Fluconazole; Humans; Itraconazole; Lipopeptides; Liver; Mycoses; Patient Care; Peptides, Cyclic | 2005 |
An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; Griseofulvin; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Severity of Illness Index | 2005 |
In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
Topics: Antifungal Agents; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Mycoses; Opportunistic Infections | 2006 |
Fungal nail infections.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2005 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Nystatin; Secondary Prevention | 2005 |
[Onychomycosis: recent progress in the epidemiology, diagnosis and treatment].
Topics: Administration, Topical; Antifungal Agents; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Risk Factors; Terbinafine | 2006 |
Fungal toenail infections.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2006 |
Tinea capitis.
Topics: Antifungal Agents; Fluconazole; Global Health; Griseofulvin; Humans; Itraconazole; Microsporum; Naphthalenes; Terbinafine; Tinea Capitis; Trichosporon; United States | 2006 |
Coccidioidal meningitis.
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Comorbidity; Fluconazole; Humans; Hydrocephalus; Itraconazole; Meningitis, Fungal; Treatment Outcome; Vasculitis | 2007 |
Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
Topics: Animals; Antifungal Agents; Fluconazole; Foot Dermatoses; Humans; Immunity, Cellular; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine | 2007 |
The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.
Topics: Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Liver Function Tests; Models, Statistical; Naphthalenes; Onychomycosis; Pulse Therapy, Drug; Risk Assessment; Terbinafine; Transaminases | 2007 |
The assessment and management of tinea capitis in children.
Topics: Antifungal Agents; Child; Diagnosis, Differential; Fluconazole; Griseofulvin; Humans; Incidence; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis | 2007 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
Systemic antifungal therapy for tinea capitis in children.
Topics: Antifungal Agents; Child; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Randomized Controlled Trials as Topic; Terbinafine; Tinea Capitis | 2007 |
Recurrent tinea versicolor: treatment with itraconazole or fluconazole?
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Humans; Itraconazole; Recurrence; Tinea Versicolor | 2007 |
Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials.
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2008 |
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: point.
Topics: Antifungal Agents; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Myelodysplastic Syndromes; Neoplasms; Neutropenia; Risk Assessment; Triazoles | 2008 |
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Two cases of vaginitis caused by itraconazole-resistant Saccharomyces cerevisiae and a review of recently published studies.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Diagnosis, Differential; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Middle Aged; Mycoses; Saccharomyces cerevisiae; Vaginitis; Vulvovaginitis | 2008 |
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2008 |
Treatment of invasive candidal infections: systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Clinical efficacies of antifungal injections].
Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Genital candidiasis].
Topics: Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Diagnosis, Differential; Dosage Forms; Drug Administration Schedule; Female; Fluconazole; Genitalia; Humans; Imidazoles; Itraconazole; Male; Microbiological Techniques; Sexual Behavior; Sexually Transmitted Diseases | 2009 |
Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Dipodascus; Discitis; Fluconazole; Humans; Itraconazole; Ketoconazole; Lumbar Vertebrae; Male; Microbial Sensitivity Tests; Naphthalenes; Opportunistic Infections; Radiography; Terbinafine; Treatment Outcome | 2009 |
Toenail onychomycosis in diabetic patients: issues and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes Mellitus; Diabetic Foot; Drug Interactions; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Risk Factors; Terbinafine; Therapies, Investigational; Treatment Outcome | 2009 |
[Role of anidulafungin in critically ill patients].
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Critical Illness; Cross Infection; Drug Therapy, Combination; Echinocandins; Fluconazole; Fungemia; Humans; Immunocompetence; Intensive Care Units; Itraconazole; Practice Guidelines as Topic | 2008 |
Efficacy of fluconazole for the treatment of onychomycosis.
Topics: Antifungal Agents; Arthrodermataceae; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2009 |
Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Mycoses; Neutropenia; Prospective Studies; Randomized Controlled Trials as Topic | 2010 |
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
Topics: Amino Acid Substitution; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Pyrimidines; Sequence Analysis, DNA; Sterol 14-Demethylase; Triazoles; Voriconazole | 2010 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Traditional and emerging antifungal therapies.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2010 |
Conazoles.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole | 2010 |
Disseminated Penicillium marneffei infection in an SLE patient: a case report and literature review.
Topics: Amphotericin B; Antifungal Agents; China; Dermatomycoses; Female; Fluconazole; Humans; Itraconazole; Lupus Erythematosus, Systemic; Middle Aged; Mycoses; Opportunistic Infections; Penicillium | 2011 |
[Three cases of allergic bronchopulmonary mycosis due to Schizophyllum commune].
Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Diagnosis, Differential; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Middle Aged; Prednisolone; Schizophyllum | 2010 |
Candidiasis (vulvovaginal).
Topics: Acute Disease; Administration, Oral; Candida albicans; Candidiasis, Vulvovaginal; Evidence-Based Medicine; Fluconazole; Humans; Itraconazole; Vaginosis, Bacterial | 2010 |
Systemic drugs in patients with skin diseases.
Topics: Cyclosporine; Fluconazole; Glucocorticoids; Humans; Immunologic Factors; Immunosuppression Therapy; Itraconazole; Methotrexate; Mycophenolic Acid; Naphthalenes; Retinoids; Skin Diseases; Terbinafine | 2011 |
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Triazole antifungal agents in invasive fungal infections: a comparative review.
Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Onychomycosis: modern diagnostic and treatment approaches.
Topics: Antifungal Agents; Candidiasis; Combined Modality Therapy; Dermatomycoses; DNA, Fungal; Enzyme-Linked Immunosorbent Assay; Fluconazole; Humans; Itraconazole; Lasers, Solid-State; Low-Level Light Therapy; Naphthalenes; Onychomycosis; Opportunistic Infections; Polymerase Chain Reaction; Risk Factors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Terbinafine; Tinea | 2013 |
Rhodotorula minuta as onychomycosis agent in a Chinese patient: first report and literature review.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Asian People; China; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Rhodotorula; Triazoles; Voriconazole | 2014 |
Oral therapy for onychomycosis: an evidence-based review.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2014 |
Antifungal drugs during pregnancy: an updated review.
Topics: Administration, Intravenous; Administration, Topical; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious; Teratogens | 2015 |
Intracranial Fungal Granulomas: A Single Institutional Clinicopathologic Study of 66 Patients and Review of the Literature.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain; Central Nervous System Fungal Infections; Child; Craniotomy; Drug Therapy, Combination; Emergency Treatment; Female; Fluconazole; Granuloma; Humans; Immunocompromised Host; Itraconazole; Male; Middle Aged; Neuroimaging; Recurrence; Renal Insufficiency; Reoperation; Retrospective Studies; Risk Factors; Survival Rate | 2015 |
Systemic Review of Published Reports on Primary Cutaneous Cryptococcosis in Immunocompetent Patients.
Topics: Age Factors; Antifungal Agents; Cryptococcosis; Cryptococcus; Dermatomycoses; Female; Fluconazole; Humans; Itraconazole; Male; Sex Factors; Treatment Outcome | 2015 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Complementary Therapies; Female; Fluconazole; Humans; Itraconazole; Yogurt | 2015 |
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole | 2016 |
Sporotrichosis in the Ocular Adnexa: 21 Cases in an Endemic Area in Peru and Review of the Literature.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Conjunctival Diseases; Dacryocystitis; Endemic Diseases; Eye Infections, Fungal; Eyebrows; Eyelid Diseases; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Peru; Potassium Iodide; Retrospective Studies; Sporothrix; Sporotrichosis | 2016 |
Delay and misdiagnosis of basidiobolomycosis in tropical South India: case series and review of the literature.
Topics: Antifungal Agents; Child; Child, Preschool; Diagnosis, Differential; Diagnostic Errors; Entomophthorales; Female; Fluconazole; Humans; India; Infant; Itraconazole; Male; Zygomycosis | 2016 |
Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Voriconazole | 2016 |
Systemic antifungal therapy for tinea capitis in children.
Topics: Antifungal Agents; Child; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Randomized Controlled Trials as Topic; Terbinafine; Tinea Capitis | 2016 |
Solid lipid nanoparticles for antifungal drugs delivery for topical applications.
Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Fluconazole; Humans; Itraconazole; Lipids; Nanoparticles | 2016 |
Onychomycosis in children. A review.
Topics: Administration, Oral; Administration, Topical; Adolescent; Antifungal Agents; Child; Child, Preschool; Fluconazole; Humans; Infant; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2017 |
Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
Topics: Anidulafungin; Antifungal Agents; Asia; Azoles; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Candidiasis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Phenotype; Prevalence; Voriconazole | 2016 |
[Current Status and Future Perspectives of Primary Antifungal Prophylaxis in Patients with Hematological Malignancies-Review].
Topics: Antifungal Agents; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Mycoses | 2017 |
The Current Status of Feline Sporotrichosis in Malaysia.
Topics: Amphotericin B; Animals; Antifungal Agents; Cat Diseases; Cats; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Malaysia; Naphthalenes; Prevalence; Sporothrix; Sporotrichosis; Terbinafine; Zoonoses | 2017 |
Tinea capitis in children: a systematic review of management.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Child; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microsporum; Specimen Handling; Terbinafine; Tinea Capitis; Trichophyton | 2018 |
Onychomycosis: Treatment and prevention of recurrence.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles | 2019 |
Primary antifungal prophylaxis for cryptococcal disease in HIV-positive people.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Cause of Death; CD4 Lymphocyte Count; Child; Cryptococcosis; Drug Resistance, Fungal; Fluconazole; HIV Seropositivity; Humans; Itraconazole; Primary Prevention; Randomized Controlled Trials as Topic | 2018 |
Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis.
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Drug Discovery; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Triazoles | 2019 |
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Fetal outcomes after maternal exposure to oral antifungal agents during pregnancy: A systematic review and meta-analysis.
Topics: Abortion, Spontaneous; Antifungal Agents; Case-Control Studies; Cohort Studies; Congenital Abnormalities; Female; Fluconazole; Humans; Itraconazole; Pregnancy; Prenatal Exposure Delayed Effects; Stillbirth | 2020 |
The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Humans; Itraconazole; Onychomycosis; Terbinafine; Treatment Outcome | 2020 |
Onychomycosis: a review.
Topics: Administration, Topical; Antifungal Agents; Fluconazole; Humans; Itraconazole; Onychomycosis; Terbinafine | 2020 |
Treating progressive disseminated histoplasmosis in people living with HIV.
Topics: Amphotericin B; Anti-HIV Agents; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Administration Schedule; Fluconazole; Histoplasmosis; HIV Infections; Humans; Induction Chemotherapy; Itraconazole; Kidney; Liposomes; Maintenance Chemotherapy; Randomized Controlled Trials as Topic | 2020 |
Pseudozyma spp. human infections: A systematic review.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Mycoses; Voriconazole; Yeasts | 2021 |
Primary Cutaneous Coccidioidomycosis: An Update.
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Dermatomycoses; Diagnosis, Differential; DNA, Fungal; Endemic Diseases; Fluconazole; Humans; Incidence; Itraconazole; Mexico; Mycology; Observational Studies as Topic; Polymerase Chain Reaction; Skin; South America; Travel-Related Illness; United States | 2020 |
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Triazoles; Voriconazole | 2020 |
1,2,4-Triazole: A Privileged Scaffold for the Development of Potent Antifungal Agents - A Brief Review.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Invasive; Drug Design; Fluconazole; Humans; Itraconazole; Structure-Activity Relationship; Treatment Outcome; Triazoles | 2020 |
[Azoles of then and now: a review].
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2020 |
Efficacy of different antifungal drugs as initial treatment for patients with talaromycosis: A systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Mycoses; Pharmaceutical Preparations; Randomized Controlled Trials as Topic; Retrospective Studies | 2021 |
Clinical Pharmacokinetics of Triazoles in Pediatric Patients.
Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Mycoses; Triazoles; Voriconazole | 2021 |
Tinea capitis: advances and a needed paradigm shift.
Topics: Antifungal Agents; Arthrodermataceae; Child; Fluconazole; Humans; Itraconazole; Microsporum; Naphthalenes; Tinea Capitis | 2021 |
Antifungal Drugs TDM: Trends and Update.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Humans; Itraconazole; Voriconazole | 2022 |
The emergence of Trichophyton indotineae: Implications for clinical practice.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Trichophyton | 2023 |
Efficacy of anti-fungal agents for invasive fungal infection prophylaxis in liver transplant recipients: A network meta-analysis.
Topics: Anidulafungin; Antifungal Agents; Echinocandins; Fluconazole; Humans; Invasive Fungal Infections; Itraconazole; Liver Transplantation; Mycoses; Network Meta-Analysis; Randomized Controlled Trials as Topic; Transplant Recipients | 2022 |
The biology and chemistry of antifungal agents: a review.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Imidazoles; Mycoses | 2012 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
Topics: Animals; Chemistry Techniques, Synthetic; Humans; Pyrazoles; Pyrimidines | 2017 |
An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
Topics: 14-alpha Demethylase Inhibitors; Antiprotozoal Agents; Azoles; Humans; Leishmania; Molecular Structure; Sterol 14-Demethylase | 2017 |
Antifungal amphiphilic kanamycins: new life for an old drug.
Topics: | 2018 |
Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies.
Topics: Animals; Antifungal Agents; Candida; Candidiasis; Drug Design; Drug Discovery; Fluconazole; Fungi; Humans; Models, Molecular; Mycoses; Triazoles | 2019 |
Tetrazole hybrids and their antifungal activities.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development.
Topics: Antifungal Agents; Drug Development; Fungi; Voriconazole | 2022 |
78 trial(s) available for itraconazole and fluconazole
| Article | Year |
|---|---|
Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Cryptococcosis; Double-Blind Method; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections; Oropharynx; Pilot Projects | 1992 |
The triazole antifungal agents: a review of itraconazole and fluconazole.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Cryptococcus neoformans; Fluconazole; Half-Life; Humans; Itraconazole; Ketoconazole; Metabolic Clearance Rate | 1990 |
Fluconazole versus itraconazole in the treatment of tinea versicolor.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Tinea Versicolor; Treatment Outcome | 1995 |
Comparative pharmacokinetics of fluconazole and of itraconazole in Japanese and in German subjects.
Topics: Administration, Oral; Adolescent; Adult; Cross-Over Studies; Diet; Female; Fluconazole; Germany; Humans; Itraconazole; Japan; Male; Middle Aged | 1995 |
Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged; Reproducibility of Results | 1995 |
Influence of concomitant food intake on the gastrointestinal absorption of fluconazole and itraconazole in Japanese subjects.
Topics: Administration, Oral; Adult; Biological Availability; Digestive System; Eating; Ethnicity; Female; Fluconazole; Gastric Emptying; Gastric Mucosa; Germany; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Itraconazole; Japan; Male; Middle Aged | 1994 |
Administration of the antimycotic agents fluconazole and itraconazole to leukaemia patients: a comparative pharmacokinetic study.
Topics: Adolescent; Adult; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Interactions; Female; Fluconazole; Humans; Itraconazole; Leukemia; Male; Middle Aged; Spectrophotometry, Ultraviolet | 1994 |
Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole.
Topics: Administration, Oral; Adult; Analysis of Variance; Eating; Female; Fluconazole; Gastric Acidity Determination; Humans; Intestinal Absorption; Itraconazole; Male; Reference Values; Time Factors | 1994 |
[Comparative evaluation of fluconazole 50 mg and 100 mg versus itraconazole 100 mg in the treatment of dermatomycoses].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Tinea | 1994 |
Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Double-Blind Method; Esophagitis; Female; Fluconazole; Humans; Itraconazole; Male | 1995 |
The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.
Topics: Administration, Oral; Adult; Antifungal Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Fluconazole; Humans; Hypnotics and Sedatives; Injections, Intravenous; Itraconazole; Male; Metabolic Clearance Rate; Midazolam; Placebos; Psychomotor Performance | 1996 |
Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Confidence Intervals; Double-Blind Method; Esophagitis; Esophagoscopy; Female; Fluconazole; Humans; Itraconazole; Male; Prognosis; Treatment Outcome | 1995 |
[Prerequisites for effective therapy of chronic recurrent vaginal candidiasis].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Child; Child, Preschool; Chronic Disease; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Recurrence | 1996 |
Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Esophagitis; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Patient Compliance; Treatment Failure | 1996 |
Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis, Oral; Cyclodextrins; Drug Resistance, Microbial; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Oropharynx; Prospective Studies; Solutions | 1996 |
Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial.
Topics: Adult; Aged; Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Middle Aged; Neoplasms; Pharyngeal Diseases; Prospective Studies | 1995 |
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Reference Values; Risk Factors | 1996 |
Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Double-Blind Method; Drug Therapy, Combination; Esophagitis; Esophagoscopy; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Treatment Outcome | 1996 |
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Double-Blind Method; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged; Multivariate Analysis; Survival Analysis | 1997 |
A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Double-Blind Method; Esophageal Diseases; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Recurrence; Solutions; Tablets | 1997 |
Response to fluconazole and itraconazole of Candida spp. in denture stomatitis.
Topics: Binomial Distribution; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth Mucosa; Stomatitis, Denture | 1997 |
Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174.
Topics: Adult; Antifungal Agents; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Drug Interactions; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Losartan; Male; Mixed Function Oxygenases; Reference Values; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Tetrazoles | 1998 |
A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Double-Blind Method; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged | 1998 |
A comparison of fluconazole and itraconazole in the management of denture stomatitis: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Denture, Complete, Upper; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Pilot Projects; Stomatitis, Denture | 1998 |
Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Cross-Over Studies; Double-Blind Method; Female; Fluconazole; Half-Life; Humans; Hypnotics and Sedatives; Itraconazole; Ketoconazole; Male; Pyridines; Reference Values; Zolpidem | 1998 |
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Cryptococcosis; Double-Blind Method; Female; Fluconazole; Humans; Itraconazole; Male; Meningitis, Fungal; Treatment Outcome | 1999 |
Fluconazole vs. itraconazole in the treatment of tinea versicolor.
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Prospective Studies; Recurrence; Tinea Versicolor; Treatment Outcome | 1999 |
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents, Phytogenic; Drug Interactions; Female; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Male; Middle Aged; Mycoses; Opportunistic Infections; Vincristine | 1999 |
Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Treatment Outcome | 1999 |
Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.
Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Patient Compliance; Survival Rate | 1999 |
Pre-emptive therapy with azoles in lung transplant patients. Geneva Lung Transplantation Group.
Topics: Adult; Antifungal Agents; Child; Female; Fluconazole; Humans; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Prospective Studies; Treatment Outcome | 1999 |
Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Terbinafine; Trichophyton | 1999 |
Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antifungal Agents; Bone Diseases; Child; Coccidioidomycosis; Data Interpretation, Statistical; Double-Blind Method; Drug Administration Schedule; Female; Fluconazole; Humans; Itraconazole; Lung Diseases, Fungal; Middle Aged; Recurrence; Soft Tissue Infections; Treatment Outcome | 2000 |
Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Follow-Up Studies; Foot Dermatoses; Gastrointestinal Diseases; Griseofulvin; Humans; Itraconazole; Male; Middle Aged; Mitosporic Fungi; Naphthalenes; Nausea; Onychomycosis; Photosensitivity Disorders; Prospective Studies; Single-Blind Method; Terbinafine; Treatment Outcome; Vomiting | 2001 |
Absence of clinically relevant drug interactions following simultaneous administration of didanosine-encapsulated, enteric-coated bead formulation with either itraconazole or fluconazole.
Topics: Adolescent; Adult; Anti-HIV Agents; Antifungal Agents; Area Under Curve; Capsules; Cross-Over Studies; Didanosine; Drug Interactions; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Tablets, Enteric-Coated | 2002 |
An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 2002 |
Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluconazole; Humans; Immunosuppressive Agents; Itraconazole; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mycoses; Placebos; Postoperative Complications; Survival Analysis | 2002 |
Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.
Topics: Administration, Oral; Adult; Aged; Drug Therapy, Combination; Female; Fluconazole; Fungi; Humans; Immunosuppressive Agents; Infusions, Intravenous; Itraconazole; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications | 2002 |
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Liposomes; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Prospective Studies; Survival Analysis | 2003 |
Fluconazole 150 mg single dose versus itraconazole 200 mg per day for 3 days in the treatment of acute vaginal candidiasis: a double-blind randomized study.
Topics: Acute Disease; Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Drug Administration Schedule; Female; Fluconazole; Humans; Itraconazole; Statistics, Nonparametric | 2003 |
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Itraconazole; Male; Middle Aged; Mycoses; Opportunistic Infections; Survival Analysis | 2003 |
The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Dose-Response Relationship, Drug; Female; Fluconazole; Humans; Itraconazole; Male; Meningitis, Cryptococcal; Middle Aged | 2003 |
Cyclophosphamide metabolism is affected by azole antifungals.
Topics: Adolescent; Adult; Antifungal Agents; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Candidiasis; Cyclophosphamide; Drug Interactions; Fluconazole; Humans; Itraconazole | 2004 |
Cryptococcal meningitis in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Treatment Outcome | 2002 |
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.
Topics: Adult; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Female; Fluconazole; Graft vs Host Disease; Humans; Incidence; Itraconazole; Male; Stem Cell Transplantation; Treatment Outcome | 2004 |
Single-dose fluconazole versus itraconazole in pityriasis versicolor.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Tinea Versicolor; Treatment Outcome | 2004 |
Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Fluconazole; Griseofulvin; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Prospective Studies; Skin; Terbinafine; Tinea; Treatment Outcome | 2004 |
Correlation of in vitro itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Treatment Outcome | 2004 |
[Comparative study of itraconazole and fluconazole therapy in vaginal candidosis].
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Administration Schedule; Female; Fluconazole; Humans; Itraconazole; Middle Aged; Treatment Outcome | 2004 |
An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Oral; Female; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Liver; Liver Function Tests; Male; Middle Aged; Neoplasms | 2004 |
Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study.
Topics: Antifungal Agents; Candidiasis; Child; Child, Preschool; Cross Infection; Double-Blind Method; Female; Fluconazole; Fungemia; Humans; Infant; Intensive Care Units, Pediatric; Itraconazole; Male | 2004 |
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Child; False Negative Reactions; Female; Fluconazole; Galactose; Humans; Immunoenzyme Techniques; Itraconazole; Male; Mannans; Middle Aged; Sensitivity and Specificity | 2005 |
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Endpoint Determination; Female; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Leukocyte Count; Male; Middle Aged; Mycoses; Neutropenia; Neutrophils | 2006 |
Short-term therapy for mixed vaginal infections.
Topics: Administration, Oral; Antifungal Agents; Antiprotozoal Agents; Antitrichomonal Agents; Candidiasis, Vulvovaginal; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Metronidazole; Patient Compliance; Tinidazole; Treatment Outcome; Trichomonas Vaginitis; Vaginosis, Bacterial | 2006 |
A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia; Male; Middle Aged; Neutropenia; Predictive Value of Tests; Prospective Studies; Risk Factors; Transplantation, Homologous; Treatment Outcome | 2006 |
Antifungal treatment in sarcoidosis--a pilot intervention trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Pilot Projects; Sarcoidosis; Treatment Outcome | 2007 |
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Esophageal Diseases; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Probability; Severity of Illness Index; Treatment Failure; Treatment Outcome; Triazoles | 2007 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fluconazole; Humans; Itraconazole; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Single-Blind Method; Treatment Outcome; Triazoles | 2007 |
The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Capsules; Female; Fluconazole; Humans; Itraconazole; Japan; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes | 2007 |
Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Female; Fluconazole; Flucytosine; Humans; Infant; Infant, Newborn; Itraconazole; Leukemia, Myelomonocytic, Acute; Male; Retrospective Studies | 2007 |
[The impact of itraconazole versus fluconazole on the prevention of postoperative invasive fungal infections after orthotopic liver transplantation].
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Fluconazole; Humans; Itraconazole; Liver Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Prospective Studies; Treatment Outcome | 2007 |
A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor.
Topics: Adolescent; Adult; Antifungal Agents; Bangladesh; Female; Fluconazole; Humans; Incidence; Itraconazole; Ketoconazole; Male; Middle Aged; Prevalence; Risk Factors; Tinea Versicolor; Treatment Outcome; Young Adult | 2009 |
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Triazoles; Young Adult | 2009 |
[Cost benefit analysis for prophylactic use of itraconazole versus fluconazole after hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infusions, Intravenous; Itraconazole; Male; Middle Aged; Mycoses; Prospective Studies; Young Adult | 2010 |
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Drug Costs; Equipment and Supplies; Fluconazole; Follow-Up Studies; Hospital Costs; Humans; Immunocompromised Host; Infusions, Intravenous; Italy; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Nursing; Treatment Outcome; Triazoles | 2010 |
Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations.
Topics: Adult; Anti-Asthmatic Agents; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Fluconazole; Genetic Association Studies; Half-Life; Humans; Indoles; Itraconazole; Leukotriene Antagonists; Male; Phenylcarbamates; Polymorphism, Genetic; Sulfonamides; Tosyl Compounds; Young Adult | 2012 |
Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease.
Topics: Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Models, Economic; Mycoses; Severity of Illness Index; Transplantation, Homologous; United States | 2012 |
Treatment of Onychomycosis - a Clinical Study.
Topics: Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pulse Therapy, Drug; Pyridones; Terbinafine | 2015 |
A clinical drug-drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor on the pharmacokinetics of vismodegib.
Topics: Anilides; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Fluconazole; Humans; Hydrogen-Ion Concentration; Itraconazole; Proton Pump Inhibitors; Pyridines; Rabeprazole; Solubility | 2016 |
Effects of cytochrome P450 (CYP3A4 and CYP2C19) inhibition and induction on the exposure of selumetinib, a MEK1/2 inhibitor, in healthy subjects: results from two clinical trials.
Topics: Adolescent; Adult; Benzimidazoles; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inducers; Female; Fluconazole; Healthy Volunteers; Humans; Itraconazole; Male; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinase 2; Rifampin; Young Adult | 2017 |
Pharmacokinetic/pharmacodynamic drug-drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs.
Topics: Adolescent; Adult; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Fluconazole; Healthy Volunteers; Humans; Itraconazole; Male; Middle Aged; Platelet Count; Receptors, Thrombopoietin; Rifampin; Thiazoles; Thiophenes; Young Adult | 2018 |
Effect of CYP3A inhibitors on the pharmacokinetics of pevonedistat in patients with advanced solid tumours.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cyclopentanes; Cytochrome P-450 CYP3A Inhibitors; Docetaxel; Drug Interactions; Enzyme Inhibitors; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Neoplasms; Paclitaxel; Pyrimidines | 2019 |
Effect of Fluconazole and Itraconazole on the Pharmacokinetics of Erdafitinib in Healthy Adults: A Randomized, Open-Label, Drug-Drug Interaction Study.
Topics: Adult; Area Under Curve; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme Inhibitors; Drug Combinations; Drug Interactions; Female; Fluconazole; Healthy Volunteers; Humans; Itraconazole; Male; Middle Aged; Protein Kinase Inhibitors; Pyrazoles; Quinoxalines; Receptors, Fibroblast Growth Factor | 2020 |
Multicenter-Based Population Pharmacokinetic Analysis of Ciclosporin in Hematopoietic Stem Cell Transplantation Patients.
Topics: Adolescent; Adult; Aged; Body Weight; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Itraconazole; Male; Middle Aged; Models, Biological; Reproducibility of Results; Transplantation Conditioning; Voriconazole | 2019 |
D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial.
Topics: Adult; Aged; Antifungal Agents; Febrile Neutropenia; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukocyte Count; Male; Micafungin; Middle Aged; Mycoses; Neutrophils; Young Adult | 2020 |
Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
Topics: Antifungal Agents; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Naphthalenes; Pharmaceutical Preparations; Terbinafine; Tinea | 2020 |
Effect of itraconazole and fluconazole on the pharmacokinetics of valemetostat: An open-label, phase I study in healthy subjects.
Topics: Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Fluconazole; Healthy Volunteers; Humans; Itraconazole; Male; Neoplasms | 2023 |
Intracellular concentrations of posaconazole in different compartments of peripheral blood.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Erythrocytes; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Neutrophils; Triazoles | 2010 |
874 other study(ies) available for itraconazole and fluconazole
| Article | Year |
|---|---|
Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.
Topics: Cholesterol; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Host-Pathogen Interactions; Humans; Hydroxylation; Mycobacterium tuberculosis; Oxidation-Reduction; Protein Structure, Tertiary | 2010 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections | 1992 |
The evaluation of therapeutic responses in experimental keratomycosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Disease Models, Animal; Eye Infections, Fungal; Fluconazole; Itraconazole; Keratitis; Ketoconazole; Observer Variation; Rabbits | 1992 |
Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
Topics: Adult; Aged; Antifungal Agents; Azoles; Carbamazepine; Coccidioides; Cryptococcus neoformans; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Male; Middle Aged; Mycoses; Phenytoin; Rifampin | 1992 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Morpholines; Onychomycosis; Pyridones | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Guinea Pigs; Immunocompromised Host; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Sporotrichosis | 1992 |
[Sphenoid sinus aspergillosis presenting abducens nerve palsy and visual field impairment; a case report].
Topics: Abducens Nerve; Aged; Antifungal Agents; Aspergillosis; Cranial Nerve Diseases; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Paralysis; Paranasal Sinus Diseases; Sphenoid Sinus; Visual Fields | 1992 |
Effects of culture media on the in vitro susceptibility of selected opportunistic fungi to fluconazole and itraconazole.
Topics: Alternaria; Antifungal Agents; Aspergillus; Candida; Culture Media; Fluconazole; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Pseudallescheria | 1992 |
New antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine | 1992 |
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles | 1992 |
In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Species Specificity | 1992 |
The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells.
Topics: Antifungal Agents; Cells, Cultured; Cyclosporine; Cytokines; Fluconazole; Gene Expression; Humans; Itraconazole; Ketoconazole; Lymphocytes; Miconazole; Tacrolimus | 1992 |
Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cells.
Topics: Antifungal Agents; Cytokines; Fluconazole; Humans; Immunosuppressive Agents; In Vitro Techniques; Interleukin-2; Itraconazole; Ketoconazole; Lymphocyte Activation; Miconazole; T-Lymphocytes | 1991 |
Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
Topics: Antifungal Agents; Candida; Cryptococcus; Fluconazole; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1991 |
Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.
Topics: Adult; Antifungal Agents; Cyclosporine; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microsomes, Liver; Naphthalenes; Terbinafine | 1991 |
The anti-fungal agent itraconazole exerts immunosuppressive effects on alloreactivity but not on natural immunity in vitro.
Topics: Antifungal Agents; Fluconazole; Humans; Immunity; Immunity, Innate; Immunosuppressive Agents; In Vitro Techniques; Itraconazole; Ketoconazole; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lymphocyte Culture Test, Mixed | 1991 |
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Miconazole; Middle Aged | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Disease Models, Animal; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluconazole; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Meningitis; Mice; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Triazoles | 1990 |
Treatment of murine coccidioidal meningitis with SCH39304.
Topics: Animals; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluconazole; Itraconazole; Ketoconazole; Meningitis; Mice; Mice, Inbred BALB C; Triazoles | 1990 |
Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Cells, Cultured; Colony Count, Microbial; Fluconazole; Itraconazole; Ketoconazole; Macrophages; Mice; Phagocytosis | 1990 |
[Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod].
Topics: Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Yeasts | 1990 |
The pharmacokinetics of BAY R3783 and its efficacy in the treatment of experimental cryptococcal meningitis.
Topics: Animals; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Itraconazole; Ketoconazole; Meningitis; Rabbits; Triazoles | 1990 |
Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole.
Topics: Antifungal Agents; Aspergillus fumigatus; Binding, Competitive; Carbon Monoxide; Cytochrome P-450 Enzyme System; Fluconazole; Itraconazole; Ketoconazole; Microsomes; Spectrophotometry | 1990 |
A novel method for studying ergosterol biosynthesis by a cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal agents.
Topics: Antifungal Agents; Aspergillus fumigatus; Autoradiography; Azoles; Chromatography, Thin Layer; Ergosterol; Fluconazole; Gas Chromatography-Mass Spectrometry; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Molecular Structure | 1990 |
Suppression of neutrophil and lymphoproliferative responses in vitro by itraconazole but not fluconazole.
Topics: Antifungal Agents; Cells, Cultured; Chemotaxis, Leukocyte; Deoxyglucose; Fluconazole; Humans; Immunosuppressive Agents; Itraconazole; Ketoconazole; Lymphocyte Activation; Neutrophils | 1990 |
[Recent antifungal agents].
Topics: Allylamine; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Morpholines; Mycoses; Triazoles | 1989 |
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Half-Life; Itraconazole; Ketoconazole; Male; Mice; Neutropenia; Triazoles | 1989 |
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Diseases; Humans; Itraconazole; Ketoconazole; Triazoles | 1989 |
Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Fluconazole; Guinea Pigs; Itraconazole; Ketoconazole; Male; Mucormycosis; Rhizopus; Triazoles | 1989 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 1989 |
[Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Flucytosine; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Yeasts | 1989 |
5-Lipoxygenase inhibition by antifungal azole derivatives: new tools for immunosuppression?
Topics: Antifungal Agents; Arachidonate Lipoxygenases; Fluconazole; Humans; Immunosuppressive Agents; In Vitro Techniques; Itraconazole; Ketoconazole; Lipoxygenase Inhibitors; Neutrophils | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
[New antiparasitic drugs].
Topics: Amebicides; Anthelmintics; Antifungal Agents; Antimalarials; Artemisinins; Fluconazole; Humans; Itraconazole; Ketoconazole; Mefloquine; Phenanthrenes; Quinolines; Sesquiterpenes; Triazoles | 1988 |
Improved method for azole antifungal susceptibility testing.
Topics: Antifungal Agents; Azoles; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Triazoles | 1988 |
Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes.
Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Cholesterol; Chromatography, Gas; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Fluconazole; Gas Chromatography-Mass Spectrometry; Itraconazole; Ketoconazole; Leishmania; Leishmania braziliensis; Leishmania donovani; Leishmania mexicana; Leishmania tropica; Sterols; Triazoles | 1988 |
Activity of triazole derivatives against Pityrosporum orbiculare in vitro and in vivo.
Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Rabbits; Structure-Activity Relationship; Tinea Versicolor; Triazoles | 1988 |
The new generation of antifungal drugs.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Triazoles | 1988 |
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Meningitis, Haemophilus; Rabbits; Triazoles | 1985 |
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immunity; Itraconazole; Ketoconazole; Meningitis; Pyelonephritis; Rabbits; Triazoles | 1986 |
Azole resistance in Candida albicans.
Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Disease Models, Animal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Guinea Pigs; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Mice; Miconazole; Rats; Rats, Inbred Strains; Triazoles | 1986 |
Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye; Fluconazole; Itraconazole; Ketoconazole; Kinetics; Male; Rabbits; Tissue Distribution; Triazoles | 1987 |
Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
Topics: Animals; Antifungal Agents; Cell Survival; Centrifugation; Fluconazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Luminescent Measurements; Luminol; Mice; Mice, Inbred BALB C; Naphthalenes; Phagocytes; Rabbits; Rifampin; Spleen; Terbinafine; Triazoles | 1987 |
Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Imidazoles; Itraconazole; Kinetics; Microbial Sensitivity Tests; Spain | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.
Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Therapy, Combination; Fluconazole; Itraconazole; Miconazole; Microbial Sensitivity Tests; Pseudallescheria | 1995 |
Effect of azoles on the glucuronidation of zidovudine by human liver UDP-glucuronosyltransferase.
Topics: Antifungal Agents; Antiviral Agents; Drug Interactions; Fluconazole; Glucuronosyltransferase; Humans; Itraconazole; Ketoconazole; Liver; Zidovudine | 1995 |
Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
Topics: Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Female; Fluconazole; Half-Life; Itraconazole; Mice; Microbial Sensitivity Tests; Triazoles | 1995 |
Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Cryptococcosis; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance, Microbial; Drug Tolerance; Ergosterol; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microsomes; Oxidoreductases; Sterol 14-Demethylase; Sterols; Treatment Failure | 1995 |
[Post-antibiotic effect and post-exposure polyene antagonism of azole antimycotics in Candida albicans: dependency on lipophilia].
Topics: Amphotericin B; Candida albicans; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Lipids; Miconazole; Microbial Sensitivity Tests; Structure-Activity Relationship | 1995 |
Increased resistance to antifungal antibiotics of Candida spp. adhered to silicone.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Cell Adhesion; Drug Resistance, Microbial; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Silicones; Urinary Catheterization | 1995 |
Efficacy of itraconazole in treating AIDS-associated infections due to Candida krusei.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida; Candidiasis; Candidiasis, Oral; Dermatomycoses; Fluconazole; Fungemia; Humans; Itraconazole; Lung Diseases, Fungal; Male | 1995 |
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Double-Blind Method; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prospective Studies; Sensitivity and Specificity | 1995 |
Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay.
Topics: Amphotericin B; Aspergillus fumigatus; Candida albicans; Dose-Response Relationship, Drug; Fluconazole; Formazans; Itraconazole; Microbial Sensitivity Tests; Mitochondria; Tetrazolium Salts; Thiazoles; Vitamin K | 1995 |
In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Triazoles | 1995 |
Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.
Topics: Amphotericin B; Candida; Candidiasis; Cross Infection; DNA, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Karyotyping; Microbial Sensitivity Tests; Molecular Epidemiology | 1995 |
Use of a colorimetric system for yeast susceptibility testing.
Topics: AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; Colorimetry; Coloring Agents; Evaluation Studies as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycology; Oxazines; Quality Control; Reference Standards; Reproducibility of Results; Xanthenes | 1995 |
Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged | 1994 |
Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata.
Topics: Antifungal Agents; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Triazoles | 1994 |
Fluconazole, itraconazole and ketoconazole in vitro activity against Candida spp.
Topics: Candida; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1994 |
Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Candida albicans; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Oropharynx | 1994 |
Protein binding of itraconazole and fluconazole in patients with chronic renal failure.
Topics: Adult; Aged; Fluconazole; Humans; Itraconazole; Kidney Failure, Chronic; Middle Aged; Orosomucoid; Protein Binding; Serum Albumin; Ultrafiltration | 1994 |
The efficacy of orally applied terbinafine, itraconazole and fluconazole in models of experimental trichophytoses.
Topics: Administration, Oral; Animals; Antifungal Agents; Disease Models, Animal; Female; Fluconazole; Guinea Pigs; Hair; Itraconazole; Naphthalenes; Skin Temperature; Terbinafine; Tinea; Treatment Outcome | 1994 |
In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
Topics: Candida albicans; Drug Resistance, Microbial; Fluconazole; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth | 1994 |
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Blood; Cerebrospinal Fluid; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Skin | 1994 |
Pneumocystis carinii is resistant to imidazole antifungal agents.
Topics: Animals; Antifungal Agents; Ergosterol; Female; Fluconazole; Gas Chromatography-Mass Spectrometry; Itraconazole; Ketoconazole; Miconazole; Pneumocystis; Rats; Rats, Sprague-Dawley; Triazoles | 1994 |
Itraconazole and fluconazole for treatment of coccidioidomycosis.
Topics: Coccidioidomycosis; Fluconazole; Humans; Itraconazole; Meningitis, Fungal | 1994 |
[Invasive bronchopulmonary aspergillosis treated with itraconazole in a patient with acute leukemia].
Topics: Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Bronchitis; Combined Modality Therapy; Female; Fluconazole; Humans; Incidence; Itraconazole; Lung Diseases, Fungal; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction | 1993 |
Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Aspergillosis; Aspergillus; Bone Marrow Transplantation; Candida; Candidiasis; Female; Fluconazole; Humans; Incidence; Itraconazole; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lung Diseases; Male; Mycetoma; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Recurrence; Risk Factors | 1994 |
Severe candidal infections in neutropenic patients.
Topics: Amphotericin B; Candidiasis; Fluconazole; Humans; Itraconazole; Ketoconazole; Neutropenia | 1993 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Penicillium; Phenotype | 1993 |
Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Chagas Disease; Drug Therapy, Combination; Encephalitis; Fluconazole; Hemophilia A; Humans; Itraconazole; Ketoconazole; Male; Nitroimidazoles; Transfusion Reaction; Trypanocidal Agents | 1993 |
Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Gentian Violet; Humans; Itraconazole; Ketoconazole; Medroxyprogesterone Acetate; Microbial Sensitivity Tests; Nystatin | 1993 |
Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Antifungal Agents; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Middle Aged; Retrospective Studies; Treatment Outcome | 1993 |
[Strategy for examination and therapy of mycotic keratitis].
Topics: Acremonium; Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Contact Lenses; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Keratitis; Ketoconazole; Mycoses; Ophthalmic Solutions; Therapeutic Irrigation | 1993 |
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Fluconazole; Flucytosine; Glucuronates; Humans; Itraconazole; Ketoconazole; Miconazole; Microsomes, Liver; Zidovudine | 1995 |
Evaluation of the E test system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconazole and itraconazole.
Topics: Antifungal Agents; Culture Media; Evaluation Studies as Topic; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Quality Control; Reagent Strips; Yeasts | 1995 |
[Development of infection with Aspergillus flavus in woman being treated for allergic pulmonary Aspergillosis caused by Aspergillus fumigatus].
Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus flavus; Aspergillus fumigatus; Female; Fluconazole; Humans; Itraconazole | 1995 |
Protein binding of itraconazole and fluconazole in patients with cancer.
Topics: Adult; Aged; Antifungal Agents; Blood Proteins; Breast Neoplasms; Colonic Neoplasms; Esophageal Neoplasms; Female; Fluconazole; Humans; Itraconazole; Linear Models; Lung Neoplasms; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Protein Binding; Serum Albumin | 1995 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1996 |
Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assays.
Topics: Antifungal Agents; Candida; Candidiasis; Colorimetry; Dose-Response Relationship, Drug; Fluconazole; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests | 1995 |
Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alleles; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Electrophoresis; Enzymes; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles | 1995 |
Azole drug resistance in yeasts.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1995 |
Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests | 1995 |
New drugs for the nail fungus prevalent in elderly.
Topics: Aged; Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Culture Media; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results | 1996 |
In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Peptides | 1996 |
Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Humans; Itraconazole; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Survival Rate | 1996 |
[Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Esophagitis; Fluconazole; HIV Infections; Humans; Itraconazole; Retrospective Studies; Suspensions | 1996 |
New therapies for onychomycosis.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Quality Control; Reproducibility of Results | 1996 |
Strain variation among and antifungal susceptibilities of isolates of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Deoxyribonucleases, Type II Site-Specific; DNA, Fungal; Drug Resistance, Microbial; Fluconazole; Flucytosine; Genetic Variation; Humans; Itraconazole; Molecular Epidemiology | 1996 |
[New antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole | 1996 |
Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Candida; Drug Resistance, Microbial; Fluconazole; Fluorescent Dyes; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Rhodamine 123; Rhodamines | 1996 |
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Blood; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Rabbits; Triazoles | 1996 |
Successful treatment of fungus ball in a patient with allergic bronchopulmonary aspergillosis: continuous percutaneous instillation of antifungal agents into the cavity.
Topics: Administration, Inhalation; Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Humans; Infusions, Intravenous; Itraconazole; Male; Middle Aged; Prednisolone; Remission Induction | 1996 |
Suspected drug eruption in seven dogs during administration of flucytosine.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Cryptococcosis; Dog Diseases; Dogs; Drug Eruptions; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Itraconazole; Male | 1996 |
Identification of an amphotericin B resistant strain of Candida albicans using a rapid 3H-glucose incorporation microassay.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Microbial Sensitivity Tests | 1996 |
T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida; Candidiasis; Cryptococcus neoformans; Dogs; Fluconazole; Hydroxybutyrates; Itraconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rabbits; Rats; Triazoles | 1997 |
In vitro susceptibility of Trichosporon beigelii to antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon | 1996 |
Cryptococcal cellulitis in an immunocompetent host.
Topics: Aged; Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Dermatomycoses; Female; Fluconazole; Flucytosine; Humans; Immunocompetence; Itraconazole; Leg Dermatoses | 1997 |
Variable antifungal susceptibility of wild-type Candida albicans phenotypes from neutropenic hosts.
Topics: Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Neutropenia; Phenotype | 1996 |
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Triazoles | 1997 |
Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Drug Resistance, Microbial; Ergosterol; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction | 1997 |
In vitro susceptibility of 115 isolates of Candida to amphotericin B, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; France; Humans; Itraconazole; Microbial Sensitivity Tests | 1996 |
[White piedra. Report of a case].
Topics: Adolescent; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Piedra; Scalp Dermatoses; Trichosporon | 1996 |
Update on treatment of coccidioidomycosis.
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Pneumonia | 1997 |
Early surgical management of invasive gingival aspergillosis in a neutropenic patient with leukemia: a case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Fluconazole; Flucytosine; Gingival Diseases; Granulocyte Colony-Stimulating Factor; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Neutropenia | 1997 |
In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans.
Topics: Anticholesteremic Agents; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Synergism; Fatty Acids, Monounsaturated; Fluconazole; Fluvastatin; Indoles; Itraconazole; Microbial Sensitivity Tests; Time Factors | 1997 |
Biotransformation of mestranol to ethinyl estradiol in vitro: the role of cytochrome P-450 2C9 and metabolic inhibitors.
Topics: Adult; Antifungal Agents; Biotransformation; Cells, Cultured; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Estradiol Congeners; Ethinyl Estradiol; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Mestranol; Microsomes, Liver | 1997 |
[Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Drug Resistance, Microbial; Evaluation Studies as Topic; Fluconazole; Flucytosine; Indicator Dilution Techniques; Itraconazole; Miconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae | 1997 |
Candida parapsilopsis fungemias in bone marrow transplant recipients: implications for azole prophylactic therapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bone Marrow Transplantation; Candida; Candidiasis; Female; Fluconazole; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications | 1997 |
Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; CD4 Lymphocyte Count; Fluconazole; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results; Sensitivity and Specificity | 1997 |
Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
Topics: Amphotericin B; Antifungal Agents; Buffers; Candida; Culture Media; Fluconazole; Flucytosine; Fungi; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results; Species Specificity; Spectrophotometry | 1997 |
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Triazoles | 1997 |
Candida norvegensis: a fluconazole-resistant species.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged | 1997 |
Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Fatal Outcome; Fluconazole; Humans; Itraconazole; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged | 1997 |
Rapid high performance liquid chromatographic assay for antifungal agents in human sera.
Topics: Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Spectrophotometry, Ultraviolet | 1996 |
[Controversies in the standardization of susceptibility testing on yeasts to azole antimycotics].
Topics: Antifungal Agents; Azoles; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Quality Control | 1996 |
[Fluconazole and itraconazole susceptibility testing with clinical yeast isolates and algae of the genus Prototheca by means of the Etest].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Evaluation, Preclinical; Fluconazole; Humans; Infections; Itraconazole; Microbial Sensitivity Tests; Mycoses; Prototheca; Yeasts | 1996 |
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Biological Transport; Candida albicans; Drug Resistance, Microbial; Fluconazole; Genes, Fungal; Genes, MDR; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; RNA, Messenger | 1997 |
[Systematic therapy of vaginal mycoses. Three quarters of women are affected].
Topics: Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Itraconazole; Mycoses; Vaginal Diseases | 1994 |
In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida; Carbon Monoxide; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Ergosterol; Fluconazole; Itraconazole; Time Factors; Triazoles | 1997 |
Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes.
Topics: Antifungal Agents; Candida; Cell Division; Culture Media; DNA Fingerprinting; DNA, Fungal; Fluconazole; HIV Seropositivity; Humans; Itraconazole; Lethal Dose 50; Microbial Sensitivity Tests; Phenotype | 1997 |
In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
Topics: Antifungal Agents; Azoles; Candida albicans; Drug Interactions; Drug Therapy, Combination; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1997 |
[How I treat onychomycosis using pulsed therapy].
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Diagnosis, Differential; Drug Administration Schedule; Fluconazole; Humans; Itraconazole; Nail Diseases; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Topics: AIDS-Related Opportunistic Infections; Ambulatory Care; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Esophagitis; Fluconazole; Guidelines as Topic; Humans; Itraconazole; Ketoconazole; Medical Audit; Nystatin; Retrospective Studies | 1997 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cryptococcosis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Flucytosine; Gynecomastia; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney Diseases; Liposomes; Male; Mixed Function Oxygenases; Mucormycosis; Nausea; Paracoccidioidomycosis; Sporotrichosis; Teratogens | 1997 |
Contempo 1997: dermatology.
Topics: Antifungal Agents; Contraceptives, Oral; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Triazoles | 1997 |
Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1997 |
Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods.
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Fatal Outcome; Female; Fluconazole; Flucytosine; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Saccharomyces cerevisiae | 1995 |
Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Humans; Itraconazole; Ketoconazole | 1997 |
[Effect of keratin on the efficacy of fluconazole].
Topics: Animals; Antifungal Agents; Blood Proteins; Fluconazole; Itraconazole; Keratins; Ketoconazole; Kinetics; Sheep; Skin; Wool | 1997 |
[Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Recurrence | 1997 |
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Effects of three azole derivatives on the lipids of different strains of Sporothrix schenckii.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Lanosterol; Lipids; Sporothrix | 1997 |
Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy.
Topics: Adolescent; Adult; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Europe; Female; Fluconazole; HIV Seronegativity; HIV Seropositivity; Humans; Italy; Itraconazole; Male; Microbial Sensitivity Tests; Serotyping | 1997 |
[Evaluation of the E-test: comparison of E-test and microbroth dilution method in azole antifungal susceptibility test].
Topics: Antifungal Agents; Candida albicans; Fluconazole; Indicator Dilution Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results | 1998 |
Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
Topics: Analysis of Variance; Animals; Antifungal Agents; Aspergillus; Cornea; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Fungal; Fluconazole; Fungi; Fusarium; Horse Diseases; Horses; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Natamycin; Penicillium | 1998 |
In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Drug Synergism; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1998 |
Comparison of the E test with broth microdilution for antifungal susceptibility testing of yeasts.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Yeasts | 1998 |
Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole.
Topics: Antifungal Agents; Blastomyces; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1998 |
Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1998 |
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Fluconazole; Fungemia; Humans; Incidence; Itraconazole; Ketoconazole; Male; Mitosporic Fungi; Neoplasms; Pichia; Retrospective Studies; Risk Factors; Slovakia; Treatment Outcome | 1998 |
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Resistance, Microbial; Fluconazole; Health Surveys; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests | 1998 |
In vitro activity of voriconazole against Candida species.
Topics: Antifungal Agents; Candida; Drug Evaluation, Preclinical; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Itraconazole; Microbial Sensitivity Tests | 1998 |
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participa
Topics: Antifungal Agents; Canada; Candida; Candidiasis; Fluconazole; Fungemia; Humans; International Cooperation; Itraconazole; Microbial Sensitivity Tests; Sentinel Surveillance; South America; United States | 1998 |
Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Colorimetry; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Laboratories; Microbial Sensitivity Tests; Quality Control; Time Factors | 1998 |
Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approach.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Calcium Channel Blockers; Child; Cyclosporine; Diltiazem; Drug Administration Schedule; Drug Interactions; Fluconazole; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Individuality; Itraconazole; Ketoconazole; Linear Models; Middle Aged | 1998 |
Treatment of invasive fungal infections.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Itraconazole; Mycoses | 1998 |
Blastomycosis in dogs: 115 cases (1980-1995).
Topics: Age Distribution; Amphotericin B; Animals; Antibodies, Fungal; Antifungal Agents; Blastomyces; Blastomycosis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluconazole; Housing, Animal; Immunodiffusion; Itraconazole; Ketoconazole; Louisiana; Male; Radiography, Thoracic; Retrospective Studies; Seasons; Treatment Outcome | 1998 |
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth; North America; Pharynx; Phenotype; Pyrimidines; Triazoles; Voriconazole | 1998 |
In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Uganda | 1998 |
Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro activity of voriconazole against selected fungi.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Basidiomycota; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Evaluation Studies as Topic; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results | 1998 |
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Blood; Candida; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Peptides; Peptides, Cyclic; Sensitivity and Specificity; Serum Bactericidal Test | 1998 |
Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prototheca | 1998 |
[Effect of fluconazole and itraconazole on human polymorphonuclear leukocyte oxidative metabolism and phagocytosis].
Topics: Antifungal Agents; Fluconazole; Humans; Hydrogen Peroxide; In Vitro Techniques; Itraconazole; Neutrophils; Oxidation-Reduction; Phagocytosis; Superoxides | 1998 |
Influence of incubation time, inoculum size, and glucose concentrations on spectrophotometric endpoint determinations for amphotericin B, fluconazole, and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Fluconazole; Glucose; Humans; Itraconazole; Microbial Sensitivity Tests; Spectrophotometry; Time Factors | 1999 |
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.
Topics: Africa; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole | 1999 |
Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antifungal Agents; Azoles; Brazil; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Mycology; Prevalence; Prospective Studies; Statistics, Nonparametric | 1998 |
Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Flucytosine; Hospitals, University; Humans; Itraconazole; Ketoconazole; Lebanon; Microbial Sensitivity Tests | 1998 |
[Pediatric onychomycosis treated with oral antifungal drugs].
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Female; Fluconazole; Humans; Itraconazole; Male; Onychomycosis | 1999 |
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Fluconazole; Flucytosine; Guidelines as Topic; Itraconazole; Ketoconazole; Laboratories; Microbial Sensitivity Tests; Quality Assurance, Health Care; Reference Standards; Yeasts | 1999 |
Evaluation of the fungitest kit by using strains from human immunodeficiency virus-infected patients: study of azole drug susceptibility.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycology; Reagent Kits, Diagnostic; Sensitivity and Specificity | 1999 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus; Drug Combinations; Drug Evaluation; Female; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Leukemia; Lymphoma; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Mouth Diseases; Neutropenia | 1999 |
Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genes, MDR; Humans; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Tacrolimus | 1998 |
Editorial response: A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Itraconazole; Meningitis, Fungal | 1999 |
Using oral antifungal agents for severe fungal infections.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Humans; Itraconazole; Mycoses | 1995 |
In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Drug Combinations; Drug Synergism; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests | 1999 |
A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Evaluation Studies as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Oropharynx; Reagent Strips | 1999 |
Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates.
Topics: Antifungal Agents; Candida; Candidiasis; DNA, Fungal; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Karyotyping; Microbial Sensitivity Tests | 1999 |
[Epidemiology of fungemia in a university hospital; therapeutic incidence].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child, Preschool; Female; Fluconazole; France; Fungemia; Hospitals, University; Humans; Infant; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Postoperative Complications; Saccharomyces cerevisiae | 1999 |
Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Reagent Kits, Diagnostic | 1999 |
Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; Hydrogen-Ion Concentration; Itraconazole; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Osmolar Concentration; Phenotype; Pyrimidines; Staining and Labeling; Temperature; Triazoles; Voriconazole | 1999 |
[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
Topics: Adult; Age Factors; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross-Sectional Studies; Drug Resistance, Microbial; Female; Fluconazole; Flucytosine; Fungemia; Humans; Itraconazole; Male; Middle Aged; Mycoses; Sex Factors; Spain; Yeasts | 1999 |
Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 1999 |
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America.
Topics: Antifungal Agents; Candida; Dose-Response Relationship, Drug; Fluconazole; Humans; Itraconazole; Latin America; Microbial Sensitivity Tests; North America; Population Surveillance; Thiazoles; Triazoles | 1999 |
In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Quinazolines; Triazoles | 1999 |
[Role of Candida allergen in atopic dermatitis and efficacy of oral therapy with various antifungal agents].
Topics: Administration, Oral; Adult; Allergens; Amphotericin B; Antifungal Agents; Antigens, Fungal; Candida albicans; Dermatitis, Atopic; Female; Fluconazole; Humans; Itraconazole; Male; Nystatin | 1999 |
In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Deoxycholic Acid; Drug Carriers; Drug Combinations; Fluconazole; Humans; Itraconazole; Liposomes; Microbial Sensitivity Tests; Nystatin; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.
Topics: Amino Acid Sequence; Amino Acid Substitution; Antifungal Agents; Candida albicans; Chromosome Mapping; Cytochrome P-450 Enzyme System; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutation; Oxidoreductases; Protein Conformation; Protein Structure, Secondary; Sequence Alignment; Sequence Analysis, DNA; Sterol 14-Demethylase | 1999 |
[Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Yeasts | 1999 |
In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles | 1999 |
Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clotrimazole; Community-Acquired Infections; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Fungemia; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged | 1999 |
Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species.
Topics: Antifungal Agents; Candida; Colorimetry; Coloring Agents; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Oxazines; Pyrimidines; Triazoles; Voriconazole; Xanthenes | 1999 |
Case report. Osteomyelitis caused by high resistant Candida guilliermondii.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fingers; Fluconazole; Hand Dermatoses; Humans; Itraconazole; Middle Aged; Osteomyelitis | 1999 |
In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs.
Topics: Antifungal Agents; Chromoblastomycosis; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests | 1999 |
In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test.
Topics: Antifungal Agents; Candida; Cryptococcus; Fluconazole; Geotrichum; Humans; Itraconazole; Microbial Sensitivity Tests; Saccharomyces; Trichosporon; Yeasts | 1999 |
The use of systemic antimycotics in dermatotherapy.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Dermatomycoses; Fluconazole; Griseofulvin; Hair Diseases; Humans; Itraconazole; Ketoconazole; Naphthalenes; Odds Ratio; Onychomycosis; Terbinafine; Tinea | 2000 |
Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis.
Topics: Adult; Animals; Antibodies, Anti-Idiotypic; Antibodies, Fungal; Antibodies, Monoclonal; Antifungal Agents; Antigens, Fungal; Fluconazole; Follow-Up Studies; Fungal Proteins; Glycoproteins; Humans; Itraconazole; Mice; Oligosaccharides; Paracoccidioides; Paracoccidioidomycosis | 2000 |
1H and 13C nuclear magnetic resonance studies of the sites of protonation in itraconazole and fluconazole.
Topics: Antifungal Agents; Carbon; Fluconazole; Itraconazole; Magnetic Resonance Spectroscopy; Models, Molecular; Protons; Solutions | 1999 |
Itraconazole verus fluconazole in neutropenic patients.
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Humans; Itraconazole; Neutropenia | 2000 |
Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Colony Count, Microbial; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Sensitivity and Specificity | 2000 |
Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.
Topics: Animals; Antifungal Agents; Coccidioidomycosis; Disease Models, Animal; Fluconazole; Itraconazole; Male; Meningitis, Fungal; Rabbits | 2000 |
Efficacy of antifungal agents in tissue conditioners in treating candidiasis.
Topics: Acrylic Resins; Aged; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; Dental Care for Aged; Denture Liners; Drug Combinations; Drug Delivery Systems; Fluconazole; Humans; Itraconazole; Methylmethacrylates; Microbial Sensitivity Tests; Nystatin; Phthalic Acids; Statistics, Nonparametric; Stomatitis, Denture; Tissue Conditioning, Dental | 1999 |
Comparison of a new colorimetric assay with the NCCLS broth microdilution method (M-27A) for antifungal drug MIC determination.
Topics: Amphotericin B; Antifungal Agents; Colorimetry; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests | 2000 |
[Susceptibility to fluconazole and itraconazole in isolates of Candida spp. from HIV-positive and HIV-negative patients].
Topics: Antifungal Agents; Candida; Fluconazole; HIV Seronegativity; HIV Seropositivity; Humans; Itraconazole; Microbial Sensitivity Tests | 2000 |
Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis.
Topics: Amphotericin B; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Paracoccidioides; Sterols | 2000 |
Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany.
Topics: Adult; Amphotericin B; Anti-HIV Agents; Antifungal Agents; CD4 Lymphocyte Count; Cross Reactions; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Germany; HIV Seropositivity; Humans; Itraconazole; Mycoses; Penicillium; Thailand; Travel | 1999 |
Fungal endophthalmitis after a single intravenous administration of presumably contaminated dextrose infusion fluid.
Topics: Adult; Antifungal Agents; Aspergillus; Candida; Drug Contamination; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Glucose; Humans; Infusions, Intravenous; Itraconazole; Male; Middle Aged; Mucor; Mycoses; Risk Factors; Visual Acuity; Vitrectomy; Vitreous Body | 2000 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
[Two cases of pulmonary aspergillosis successfully treated with multidrug therapy].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Radiography; Treatment Outcome | 2000 |
[Four cases of pulmonary aspergilloma successfully treated with drug therapy].
Topics: Administration, Inhalation; Administration, Oral; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Fluconazole; Humans; Infusions, Intravenous; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Radiography; Treatment Outcome | 2000 |
Case report. Primary cutaneous histoplasmosis in an immunosuppressed patient.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Dermatomycoses; Fluconazole; Follow-Up Studies; Forearm; Hand; Histoplasma; Histoplasmosis; Humans; Immunocompromised Host; Itraconazole; Male; Methylprednisolone; Skin | 2000 |
Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis.
Topics: Amphotericin B; Animals; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; Histoplasmosis; Itraconazole; Mice; Microbial Sensitivity Tests | 2000 |
Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles | 2000 |
Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cross Infection; Drug Resistance, Microbial; Female; Finland; Fluconazole; Hematologic Neoplasms; Hospital Units; Humans; Infection Control; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Neutropenia; Saccharomyces cerevisiae | 2000 |
Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Echinocandins; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic | 2000 |
In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2000 |
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 2000 |
A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Time Factors | 2000 |
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole | 2000 |
Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Female; Fluconazole; Humans; Itraconazole; Lactoferrin; Mouthwashes; Muramidase | 2000 |
The implications and management of drug interactions with itraconazole, fluconazole and terbinafine.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine | 2000 |
Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Retrospective Studies | 2000 |
The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Azoles; Bone Marrow Transplantation; Candida; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Ketoconazole; Neutropenia; Prospective Studies; Retrospective Studies | 2001 |
Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Itraconazole; Microbial Sensitivity Tests; Prospective Studies; Treatment Outcome | 2001 |
[Current problems in etiotropic therapy of mycoses].
Topics: Amphotericin B; Antifungal Agents; Candicidin; Candida; Fluconazole; Humans; Itraconazole; Miconazole; Mycoses; Nystatin | 2001 |
Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Digestive System; Fluconazole; Itraconazole; Ketoconazole; Mice | 2001 |
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1999 |
Serum protein binding of itraconazole and fluconazole in patients with diabetes mellitus.
Topics: Adult; Antifungal Agents; Blood Proteins; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fatty Acids; Female; Fluconazole; Humans; Itraconazole; Kinetics; Male; Middle Aged; Reference Values; Serum Albumin | 1999 |
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
In vitro activity of propyl gallate-azole drug combination against fluconazole- and itraconazole-resistant Candida albicans strains.
Topics: Antifungal Agents; Antioxidants; Candida albicans; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Propyl Gallate | 2001 |
Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospital.
Topics: Antifungal Agents; Candida; Colony Count, Microbial; Cross Infection; Drug Resistance, Microbial; Fluconazole; Fungemia; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests | 2001 |
Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Child; Drug Resistance, Microbial; Female; Fluconazole; HIV-1; Humans; Immune Tolerance; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Oropharynx; Pharyngeal Diseases | 2001 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as Topic; Clotrimazole; Cytomegalovirus Infections; Dapsone; Fluconazole; Ganciclovir; Humans; Itraconazole; Leucovorin; Mycobacterium avium-intracellulare Infection; Mycoses; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Valacyclovir; Valine | 1995 |
Fungal infection overview.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Clotrimazole; Fluconazole; Histoplasmosis; Humans; Itraconazole; Meningitis, Cryptococcal; Mycoses | 1995 |
Candidiasis at ICAAC.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Biological Availability; Candida albicans; Candidiasis, Oral; Clinical Trials as Topic; Drug Resistance, Microbial; Fluconazole; HIV; Humans; Itraconazole; Ketoconazole; Mutation | 1995 |
Coccidioidomycosis.
Topics: Amphotericin B; Antifungal Agents; Coccidioides; Coccidioidomycosis; Fluconazole; HIV Infections; Humans; Itraconazole; Risk Factors; Southwestern United States | 1997 |
Histoplasmosis: update 1998.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Clinical Trials as Topic; Dosage Forms; Fluconazole; Histoplasmosis; Itraconazole; Ketoconazole; Remission Induction | 1998 |
[Endemic mycotic infections].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Diagnosis, Differential; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Travel | 2001 |
[Endogenous fungal endophthalmitis: results of antifungal treatment with and without vitrectomy].
Topics: Adult; Aged; Aspergillosis; Candidiasis; Combined Modality Therapy; Enophthalmos; Female; Fluconazole; Fluorescein Angiography; Humans; Itraconazole; Male; Middle Aged; Treatment Outcome; Vitrectomy | 2001 |
Application of capillary zone electrophoresis with off-line solid-phase extraction to in vitro metabolism studies of antifungals.
Topics: Acetic Acid; Acetonitriles; Antifungal Agents; Clotrimazole; Drug Stability; Electrophoresis, Capillary; Fluconazole; Humans; Itraconazole; Ketoconazole; Methanol; Microsomes, Liver; Molecular Structure; Molecular Weight; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Solvents; Triazoles; Verapamil; Voriconazole | 2001 |
In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles | 2001 |
Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Treatment Outcome | 2001 |
Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Disease Susceptibility; Drug Resistance, Fungal; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; Microbial Sensitivity Tests; Recurrence; Treatment Failure | 2001 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
[In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Topics: Agar; Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi | 2001 |
Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia.
Topics: Acute Disease; Aged; Aged, 80 and over; Antifungal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; Clone Cells; Female; Fluconazole; Humans; Interferon-gamma; Interleukin-4; Itraconazole; Ketoconazole; Leukemia, Myeloid; Leukopenia; Lymphocyte Activation; Male; Miconazole; Middle Aged; Neoplastic Stem Cells; T-Lymphocytes | 2001 |
Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Antigens, Fungal; Fluconazole; Histoplasmosis; Humans; Itraconazole; Treatment Outcome | 2002 |
Case report. Hepatic abscesses due to Aspergillus terreus in an immunodeficient child.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunocompromised Host; Itraconazole; Liposomes; Liver Abscess; Lung Diseases; Male; Treatment Outcome | 2001 |
Case report. Successful treatment of two cases of post-surgical sternal osteomyelitis, due to Candida krusei and Candida albicans, respectively, with high doses of triazoles (fluconazole, itraconazole).
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Itraconazole; Middle Aged; Osteomyelitis; Postoperative Complications; Sternum | 2001 |
Synthesis and in vitro antifungal activities of novel triazole antifungal agent CS-758.
Topics: Antifungal Agents; Fluconazole; Fungi; Indicators and Reagents; Itraconazole; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Triazoles | 2001 |
Comparison of the therapeutic efficacy of oral doses of fluconazole and itraconazole in a guinea pig model of dermatophytosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Dermatomycoses; Disease Models, Animal; Female; Fluconazole; Guinea Pigs; Itraconazole; Tinea; Treatment Outcome; Trichophyton | 2000 |
Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Dental Plaque; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Genetic Heterogeneity; HIV Infections; Humans; Itraconazole; Karyotyping; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Triazoles | 2002 |
Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis, Oral; Capsules; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cohort Studies; Fluconazole; Flucytosine; Gingival Diseases; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Leukocyte Count; Neutropenia; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Treatment Outcome | 2002 |
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Female; Fluconazole; Histoplasmosis; Itraconazole; Liver; Mice; Spleen; Survival; Survival Analysis; Thiazoles; Triazoles | 2002 |
Transcription initiation of genes associated with azole resistance in Candida albicans.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Genes, MDR; Itraconazole; Membrane Transport Proteins; TATA Box; Transcription, Genetic | 2002 |
Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests | 2002 |
Drug susceptibility testing of Malassezia furfur strains to antifungal agents.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests | 2001 |
In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.
Topics: Antifungal Agents; Azoles; Candida; Dose-Response Relationship, Drug; Fluconazole; HIV Infections; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Mouth; Naphthalenes; Pyrimidines; Quality Control; Terbinafine; Triazoles; Voriconazole | 2002 |
Multicenter Brazilian study of oral Candida species isolated from AIDS patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Serotyping | 2002 |
[Diversified treatments of Tinea unguium].
Topics: Administration, Oral; Antifungal Agents; Combined Modality Therapy; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Occlusive Dressings; Onychomycosis; Pulse Therapy, Drug; Terbinafine | 2002 |
Itraconazole- and fluconazole-induced toxicity in rat hepatocytes: a comparative in vitro study.
Topics: Animals; Antifungal Agents; Cell Survival; Cells, Cultured; Cytochrome P-450 Enzyme System; Cytoprotection; Dose-Response Relationship, Drug; Enzyme Induction; Female; Fluconazole; Hepatocytes; Itraconazole; L-Lactate Dehydrogenase; Phenobarbital; Rats; Rats, Sprague-Dawley; Time Factors | 2002 |
Itraconazole and fluconazole and certain rare, serious adverse events.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Databases, Factual; Drug Combinations; Female; Fluconazole; Humans; Infant; Itraconazole; Liver Function Tests; Male; Middle Aged; Thrombocytopenia; United Kingdom | 2002 |
Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates.
Topics: Amphotericin B; Antifungal Agents; Culture Media; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Sensitivity and Specificity; Trichosporon | 2002 |
Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Colorimetry; Coloring Agents; Dermatomycoses; Drug Resistance, Fungal; Epidermophyton; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microsporum; Oxazines; Sensitivity and Specificity; Trichophyton; Xanthenes | 2002 |
[Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Fluconazole; Growth Inhibitors; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2002 |
Invasive subglottal aspergillosis in a patient with severe aplastic anemia: a case report.
Topics: Adult; Amphotericin B; Anemia, Aplastic; Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Fatal Outcome; Female; Fluconazole; Humans; Itraconazole; Larynx; Methylprednisolone; Opportunistic Infections | 2002 |
Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Cand
Topics: Antifungal Agents; Candida; Candidiasis; Endpoint Determination; Ergosterol; Fluconazole; Indicator Dilution Techniques; Itraconazole; Microbial Sensitivity Tests; Spectrophotometry; Sterols | 2002 |
[Pharmacoeconomic approach to onychomycosis therapy].
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Military Personnel; Naphthalenes; Onychomycosis; Terbinafine | 2002 |
In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2002 |
[Candida albicans resistance and genotyping by randomly amplified polymorphic DNA method].
Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Genotype; Humans; Inhibitory Concentration 50; Itraconazole; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique | 2000 |
Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (C
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Hospitals, Teaching; Hospitals, Urban; Humans; Itraconazole; Microbial Sensitivity Tests; New York City; Prospective Studies; Sentinel Surveillance | 2002 |
Conjunctival sporotrichosis in the absence of antecedent trauma.
Topics: Adult; Antifungal Agents; Conjunctiva; Conjunctivitis; Diagnosis, Differential; Eye Infections, Fungal; Fluconazole; Humans; Itraconazole; Male; Sporothrix; Sporotrichosis; Treatment Outcome | 2002 |
Epidemiology of clinical isolates of Candida albicans and their susceptibility to triazoles.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Retrospective Studies | 2002 |
Prevalence of dermatomycoses in Mal de Meleda patients: a field study.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Biopsy, Needle; Comorbidity; Dermatomycoses; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Keratoderma, Palmoplantar; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Risk Assessment; Sampling Studies; Skin; Treatment Outcome; Turkey | 2002 |
[Pseudozyma sp.: colonizer of the respiratory tract in critical patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Critical Care; Female; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Spain; Trichosporon | 2003 |
In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Quality Control | 2003 |
Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Base Sequence; Blotting, Northern; Candida; Chromosome Mapping; Cloning, Molecular; Cytochrome P-450 Enzyme System; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Fluconazole; Gene Deletion; Immunoblotting; Itraconazole; Lung; Molecular Sequence Data; Mutagenesis, Site-Directed; Oxidoreductases; Pneumocystis; Polymerase Chain Reaction; Protein Biosynthesis; Pyrimidines; Rats; Recombinant Proteins; RNA, Messenger; RNA, Ribosomal; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Triazoles; Voriconazole | 2003 |
Drug induced proteome changes in Candida albicans: comparison of the effect of beta(1,3) glucan synthase inhibitors and two triazoles, fluconazole and itraconazole.
Topics: Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Echinocandins; Electrophoresis, Gel, Two-Dimensional; Fluconazole; Fungal Proteins; Glucose; Glucosyltransferases; Image Processing, Computer-Assisted; Itraconazole; Kinetics; Mass Spectrometry; Membrane Proteins; Microscopy, Electron, Scanning; Microscopy, Phase-Contrast; Peptides, Cyclic; Proteome; Schizosaccharomyces pombe Proteins; Triazoles | 2003 |
In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Gas Chromatography-Mass Spectrometry; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Rats; Rats, Wistar; Tea Tree Oil; Yeasts | 2003 |
Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae.
Topics: Amino Acids; Antifungal Agents; Azoles; Cell Wall; DNA, Complementary; Drug Resistance, Fungal; Fatty Acids; Fluconazole; Gene Expression Regulation, Fungal; Genes, Fungal; Itraconazole; Lipid Metabolism; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Open Reading Frames; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; Saccharomyces cerevisiae; Sterols | 2003 |
Synthesis and antimycotic activity of N-azolyl-2,4-dihydroxythiobenzamides.
Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Thioamides; Triazoles | 2003 |
Therapeutic penetrating keratoplasty in severe fungal keratitis using cryopreserved donor corneas.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Cornea; Cryopreservation; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections, Intravenous; Itraconazole; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Postoperative Complications; Reoperation; Retrospective Studies; Treatment Outcome | 2003 |
Summaries for patients. Preventing fungal infections in patients with stem-cell transplants.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Itraconazole; Male; Middle Aged; Mycoses; Opportunistic Infections | 2003 |
[Infections by Candida sp. in intensive care. Survey of French practices].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Cross-Sectional Studies; Equipment Contamination; Female; Fluconazole; France; Fungemia; Humans; Incidence; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors | 2003 |
Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant.
Topics: Amphotericin B; Antifungal Agents; Chemoprevention; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Mycoses; Postoperative Complications; Transplantation, Autologous; Transplantation, Homologous | 2003 |
Tinea capitis in Brussels: epidemiology and new management strategy.
Topics: Adolescent; Antifungal Agents; Belgium; Child; Child, Preschool; Drug Combinations; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Naphthalenes; Prevalence; Retrospective Studies; Terbinafine; Tinea Capitis; Treatment Outcome | 2003 |
Variations in color.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Black People; Diagnosis, Differential; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Selenium Compounds; Skin Pigmentation; Tinea Versicolor | 2003 |
Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcus neoformans; Drug Resistance, Fungal; Environmental Microbiology; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Time Factors | 2003 |
Disseminated aspergillosis due to Aspergillus flavus in an experimental model: efficacy of azole therapy.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Brain; Colony Count, Microbial; Disease Models, Animal; Fluconazole; Itraconazole; Kidney; Liver; Lung; Male; Rats; Rats, Wistar | 2003 |
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole | 2003 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Fungal; Fatal Outcome; Fluconazole; Humans; Immunocompromised Host; Intensive Care Units; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Parkinson Disease; Postoperative Complications; Trichosporon; Urinary Catheterization; Urinary Tract Infections; Ventriculoperitoneal Shunt | 2003 |
Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EU
Topics: Advisory Committees; Antifungal Agents; Candida; Europe; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Multicenter Studies as Topic; Reproducibility of Results | 2003 |
[Architecture, influencing factors, and sensitivity to antifungal agents of Candida biofilm].
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microscopy, Confocal | 2002 |
Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care.
Topics: Confidence Intervals; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; India; Itraconazole; Pilot Projects; Retrospective Studies | 2003 |
Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
Topics: Amphotericin B; Antifungal Agents; Brazil; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Inpatients; Itraconazole; Microbial Sensitivity Tests | 2003 |
In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects.
Topics: Amphotericin B; Antifungal Agents; Environmental Microbiology; Exophiala; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine | 2003 |
Scedosporium apiospermum keratitis treated with itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Eye Infections, Fungal; Fluconazole; Humans; Itraconazole; Keratitis; Male; Microbial Sensitivity Tests; Mycetoma; Scedosporium; Treatment Outcome | 2003 |
[Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
Topics: Adult; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mice; Peptides, Cyclic | 2003 |
Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Antifungal Agents; Azoles; Candida; Cyclic AMP; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genotype; Imines; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Naphthalenes; Protein Synthesis Inhibitors; Saccharomyces cerevisiae; Signal Transduction; Sterols; Terbinafine; Up-Regulation | 2003 |
High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Mouth; Mouth Diseases; Mycoses; Neoplasms; Opportunistic Infections; Palliative Care; Yeasts | 2003 |
Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Humans; Itraconazole; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Treatment Outcome | 2003 |
In vitro antifungal activity of N,N-phenyl-1,2,3,4-thiatriazole-5-yl-2,4-beta-resorcylcarbothioamide.
Topics: Antifungal Agents; Arthrodermataceae; Candida albicans; Fluconazole; Fungi; Indicators and Reagents; Itraconazole; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Resorcinols; Thiones | 2003 |
[In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Pyrimidines; Species Specificity; Terbinafine; Triazoles; Trichophyton; Voriconazole | 2003 |
Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.
Topics: Antifungal Agents; Aspergillus fumigatus; Colorimetry; Fluconazole; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole | 2003 |
In vitro susceptibility characteristics of Cryptococcus neoformans varieties from AIDS patients in Goiânia, Brazil.
Topics: Adolescent; Adult; Agglutination Tests; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Serotyping | 2003 |
Imported paracoccidioidomycosis in Spain.
Topics: Aged; Antifungal Agents; Fluconazole; Humans; Itraconazole; Male; Paracoccidioides; Paracoccidioidomycosis; South America; Spain; Time Factors | 2003 |
Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD).
Topics: Acremonium; Aged; Antifungal Agents; Aspergillus; Candida; Child; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Kidney Failure, Chronic; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 2003 |
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula | 2003 |
Intracutaneous distributions of fluconazole, itraconazole, and griseofulvin in Guinea pigs and binding to human stratum corneum.
Topics: Administration, Topical; Animals; Antifungal Agents; Area Under Curve; Fluconazole; Griseofulvin; Guinea Pigs; Half-Life; Humans; In Vitro Techniques; Itraconazole; Keratins; Nails; Skin | 2004 |
Diagnostic and therapeutic challenges.
Topics: Adolescent; Antifungal Agents; Choroiditis; Complement Fixation Tests; Diagnosis, Differential; Eye Infections, Fungal; Female; Fluconazole; Fluorescein Angiography; Granuloma; Histoplasmosis; Humans; Itraconazole; Visual Acuity | 2003 |
Therapy for severe histoplasmosis: what's best?
Topics: Amphotericin B; Antifungal Agents; Chemistry, Pharmaceutical; Drug Combinations; Fluconazole; Histoplasmosis; Humans; Itraconazole; Male | 2004 |
Tacrolimus dosage requirements after initiation of azole antifungal therapy in pediatric thoracic organ transplantation.
Topics: Analysis of Variance; Antifungal Agents; Child; Female; Fluconazole; Humans; Immunosuppressive Agents; Itraconazole; Male; Mycoses; Organ Transplantation; Retrospective Studies; Tacrolimus | 2003 |
[Onychomycosis].
Topics: Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Morpholines; Mycological Typing Techniques; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Time Factors | 2004 |
[Modern antimycotics. What the treating physician needs to know].
Topics: Antifungal Agents; Arthrodermataceae; Child; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors | 2004 |
[In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
Topics: Amphotericin B; Antifungal Agents; Candida; DNA Fingerprinting; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Random Amplified Polymorphic DNA Technique; Time Factors | 2003 |
Itraconazole versus fluconazole for antifungal prophylaxis.
Topics: Antifungal Agents; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Mycoses | 2004 |
Itraconazole versus fluconazole for antifungal prophylaxis.
Topics: Antifungal Agents; Data Interpretation, Statistical; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Mycoses | 2004 |
Itraconazole versus fluconazole for antifungal prophylaxis.
Topics: Antifungal Agents; Data Interpretation, Statistical; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Mycoses; Research Design | 2004 |
Modified colorimetric assay for susceptibility testing of azole antifungal drugs against Candida species.
Topics: Antifungal Agents; Azoles; Candida; Colorimetry; Culture Media; Fluconazole; Glucose; Humans; Itraconazole; Microbial Sensitivity Tests | 2004 |
Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.
Topics: Adult; Aged; Amphotericin B; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Respiratory System; Saudi Arabia; Serotyping | 2004 |
Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Vagina | 2004 |
In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2004 |
[Antifungal susceptibility of Acremonium species using E-test and Sensititre].
Topics: Acremonium; Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests | 2004 |
Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chile; Critical Care; Drug Resistance, Fungal; Fluconazole; Humans; Inpatients; Intensive Care Units; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2004 |
Altered susceptibility of Candida glabrata bloodstream isolates to triazoles at clinically relevant pH values: comparison of the NCCLS M27-A2, Sensititre YeastOne, and Etest methods.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Hydrogen-Ion Concentration; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2004 |
[Antifungal prophylaxis in allogenic hematopoietic stem-cell transplant recipients].
Topics: Administration, Oral; Antibiotic Prophylaxis; Fluconazole; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Itraconazole; Japan; Mycoses; Societies, Medical; Transplantation, Homologous; United States | 2004 |
How to improve the design of trials of antifungal prophylaxis among neutropenic adults with acute leukemia.
Topics: Acute Disease; Adult; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Humans; Itraconazole; Leukemia; Mycoses; Neutropenia; Research Design | 2004 |
Etest for assessing the susceptibility of filamentous fungi.
Topics: Antifungal Agents; Culture Media; Fluconazole; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Quality Control; Reproducibility of Results | 2004 |
In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Clotrimazole; Econazole; Fluconazole; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Terbinafine; Thiophenes | 2004 |
Hepatotoxicity induced by antifungal drugs itraconazole and fluconazole in rats: a comparative in vivo study.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antifungal Agents; Body Weight; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Fluconazole; Hepatocytes; Injections, Intraperitoneal; Itraconazole; Liver; Male; Necrosis; Organ Size; Rats; Rats, Sprague-Dawley | 2004 |
Subcutaneous granuloma associated with Macrophomina species infection in a cat.
Topics: Animals; Anti-Infective Agents, Local; Antifungal Agents; Basidiomycota; Cat Diseases; Cats; Drug Therapy, Combination; Fluconazole; Granuloma; Itraconazole; Male; Mycoses; Povidone-Iodine; Tail; Treatment Outcome | 2005 |
Cutaneous sporotrichosis in Himachal Pradesh, India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Female; Fluconazole; Humans; India; Infant; Itraconazole; Male; Middle Aged; Potassium Iodide; Sporothrix; Sporotrichosis; Treatment Outcome | 2005 |
[Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Antineoplastic Agents; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Ketoconazole; Middle Aged; Mycoses; Neutropenia; Randomized Controlled Trials as Topic; Retrospective Studies | 2004 |
In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Saccharomyces cerevisiae; Species Specificity; Triazoles; Voriconazole | 2005 |
In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Hospitals, University; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Turkey | 2005 |
In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine; Thiazoles; Triazoles; Yeasts | 2005 |
Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Propolis; Terbinafine; Trichophyton; Turkey | 2005 |
In vitro susceptibility testing of Microsporum gypseum isolated from healthy cattle and soil samples against itraconazole, terbinafine, fluconazole and topical veterinarian drugs.
Topics: Animals; Anti-Infective Agents, Local; Antifungal Agents; Cattle; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Soil Microbiology; Terbinafine; Veterinary Drugs | 2005 |
Subcutaneous phaeohyphomycosis caused by Cladophialophora bantiana.
Topics: Adult; Antifungal Agents; Ascomycota; Biopsy; Dermatomycoses; Female; Fluconazole; Glucocorticoids; Humans; Immunocompromised Host; Itraconazole; Lupus Erythematosus, Systemic; Prednisolone; Recurrence | 2005 |
Two cases of cutaneous cryptococcosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Fluconazole; Granuloma; Humans; Itraconazole; Male; Neck; Spores, Fungal; Thigh | 2005 |
Azole resistance in neonatal intensive care units in Argentina.
Topics: Antifungal Agents; Argentina; Candida; Candidiasis; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Itraconazole; Microbial Sensitivity Tests | 2005 |
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2005 |
In vitro investigation of antifungal activities of phenotypic variation Candida albicans strains against fluconazole, itraconazole and voriconazole.
Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Phenotype; Pyrimidines; Triazoles; Voriconazole | 2005 |
[In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].
Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Dermatomycoses; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.
Topics: Antifungal Agents; Colorimetry; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Egypt; Evaluation Studies as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Reference Standards | 2005 |
Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Drug Synergism; Flow Cytometry; Fluconazole; Fungal Proteins; Ibuprofen; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Staining and Labeling; Triazoles; Voriconazole | 2005 |
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Reproducibility of Results; Spectrophotometry; Triazoles; Voriconazole | 2005 |
Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth Diseases; Mycoses; Neoplasms; Palliative Care; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2005 |
DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Soil Microbiology; Spain; Triazoles; Voriconazole | 2005 |
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Israel; Itraconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole | 2005 |
Etiology of fungaemia and catheter colonisation in Argentinean paediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Argentina; Candida; Catheterization; Child; Child, Preschool; Drug Resistance, Fungal; Fluconazole; Fungemia; Health Surveys; Humans; Incidence; Infant; Intensive Care Units, Pediatric; Itraconazole; Malassezia; Microbial Sensitivity Tests; Species Specificity | 2006 |
Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Communicable Diseases, Emerging; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Itraconazole; Male | 2005 |
[Respiratory tract mycotic infection in phthisiological practice: species composition and susceptibility of the Candida clinical isolates to antifungal agents].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Respiratory Tract Infections; Tuberculosis, Pulmonary | 2005 |
[Rhinofacial entomophthoromycosis. About two new cases in Mayotte].
Topics: Adult; Amphotericin B; Antifungal Agents; Conidiobolus; Face; Female; Fluconazole; Humans; Itraconazole; Male; Nose Diseases; Soft Tissue Infections; Treatment Outcome; Zygomycosis | 2005 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Peptide Hydrolases; Prevalence; Risk Factors; Turkey | 2006 |
What is your diagnosis? Fungal osteomyelitis.
Topics: Amputation, Surgical; Animals; Antifungal Agents; Ataxia; Dog Diseases; Dogs; Female; Fluconazole; Itraconazole; Laminectomy; Osteomyelitis; Treatment Outcome | 2006 |
Aureobasidium pullulans keratitis.
Topics: Ascomycota; Corneal Ulcer; Eye Infections, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Retrospective Studies | 2006 |
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida].
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth Diseases | 2006 |
[Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycology | 2006 |
Predisposing conditions for Candida spp. carriage in the oral cavity of denture wearers and individuals with natural teeth.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Carrier State; Dentures; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Schools, Dental; Species Specificity | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Involvement of phenobarbital and SKF 525A in the hepatotoxicity of antifungal drugs itraconazole and fluconazole in rats.
Topics: Animals; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fluconazole; Hypnotics and Sedatives; Isoenzymes; Itraconazole; Liver; Male; Microsomes, Liver; Organ Size; Phenobarbital; Proadifen; Rats; Rats, Sprague-Dawley | 2006 |
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2006 |
Clinical aspects of natural infection with Blastomyces dermatitidis in cats: 8 cases (1991-2005).
Topics: Animals; Antifungal Agents; Blastomyces; Blastomycosis; Cat Diseases; Cats; Diagnosis, Differential; Female; Fluconazole; Itraconazole; Male; Retrospective Studies; Treatment Outcome | 2006 |
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity | 2006 |
[Profile of antifungal susceptibility of species of Candida isolated from hemocultures in a university hospital, Maracaibo, Venezuela].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Venezuela | 2006 |
In vitro susceptibility to antifungal agents of environmental Cryptococcus spp. isolated in the city of Ribeirão Preto, São Paulo, Brazil.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcus; Drug Resistance, Fungal; Environmental Microbiology; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests | 2006 |
[Current treatment recommendations in tinea corporis?].
Topics: Antifungal Agents; Clotrimazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea | 2006 |
The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Chemoprevention; Chronic Disease; Cohort Studies; Comprehensive Health Care; Female; Fluconazole; Follow-Up Studies; Heterosexuality; Humans; Itraconazole; Male; Miconazole; Middle Aged; Nystatin; Population Surveillance; Retrospective Studies; South Africa; Treatment Outcome | 1999 |
Fluconazole and itraconazole resistance of yeasts isolated from the bloodstream and catheters of hospitalized pediatric patients.
Topics: Adolescent; Antifungal Agents; Candida; Catheters, Indwelling; Child; Child, Preschool; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Infant; Itraconazole; Microbial Sensitivity Tests; Neoplasms | 2006 |
[Studies on the correlation of the method currently used by the Japanese Society for Medical Mycology and its modified method with the NCCLS M27-A2 microdilution method for azole susceptibility testing of Candida species].
Topics: Azoles; Candida; Fluconazole; Itraconazole; Japan; Microbial Sensitivity Tests; Societies, Medical | 2006 |
The postantifungal effect (PAFE) of itraconazole, in comparison with those of miconazole and fluconazole, on Candida Species.
Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Itraconazole; Miconazole; Microbial Sensitivity Tests; Time Factors | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients.
Topics: Candida; Candidiasis; Fluconazole; Fungemia; Itraconazole; Leukemia; Microbial Sensitivity Tests; Oropharynx; Retrospective Studies | 2006 |
In vitro methods for antifungal susceptibility testing of Trichophyton spp.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Trichophyton | 2006 |
Long-term outcome of therapy for 59 cats and 11 dogs with cryptococcosis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cat Diseases; Cats; Cryptosporidiosis; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Fluconazole; Itraconazole; Male; Prognosis; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 2006 |
Successful treatment of azole-resistant chronic mucocutaneous candidosis with caspofungin.
Topics: Adolescent; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Itraconazole; Lipopeptides; Peptides, Cyclic | 2006 |
Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis.
Topics: Animals; Antifungal Agents; Coccidioides; Coccidiosis; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluconazole; Injections, Spinal; Itraconazole; Male; Meningitis, Fungal; Mice | 2007 |
The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model.
Topics: Amphotericin B; Animal Structures; Animals; Antibiotic Prophylaxis; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Fluconazole; Fungemia; Itraconazole; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Survival Analysis; Treatment Outcome; Trichosporon | 2007 |
[Prophylactic administration of fluconazole and itraconazole in febrile neutropenia associated with hematopoietic malignancy].
Topics: Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neutropenia; Retrospective Studies | 2006 |
Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, cas
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
Antifungal activities of azole agents against the Malassezia species.
Topics: Antifungal Agents; Azoles; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Tinea Versicolor; Triazoles; Voriconazole | 2007 |
Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is common.
Topics: Aniline Compounds; Aryl Hydrocarbon Hydroxylases; Benzodioxoles; Binding Sites; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fluconazole; Heme; Humans; Imidazoles; Itraconazole; Kinetics; Ligands; Light; Models, Chemical; Molecular Structure; NADP; Nonlinear Dynamics; Protein Binding; Pyrimidines; Recombinant Proteins; Reference Standards; Regression Analysis; Spectrum Analysis; Sulfaphenazole; Triazoles | 2007 |
Prophylaxis and aspergillosis--has the principle been proven?
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Mycoses; Neutropenia; Opportunistic Infections; Triazoles | 2007 |
Paecilomyces lilacinus scleritis with secondary keratitis.
Topics: Administration, Oral; Aged, 80 and over; Antifungal Agents; Debridement; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Keratitis; Male; Natamycin; Ophthalmic Solutions; Paecilomyces; Sclera; Scleritis | 2007 |
Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.
Topics: Amphotericin B; Antifungal Agents; Cross Infection; Fluconazole; Fungemia; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia | 2007 |
Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines.
Topics: Animals; Antifungal Agents; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Fluconazole; Genes, Reporter; Humans; Itraconazole; Ketoconazole; Liver Neoplasms; Luciferases; Mice; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; RNA, Messenger; Time Factors; Transcription, Genetic | 2007 |
Co-prescriptions with itraconazole and fluconazole as a signal for possible risk of drug-drug interactions: a four-year analysis from Italian general practice.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Databases as Topic; Drug Interactions; Drug Prescriptions; Drug Utilization; Family Practice; Female; Fluconazole; Humans; Italy; Itraconazole; Male; Middle Aged; Mycoses; Odds Ratio; Polypharmacy; Practice Patterns, Physicians'; Risk Assessment; Time Factors | 2007 |
Antifungal susceptibility testing of Trichophyton rubrum by E-test.
Topics: Antifungal Agents; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Tinea; Triazoles; Trichophyton; Voriconazole | 2007 |
Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A).
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Trichophyton | 2007 |
Posaconazole.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Capsules; Drug Approval; Drug Design; Economics, Pharmaceutical; Fluconazole; Humans; Injections, Intravenous; Itraconazole; Molecular Structure; Randomized Controlled Trials as Topic; Suspensions; Technology, Pharmaceutical; Treatment Failure; Triazoles; United States | 2007 |
Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Disease Outbreaks; Drug Resistance, Fungal; Female; Fluconazole; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Itraconazole; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
Onychocryptosis as consequence of effective treatment of dermatophytic onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Nails, Ingrown; Naphthalenes; Onychomycosis; Retrospective Studies; Terbinafine; Treatment Outcome | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcus neoformans; Drug Resistance, Viral; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Time Factors; Triazoles; Voriconazole | 2007 |
Comparison of the effects of three different anti-fungus drugs on Candida albicans of murine vaginal mucosa.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Itraconazole; Mice; Mice, Inbred ICR; Naphthalenes; Random Allocation; Terbinafine; Treatment Outcome; Vagina | 2007 |
Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
Topics: Antifungal Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Flow Cytometry; Fluconazole; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Itraconazole; Ketoconazole; Neoplasm Proteins; Pyrimidines; Topotecan; Transfection; Triazoles; Voriconazole | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Opportunistic Infections; Triazoles | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Research Design; Triazoles | 2007 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2007 |
Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Immunocompetence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Onychomycosis; Terbinafine | 2007 |
[In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests | 2007 |
[Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients].
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fungemia; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests | 2007 |
In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Topics: Adult; Antifungal Agents; Dose-Response Relationship, Drug; Drug Evaluation; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Trichophyton | 2007 |
Drug-drug interactions with systemic antifungals in clinical practice.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Creatinine; Cyclosporine; Drug Interactions; Female; Fluconazole; France; Furosemide; HIV Infections; Hospitals, University; Humans; Hydrocortisone; Hypokalemia; Intensive Care Units; Itraconazole; Kidney Diseases; Leukemia; Male; Middle Aged; Neoplasms; Retrospective Studies | 2007 |
Induction of the NAD(P)H:quinone oxidoreductase 1 by ketoconazole and itraconazole: a mechanism of cancer chemoprotection.
Topics: Animals; Antifungal Agents; Carcinoma, Hepatocellular; Enzyme Activation; Enzyme Induction; Fluconazole; Itraconazole; Ketoconazole; Liver Neoplasms, Experimental; Mice; NAD; NAD(P)H Dehydrogenase (Quinone); Receptors, Aryl Hydrocarbon; RNA, Messenger; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 2007 |
Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.
Topics: Antifungal Agents; Azoles; Bacteremia; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2007 |
Direct comparison of the pharmacodynamics of four antifungal drugs in a mouse model of disseminated candidiasis using microbiological assays of serum drug concentrations.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Fluconazole; Itraconazole; Kidney; Mice; Microbial Sensitivity Tests | 2007 |
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
Antifungal chemotherapy for fungal keratitis guided by in vivo confocal microscopy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Fungi; Humans; Itraconazole; Male; Microscopy, Confocal; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions | 2008 |
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole | 2008 |
Subcutaneous phaeohyphomycosis caused by Cladosporium sphaerospermum.
Topics: Antifungal Agents; Cladosporium; Dermatomycoses; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Skin; Subcutaneous Tissue | 2008 |
Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Cost-Benefit Analysis; Female; Fluconazole; Germany; Health Care Costs; Hematologic Neoplasms; Humans; Immunocompromised Host; Itraconazole; Length of Stay; Male; Middle Aged; Mycoses; Netherlands; Neutropenia; Probability; Retrospective Studies | 2008 |
[Resistance to azolic compounds in clinical Trichophyton spp. strains].
Topics: Adult; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Epidermophyton; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Mexico; Microsporum; Onychomycosis; Tinea; Tinea Capitis; Tinea Pedis; Trichophyton | 2007 |
The effect of antifungal agents and human monocytes on in vitro galactomannan release by Aspergillus spp. in liquid culture medium.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Cells, Cultured; Coculture Techniques; Culture Media; Fluconazole; Galactose; Humans; Itraconazole; Mannans; Monocytes | 2007 |
[Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Female; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged | 2008 |
Palatal zygomycosis: experience of 21 cases.
Topics: Absidia; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Child; Diabetic Ketoacidosis; Drug Combinations; Female; Fluconazole; Humans; Itraconazole; Male; Mouth Diseases; Mucormycosis; Nose Diseases; Opportunistic Infections; Oral Ulcer; Palate; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Rhizopus; Treatment Outcome; Zygomycosis | 2008 |
Fixed drug eruption caused by itraconazole: Reactivity and cross reactivity.
Topics: Antifungal Agents; Cross Reactions; Drug Eruptions; Female; Fluconazole; Humans; Itraconazole; Middle Aged; Tinea Versicolor | 2008 |
Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne panels for testing in vitro Candida antifungal susceptibility.
Topics: Amphotericin B; Antifungal Agents; Candida; Colony Count, Microbial; False Positive Reactions; Fluconazole; Flucytosine; Itraconazole; Microbial Sensitivity Tests; Reagent Strips; Reproducibility of Results | 2008 |
[Cavitary pneumonia in an AIDS patient with cryptococcosis].
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotic Prophylaxis; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcosis; Diagnosis, Differential; Fluconazole; Humans; Itraconazole; Lung Diseases, Fungal; Male; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
Widespread, chronic, and fluconazole-resistant Trichophyton rubrum infection in an immunocompetent patient.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Middle Aged; Thiophenes; Tinea; Trichophyton | 2008 |
Imidazole antifungals, but not triazole antifungals, increase membrane Zn2+ permeability in rat thymocytes Possible contribution to their cytotoxicity.
Topics: Animals; Antifungal Agents; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Chlorides; Clotrimazole; Dose-Response Relationship, Drug; Fluconazole; Imidazoles; Itraconazole; Male; Rats; Rats, Wistar; Structure-Activity Relationship; T-Lymphocytes; Thymus Gland; Triazoles; Zinc Compounds | 2008 |
Treatment of aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neutropenia; Triazoles | 2008 |
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult | 2008 |
Candida fermentati from HIV patients in Chennai, South India.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Female; Fluconazole; HIV Infections; Humans; India; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques | 2008 |
Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Pyrimidines; Triazoles; Venezuela; Voriconazole; Young Adult | 2009 |
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Utilization; Fluconazole; Hospitals; Humans; Itraconazole; Korea; Microbial Sensitivity Tests | 2009 |
In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Topics: Amphotericin B; Antifungal Agents; Corneal Diseases; Drug Evaluation; Drug Synergism; Eye; Eye Infections, Fungal; Fluconazole; Fusarium; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Natamycin; Terbinafine | 2008 |
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands.
Topics: Adult; Aged; Antifungal Agents; Costs and Cost Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Netherlands; Neutropenia; Randomized Controlled Trials as Topic; Triazoles | 2008 |
Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspartic Acid Endopeptidases; Candida albicans; Candida tropicalis; Candidiasis, Oral; Colony Count, Microbial; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Phospholipases | 2009 |
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2008 |
Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Female; Fluconazole; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Intensive Care Units, Pediatric; Itraconazole; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Turkey | 2008 |
Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Cells, Cultured; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Leukotriene B4; Molecular Structure; Neutrophils; Platelet Activating Factor; Pyrimidines; Triazoles; Voriconazole | 2008 |
Carbon analogs of antifungal dioxane-triazole derivatives: synthesis and in vitro activities.
Topics: Antifungal Agents; Carbon; Chemistry, Pharmaceutical; Dioxanes; Drug Design; Epoxy Compounds; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Models, Chemical; Stereoisomerism; Triazoles | 2008 |
International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.
Topics: Antifungal Agents; Azoles; Biological Assay; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2009 |
Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia.
Topics: Antifungal Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Monte Carlo Method; Multicenter Studies as Topic; Mycoses; Neutropenia; Triazoles | 2008 |
Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques.
Topics: Antifungal Agents; Atmospheric Pressure; Calorimetry, Differential Scanning; Carbon Dioxide; Chemical Phenomena; Cyclodextrins; Econazole; Fluconazole; Itraconazole; Molecular Structure; Powders; Solubility; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; Temperature; X-Ray Diffraction | 2009 |
Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
Topics: Agar; Amphotericin B; Antifungal Agents; Cryptococcus; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing.
Topics: Amphotericin B; Antifungal Agents; Child; Cryptococcus; Drug Resistance, Multiple, Fungal; Drug Synergism; Fluconazole; Flucytosine; Humans; Immunocompetence; Intracranial Hypertension; Itraconazole; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Spinal Puncture; Ventriculoperitoneal Shunt | 2008 |
A closer look at coccidioidomycosis.
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Itraconazole; United States | 2009 |
[Saccharomyces cerevisiae fungemia associated with multifocal pneumonia in a patient with alcohol-related hepatic cirrhosis].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Liver Cirrhosis, Alcoholic; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Saccharomyces cerevisiae; Treatment Outcome; Triazoles; Voriconazole | 2008 |
In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans.
Topics: Antifungal Agents; Azoles; Candida albicans; Fluconazole; Itraconazole; Ketoconazole; Lichens; Microbial Sensitivity Tests; Triterpenes | 2009 |
Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes.
Topics: Adult; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Fungal; Europe; Female; Fluconazole; Genotype; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prevalence | 2009 |
Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Rhodamines | 2009 |
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2009 |
The amino acid residues of transmembrane helix 5 of multidrug resistance protein CaCdr1p of Candida albicans are involved in substrate specificity and drug transport.
Topics: Adenosine Triphosphatases; Amino Acid Sequence; Azides; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Membrane Transport Proteins; Miconazole; Mutagenesis, Site-Directed; Prazosin; Protein Transport; Rhodamines; Saccharomyces cerevisiae; Substrate Specificity | 2009 |
Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Cyclooxygenase Inhibitors; Cysteine; Drug Resistance, Fungal; Fluconazole; Isoindoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Organoselenium Compounds; Proton-Translocating ATPases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2009 |
Mucocutaneous histoplasmosis in HIV with an atypical ecthyma like presentation.
Topics: Adult; Agricultural Workers' Diseases; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Diagnostic Errors; Drug Resistance, Fungal; Ecthyma; Fluconazole; Histoplasmosis; Humans; Itraconazole; Male; Maxillary Sinus; Meningitis, Cryptococcal; Nose; Palate; Skin Ulcer; Tuberculosis, Miliary | 2009 |
In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Candidiasis; Colony Count, Microbial; Ear Diseases; Fluconazole; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.
Topics: Anisomycin; Antifungal Agents; Biological Transport; Candida albicans; Curcumin; Cycloheximide; Drug Synergism; Enzyme Inhibitors; Fluconazole; Itraconazole; Ketoconazole; Methotrexate; Miconazole; Multidrug Resistance-Associated Proteins; Pyrimidines; Rhodamines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2009 |
Fungaemia due to Cryptococcus laurentii as a complication of immunosuppressive therapy--a case report.
Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Fungemia; Glomerulonephritis, Membranoproliferative; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Male; Opportunistic Infections; Renal Insufficiency | 2009 |
Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Guinea Pigs; Humans; Itraconazole; Microbial Sensitivity Tests; Phenotype; Time Factors; Treatment Outcome | 2010 |
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2009 |
Comparison of the oral pharmacokinetics of fluconazole and itraconazole in Mexicans.
Topics: Administration, Oral; Antifungal Agents; Ethnicity; Fluconazole; Humans; Itraconazole; Male; Mexico | 2008 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection.
Topics: Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluconazole; Humans; Itraconazole; Ketoconazole; Pyrimidines; Quality Control; Reproducibility of Results; Spectrophotometry, Ultraviolet; Time Factors; Triazoles; Ultraviolet Rays; Voriconazole | 2009 |
Azole resistant Candida glabrata vulvovaginitis treated with boric acid.
Topics: Adult; Antifungal Agents; Boric Acids; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Insecticides; Itraconazole; Treatment Outcome; Vulvovaginitis | 2009 |
[Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods].
Topics: Antifungal Agents; Dipodascus; Fluconazole; Geotrichosis; Humans; Itraconazole; Microbial Sensitivity Tests; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases.
Topics: Adult; Aged; Antifungal Agents; Aspartic Acid Endopeptidases; Candida albicans; Child, Preschool; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Serum Albumin, Bovine | 2009 |
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.
Topics: Adult; Antifungal Agents; Chemoprevention; Female; Fluconazole; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
Discovery of highly potent novel antifungal azoles by structure-based rational design.
Topics: Antifungal Agents; Azoles; Binding Sites; Computer Simulation; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Hydrogen Bonding; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole | 2009 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2010 |
Rhinoentomophthoromycosis with mutilation.
Topics: Anti-Bacterial Agents; Antifungal Agents; Dermatomycoses; Disease Progression; Entomophthora; Facial Dermatoses; Female; Fluconazole; Humans; Itraconazole; Middle Aged; Potassium Iodide; Suicide; Time Factors; Zygomycosis | 2010 |
Toxoplasma gondii: fluconazole and itraconazole activity against toxoplasmosis in a murine model.
Topics: Animals; Antifungal Agents; Antiprotozoal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluconazole; Inhibitory Concentration 50; Itraconazole; Mice; Time Factors; Toxoplasma; Toxoplasmosis, Animal | 2010 |
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
Topics: Acremonium; Adult; Antifungal Agents; Aspergillus; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Itraconazole; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Polymorphism, Restriction Fragment Length; Terbinafine | 2010 |
Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.
Topics: Antifungal Agents; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Endpoint Determination; Fluconazole; Itraconazole; Lipopeptides; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistance.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Evolution, Molecular; Female; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Longitudinal Studies; Male; Middle Aged; Mycological Typing Techniques | 2010 |
Multicenter comparison of the ISO standard 20776-1 and the serial 2-fold dilution procedures to dilute hydrophilic and hydrophobic antifungal agents for susceptibility testing.
Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results | 2010 |
Current concepts in systemic and topical therapy for superficial mycoses.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Azoles; Dermatomycoses; Drug Administration Schedule; Drug Resistance, Fungal; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Morpholines; Tolnaftate; United States | 2010 |
Candida species isolated from the gastrointestinal tract of cockatiels (Nymphicus hollandicus): In vitro antifungal susceptibility profile and phospholipase activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Bird Diseases; Brazil; Candida; Candidiasis; Cockatoos; Feces; Fluconazole; Gastrointestinal Diseases; Itraconazole; Microbial Sensitivity Tests; Phospholipases; Statistics, Nonparametric; Zoonoses | 2010 |
Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis, Vulvovaginal; China; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Analysis, DNA | 2010 |
Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.
Topics: Antifungal Agents; Area Under Curve; Cytochrome P-450 CYP3A; Drug Interactions; Fluconazole; Humans; Itraconazole; Microsomes, Liver; Pyrimidines; Triazoles; Voriconazole | 2010 |
Chronic disseminated histoplasmosis with prolonged latency.
Topics: Adrenal Glands; Aged, 80 and over; Chronic Disease; Fatal Outcome; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; Male; Reaction Time | 2010 |
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).
Topics: Antifungal Agents; Azoles; Candida albicans; Econazole; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Protein Binding; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2010 |
Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B.
Topics: Amino Acid Sequence; Aspergillus fumigatus; Azoles; Clotrimazole; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Isoenzymes; Itraconazole; Lanosterol; Molecular Sequence Data; Protein Binding; Pyrimidines; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Substrate Specificity; Triazoles; Voriconazole | 2010 |
Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2010 |
Drug susceptibility of 64 strains of Rhodotorula sp.
Topics: Amphotericin B; Antifungal Agents; Feces; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Rhodotorula; Skin; Species Specificity; Vagina | 2010 |
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B.
Topics: Anti-Bacterial Agents; Aspergillus fumigatus; Azoles; Clotrimazole; Cytochrome P-450 Enzyme System; Doxycycline; Ergosterol; Fluconazole; Fungal Proteins; Genetic Complementation Test; Itraconazole; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole | 2010 |
AIDS‐associated Cryptococcus neoformans and Penicillium marneffei coinfection: a therapeutic dilemma in resource‐limited settings.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Cryptococcus neoformans; Developing Countries; Diagnosis, Differential; Fluconazole; Humans; Itraconazole; Male; Mycoses; Penicillium; Prospective Studies; Retrospective Studies; Vietnam | 2010 |
Ketoconazole and miconazole alter potassium homeostasis in Saccharomyces cerevisiae.
Topics: Antifungal Agents; Cations; Fluconazole; Glucose; Glucosephosphate Dehydrogenase; Homeostasis; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Miconazole; Nucleotides; Oxygen Consumption; Potassium; Protons; Saccharomyces cerevisiae | 2011 |
Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.
Topics: Antifungal Agents; Antineoplastic Agents; Canada; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Economic; Mycoses; Myelodysplastic Syndromes; Neoplasms; Randomized Controlled Trials as Topic; Triazoles | 2011 |
Activity of antimicrobial peptide mimetics in the oral cavity: I. Activity against biofilms of Candida albicans.
Topics: Acrylic Resins; Alkynes; Amides; Antifungal Agents; Antimicrobial Cationic Peptides; Bacterial Adhesion; Biofilms; Biomimetic Materials; Candida albicans; Chlorhexidine; Culture Media; Dental Materials; Denture Bases; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Microbial Viability; Molecular Weight; Mouth; Phenethylamines; Phenols; Pyrimidines; Saliva | 2010 |
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Drug Administration Routes; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Retroperitoneal pyogranulomatous and fibrosing inflammation secondary to fungal infections in two dogs.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Blastomyces; Blastomycosis; Dog Diseases; Dogs; Doxycycline; Female; Fluconazole; Granuloma; Histoplasma; Histoplasmosis; Itraconazole | 2011 |
Two squalene synthase inhibitors, E5700 and ER-119884, interfere with cellular proliferation and induce ultrastructural and lipid profile alterations in a Candida tropicalis strain resistant to fluconazole, itraconazole, and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Candida tropicalis; Cell Proliferation; Drug Resistance, Multiple, Fungal; Farnesyl-Diphosphate Farnesyltransferase; Fatty Acids; Fluconazole; Gas Chromatography-Mass Spectrometry; Histocytochemistry; Inhibitory Concentration 50; Itraconazole; Lipid Metabolism; Microscopy, Electron, Transmission; Pyridines; Quinuclidines | 2011 |
Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Cryptococcus neoformans; Drug Synergism; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Phenols; Saccharomyces cerevisiae | 2011 |
Microbiological screening of Irish patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy reveals persistence of Candida albicans strains, gradual reduction in susceptibility to azoles, and incidences of clinical signs of oral candid
Topics: Adolescent; Adult; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Humans; Incidence; Ireland; Itraconazole; Male; Mass Screening; Mouth Mucosa; Multilocus Sequence Typing; Mycological Typing Techniques; Polyendocrinopathies, Autoimmune | 2011 |
Uncommon Neosartorya udagawae fungus as a causative agent of severe corneal infection.
Topics: Adult; Antifungal Agents; Corneal Diseases; Debridement; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Microscopy; Mycoses; Neosartorya; Phylogeny; Sequence Analysis, DNA; Wounds and Injuries | 2011 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole | 2011 |
In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.
Topics: Animals; Antifungal Agents; Azoles; Brazil; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cervix Uteri; Epithelial Cells; Female; Fluconazole; Fruit; HeLa Cells; Humans; Itraconazole; Microbial Sensitivity Tests; Plant Extracts; Rats; Rats, Wistar; Sapindus; Saponins; Triterpenes | 2011 |
In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
FPIN’s clinical inquiries: treatment of recurrent vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Evidence-Based Medicine; Female; Fluconazole; Humans; Itraconazole; Recurrence | 2011 |
Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
Topics: Antitubercular Agents; Drug Combinations; Drug Interactions; Ethambutol; Fluconazole; Histoplasma; Isoniazid; Itraconazole; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
Cryptococcal meningitis in immunocompetent children.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antigens, Fungal; Child; Child, Preschool; Cryptococcus neoformans; Drug Administration Schedule; Female; Fluconazole; Flucytosine; Humans; Immunocompetence; Itraconazole; Male; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome | 2012 |
Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Invasive; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Iron; Itraconazole; Lactoferrin; Microbial Sensitivity Tests | 2011 |
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts | 2011 |
Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Middle Aged; Mouth; Prevalence; Retrospective Studies; Risk Factors; Sjogren's Syndrome; Treatment Outcome | 2011 |
Long-term surveillance and treatment of subclinical cryptococcosis and nasal colonization by Cryptococcus neoformans and C. gattii species complex in captive koalas (Phascolarctes cinereus).
Topics: Amphotericin B; Animals; Animals, Zoo; Antifungal Agents; Carrier State; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Female; Fluconazole; Fungemia; Itraconazole; Male; Nasal Cavity; Phascolarctidae; Treatment Outcome | 2012 |
Itraconazole vs fluconazole as a primary prophylaxis for fungal infections in HIV-infected patients in Thailand.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; CD4 Lymphocyte Count; Cohort Studies; Disease-Free Survival; Female; Fluconazole; Humans; Incidence; Itraconazole; Male; Mycoses; Retrospective Studies; Thailand | 2011 |
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
[In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Topics: Adult; Amphotericin B; Antifungal Agents; Biofilms; Candida; Drug Resistance, Fungal; Ecosystem; Female; Fluconazole; Humans; Intrauterine Devices, Copper; Itraconazole; Microbial Sensitivity Tests; Vagina | 2011 |
Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genotype; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation, Missense; Phenylalanine; Pyrimidines; Sterol 14-Demethylase; Survival Rate; Triazoles; Tyrosine; Voriconazole | 2012 |
A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.
Topics: Animals; Candida albicans; Candidiasis, Oral; Disease Models, Animal; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Fungal Proteins; Itraconazole; Membrane Transport Proteins; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oligopeptides; Tongue | 2012 |
Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Boric Acids; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cell Adhesion; Epithelial Cells; Female; Fluconazole; Fungal Proteins; Hemolysis; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Phospholipases; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Saccharomyces cerevisiae; Vagina; Virulence Factors; Young Adult | 2012 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2013 |
Inadequate references in recent article.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Mycoses | 2012 |
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Caspofungin; CD4 Lymphocyte Count; Echinocandins; Female; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; L-Lactate Dehydrogenase; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Farnesol; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests | 2013 |
Candida colonization in urine samples of ICU patients: determination of etiology, antifungal susceptibility testing and evaluation of associated risk factors.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Humans; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Trichosporon; Trichosporonosis; Urine; Young Adult | 2012 |
Feline histoplasmosis: fluconazole therapy and identification of potential sources of Histoplasma species exposure.
Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Disease Reservoirs; Female; Fluconazole; Follow-Up Studies; Histoplasma; Itraconazole; Male; Risk Factors; Secondary Prevention; Species Specificity; Toxoplasmosis, Animal | 2012 |
CDR4 is the major contributor to azole resistance among four Pdr5p-like ABC transporters in Neurospora crassa.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Knockout Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Neurospora crassa; Phylogeny; Sequence Homology, Amino Acid | 2012 |
Treatment outcomes for tinea capitis in a skin of color population.
Topics: Adolescent; Age Factors; Antifungal Agents; Black or African American; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Fluconazole; Follow-Up Studies; Griseofulvin; Hispanic or Latino; Humans; Infant; Itraconazole; Male; Naphthalenes; New York City; Retrospective Studies; Terbinafine; Tinea Capitis; Treatment Outcome; Urban Population; White People | 2012 |
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole | 2012 |
Terbinafine inhibits Cryptococcus neoformans growth and modulates fungal morphology.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2012 |
A novel case of canine disseminated aspergillosis following mating.
Topics: Animals; Antifungal Agents; Aspergillosis; Copulation; Dog Diseases; Dogs; Fatal Outcome; Female; Fluconazole; Itraconazole; Male; Pyometra | 2012 |
Retigeric acid B enhances the efficacy of azoles combating the virulence and biofilm formation of Candida albicans.
Topics: Animals; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biofilms; Caco-2 Cells; Candida albicans; Candidiasis; Drug Synergism; Fluconazole; Fungal Proteins; Humans; Itraconazole; Ketoconazole; Male; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Triterpenes; Virulence | 2012 |
[Fungi isolated from the vagina and their susceptibility to antifungals].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests; Middle Aged; Poland; Retrospective Studies; Vagina; Young Adult | 2012 |
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Candidemia; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Metallic silver nanoparticle: a therapeutic agent in combination with antifungal drug against human fungal pathogen.
Topics: Antifungal Agents; Bioengineering; Biomimetic Materials; Biomimetics; Fluconazole; Fungi; Humans; Itraconazole; Metal Nanoparticles; Microscopy, Electron, Transmission; Nanotechnology; Rhizophoraceae; Silver; Silver Nitrate; Spectrometry, X-Ray Emission; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2013 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Drug Resistance, Fungal; Europe; Fluconazole; Humans; India; Itraconazole; Microbial Sensitivity Tests; North America; Pyrimidines; South Africa; South America; Triazoles; Voriconazole | 2012 |
Pseudomembranous candidiasis in HIV/AIDS patients in Cali, Colombia.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antifungal Agents; Candida; Candidiasis, Oral; CD4 Lymphocyte Count; Colombia; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Young Adult | 2013 |
[Isolation rate and susceptibilities of candida species from blood, vascular catheter, urine and stool].
Topics: Antifungal Agents; Candida; Candidiasis; Diagnosis, Differential; Echinocandins; Feces; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Vascular Access Devices | 2012 |
Adapting a global cost-effectiveness model to local country requirements: posaconazole case study.
Topics: Antifungal Agents; Cost-Benefit Analysis; Developed Countries; Drug Therapy, Combination; Fluconazole; Fungi; Humans; Itraconazole; Models, Economic; Mycoses; Triazoles | 2013 |
Preshipment testing success: resolution of a nasal sinus granuloma in a captive koala (Phascolarctos cinereus) caused by Cryptococcus gattii.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Female; Fluconazole; Granuloma; Itraconazole; Phascolarctidae; Sinusitis | 2012 |
Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.
Topics: Antifungal Agents; Candida albicans; Clotrimazole; Escherichia coli; Fluconazole; Fungal Proteins; Humans; Itraconazole; Ketoconazole; Kinetics; Lanosterol; NADP; Protein Binding; Pyrimidines; Recombinant Proteins; Species Specificity; Sterol 14-Demethylase; Triazoles; Voriconazole | 2013 |
A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans.
Topics: Ambroxol; Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Bronchodilator Agents; Budesonide; Candida albicans; Candidiasis; Ethanolamines; Expectorants; Fluconazole; Formoterol Fumarate; Glucocorticoids; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung Diseases, Fungal; Male; Methylprednisolone; Middle Aged; Ofloxacin | 2012 |
Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bacterial Infections; Cytomegalovirus Infections; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Japan; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Survival Analysis; Transplantation, Homologous | 2013 |
Differential pulse polarographic investigation of the antifungal drugs itraconazole, ketoconazole, fluconazole and voriconazole using a dropping mercury electrode.
Topics: Antifungal Agents; Electrochemistry; Electrodes; Fluconazole; Hydrogen-Ion Concentration; Indicators and Reagents; Itraconazole; Ketoconazole; Mercury; Polarography; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole | 2012 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Pityriasis versicolor: a case of resistance to treatment.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Middle Aged; Naphthalenes; Recurrence; Terbinafine; Tinea Versicolor; Treatment Failure | 2014 |
Posaconazole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: a cost-effectiveness analysis in Greece.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Greece; Health Expenditures; Humans; Immunocompromised Host; Itraconazole; Models, Economic; Mycoses; Neutropenia; Triazoles | 2013 |
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cross Infection; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Itraconazole; Kidney Transplantation; Lymphoma; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Postoperative Complications; Serbia | 2012 |
Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Microbial Sensitivity Tests; Nitriles; Phenotype; Phylogeny; Polymerase Chain Reaction; Pyridines; Pyrimidines; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles; Voriconazole; Young Adult | 2013 |
Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation.
Topics: Antifungal Agents; Cancer Care Facilities; Confidence Intervals; Cost-Benefit Analysis; Fluconazole; Health Resources; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Observational Studies as Topic; Spain; Triazoles | 2013 |
Edematous erythema, subcutaneous plaques, and severe pain in the lower extremities in an immunocompromised patient.
Topics: Antifungal Agents; Biopsy; Cryptococcosis; Cryptococcus neoformans; Edema; Erythema; Female; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Kidney Transplantation; Leg; Middle Aged; Opportunistic Infections; Pain | 2013 |
Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure.
Topics: Antifungal Agents; Culture Media; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Serial Passage; Tinea; Trichophyton | 2013 |
A quantitative analysis of the spontaneous reporting of congestive heart failure-related adverse events with systemic anti-fungal drugs.
Topics: Adverse Drug Reaction Reporting Systems; Amphotericin B; Antifungal Agents; Databases, Factual; Drug Interactions; Drug Overdose; Fluconazole; Heart Failure; Humans; Itraconazole; Propranolol | 2013 |
Azole susceptibility and resistance in Candida isolates from oral candidiasis and oral colonization in HIV positive patients.
Topics: Candida; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Itraconazole; Mouth | 2011 |
Efficacy of itraconazole versus fluconazole in vaginal candidiasis.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chi-Square Distribution; Female; Fluconazole; Humans; Itraconazole; Middle Aged; Treatment Outcome | 2012 |
Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2013 |
Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Conjunctiva; Eurotium; Female; Fluconazole; Fungi; Horses; Itraconazole; Male; Miconazole; Microbial Sensitivity Tests; Switzerland; Voriconazole | 2014 |
Mutation of the CgPDR16 gene attenuates azole tolerance and biofilm production in pathogenic Candida glabrata.
Topics: Antifungal Agents; Azoles; Biofilms; Candida glabrata; Cloning, Molecular; DNA, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Gene Expression Regulation, Fungal; Hydrophobic and Hydrophilic Interactions; Itraconazole; Microbial Sensitivity Tests; Mutation; Oxidative Stress; Phospholipid Transfer Proteins; Polyenes; Reactive Oxygen Species; Rhodamines; Sequence Analysis, DNA; Triazines; Virulence Factors | 2013 |
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult | 2014 |
Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidemia; Drug Resistance, Fungal; Fluconazole; Humans; India; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2013 |
Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated from subjects with Candida-associated denture stomatitis with or without diabetes.
Topics: Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis, Oral; Caspofungin; Diabetes Mellitus; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Stomatitis, Denture | 2013 |
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Transcription factor CCG-8 as a new regulator in the adaptation to antifungal azole stress.
Topics: Antifungal Agents; Down-Regulation; Drug Resistance, Fungal; Fluconazole; Fusarium; Gene Expression Regulation, Fungal; Genes, Fungal; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Neurospora crassa; Transcription Factors | 2014 |
Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Candida; Candida albicans; Candidemia; Cardiovascular Diseases; Drug Resistance, Fungal; Female; Fluconazole; Hospitals, University; Hospitals, Urban; Humans; Itraconazole; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors | 2014 |
Is empiric therapy with fluconazole appropriate for esophageal candidiasis?
Topics: Adult; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Esophageal Diseases; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged | 2014 |
Recurrent dermatophytosis (Majocchi granuloma) associated with chemotherapy-induced neutropenia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Fluconazole; Granuloma; Humans; Immunocompromised Host; Itraconazole; Lung Neoplasms; Middle Aged; Neutropenia; Small Cell Lung Carcinoma; Tinea | 2014 |
Itraconazole inhibits TNF-α-induced CXCL10 expression in oral fibroblasts.
Topics: Antifungal Agents; Blotting, Western; Cell Line; Chemokine CXCL10; Fibroblasts; Fluconazole; Humans; Itraconazole; Keratinocytes; Mouth; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2015 |
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Load; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Coinfection; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Miconazole; Microbial Sensitivity Tests; Middle Aged; Xerostomia | 2014 |
[Clinical analysis of invasive laryngeal mycosis].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Chemical and Drug Induced Liver Injury; Fluconazole; Humans; Itraconazole; Laryngeal Diseases; Mycoses | 2013 |
Antifungal susceptibility of Candida isolates at one institution.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole | 2014 |
Cryptococcus gattii osteomyelitis and compounded itraconazole treatment failure in a Pesquet's parrot (Psittrichas fulgidus).
Topics: Animals; Antifungal Agents; Bird Diseases; Cryptococcosis; Cryptococcus gattii; Drug Compounding; Female; Fluconazole; Flucytosine; Itraconazole; Osteomyelitis; Psittaciformes; Treatment Failure | 2014 |
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in Sweden.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Life Expectancy; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Quality of Life; Quality-Adjusted Life Years; Sweden; Triazoles | 2014 |
Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Candida; Candida albicans; Candidiasis, Oral; Case-Control Studies; CD4 Lymphocyte Count; Colony Count, Microbial; Drug Resistance, Fungal; Female; Fluconazole; Follow-Up Studies; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Prospective Studies; Saliva | 2014 |
Evaluation of possibilities in identification and susceptibility testing for Candida glabrata clinical isolates with the Integral System Yeast Plus (ISYP).
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymerase Chain Reaction; Sensitivity and Specificity | 2014 |
In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei.
Topics: Antifungal Agents; Calcineurin Inhibitors; Cyclosporine; Drug Synergism; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Penicillium; Tacrolimus; Yeasts | 2014 |
Caenorhabditis elegans: a simple nematode infection model for Penicillium marneffei.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Disease Models, Animal; Fluconazole; Host-Pathogen Interactions; Hyphae; Itraconazole; Mycoses; Naphthalenes; Penicillium; Pigments, Biological; Survival Analysis; Terbinafine; Voriconazole | 2014 |
Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Nystatin; Retrospective Studies | 2015 |
Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.
Topics: 14-alpha Demethylase Inhibitors; Amino Acid Substitution; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Catalytic Domain; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Sterol 14-Demethylase; Voriconazole | 2015 |
Genotypic, phenotypic, and proteomic characterization of Candida glabrata during sequential fluconazole exposure.
Topics: Antifungal Agents; Candida glabrata; Chromosomes, Fungal; Copper Sulfate; Culture Media; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Genotype; Hemolysin Proteins; Humans; Itraconazole; Ketoconazole; Metallothionein; Phenotype; Proteome; Virulence; Voriconazole | 2011 |
Comparison of the effects of azole antifungal agents on the anticoagulant activity of warfarin.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antifungal Agents; Drug Interactions; Drug Resistance; Female; Fluconazole; Humans; International Normalized Ratio; Itraconazole; Male; Metabolism, Inborn Errors; Middle Aged; Retrospective Studies; Voriconazole; Warfarin | 2014 |
An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States.
Topics: Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid; Mycoses; Triazoles; United States | 2015 |
Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Child; Child, Preschool; China; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Infant; Itraconazole; Middle Aged; Voriconazole; Young Adult | 2015 |
Determination of MICING: a new assay for assessing minimal inhibitory concentration for invasive growth.
Topics: Agar; Amphotericin B; Antifungal Agents; Candida; Culture Media; Fluconazole; Itraconazole; Microbiological Techniques; Saccharomyces cerevisiae; Temperature; Virulence; Yeasts | 2015 |
Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Fluconazole; Humans; Incidence; Infant; Itraconazole; Male; Mycoses; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Triazoles | 2015 |
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole | 2015 |
Exogenous tyrosol inhibits planktonic cells and biofilms of Candida species and enhances their susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Drug Synergism; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Phenylethyl Alcohol | 2015 |
[Genotypes and in vitro antifungal susceptibility of Cryptococcus isolates in Sichuan Province].
Topics: Amphotericin B; Antifungal Agents; China; Cryptococcus; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Polymorphism, Restriction Fragment Length; Voriconazole | 2015 |
Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; DNA, Ribosomal Spacer; Drug Resistance, Fungal; Female; Fluconazole; Hemolysin Proteins; Humans; Itraconazole; Microbiological Techniques; Peptide Hydrolases; Phospholipases; Sequence Analysis, DNA; Treatment Outcome; Virulence Factors | 2015 |
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Carcinoma; Caspofungin; Chemoradiotherapy; Chemotherapy, Adjuvant; Drug Resistance, Fungal; Echinocandins; Exophiala; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lipopeptides; Male; Middle Aged; Mouth Diseases; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Opportunistic Infections; Phaeohyphomycosis; Radiotherapy, Intensity-Modulated; Voriconazole | 2015 |
Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).
Topics: 14-alpha Demethylase Inhibitors; Acanthamoeba castellanii; Amebiasis; Amebicides; Antifungal Agents; Azoles; Cell Proliferation; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole | 2015 |
Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.
Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Female; Fluconazole; Humans; Itraconazole; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Time Factors; Vincristine; Voriconazole | 2015 |
In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Arthrodermataceae; Colony Count, Microbial; Dermatomycoses; Drug Synergism; Fluconazole; Humans; Hyphae; Itraconazole; Microbial Sensitivity Tests; Microbial Viability; Naphthalenes; Terbinafine | 2014 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
Transcription factor ADS-4 regulates adaptive responses and resistance to antifungal azole stress.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Neurospora crassa | 2015 |
Sequence-Based Identification of a Zoophilic Strain of Trichophyton interdigitale in a Rare Case of Tinea Blepharo-Ciliaris Associated with Tinea Barbae.
Topics: Administration, Oral; Antifungal Agents; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Facial Dermatoses; Fluconazole; Humans; Itraconazole; Male; Microbiological Techniques; Microscopy; Molecular Sequence Data; Ophthalmic Solutions; Phylogeny; Romania; Sequence Analysis, DNA; Tinea; Treatment Outcome; Trichophyton; Young Adult | 2015 |
Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Cost Savings; Cost-Benefit Analysis; Drug Costs; Female; Fluconazole; Hospital Costs; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Primary Prevention; Propensity Score; Remission Induction; Republic of Korea; Retrospective Studies; Triazoles | 2015 |
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Evidence of Fluconazole-Resistant Candida Species in Tortoises and Sea Turtles.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Cloaca; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Mouth; Turtles | 2015 |
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hong Kong; Hospitals, Teaching; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Socioeconomic Factors; Triazoles | 2016 |
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
Topics: Agar; Animals; Antifungal Agents; Culture Media; Disease Models, Animal; Drosophila melanogaster; Female; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Survival Analysis; Triazoles; Virulence; Voriconazole | 2015 |
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Topics: Alleles; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candida glabrata; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Nitriles; Protein Isoforms; Pyridines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole | 2016 |
A combination approach to treating fungal infections.
Topics: Antifungal Agents; Candida albicans; Cell Line, Tumor; Cell Survival; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Epithelial Cells; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Tobramycin; Triazoles; Voriconazole | 2015 |
Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Caenorhabditis elegans; Cell Membrane; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Ergosterol; Fluconazole; HSP90 Heat-Shock Proteins; Humans; Itraconazole; Melanins; Microbial Sensitivity Tests; Plankton; Voriconazole | 2016 |
The isolation of Candida rugosa and Candida mesorugosa from clinical samples in Ghana.
Topics: Antifungal Agents; Candida; Candidiasis; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Ghana; Humans; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Phylogeny; Sequence Analysis, DNA; Temperature; Voriconazole | 2016 |
Activation of Melanin Synthesis in Alternaria infectoria by Antifungal Drugs.
Topics: Alternaria; Aminoglycosides; Amphotericin B; Antifungal Agents; Caspofungin; Cell Wall; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Melanins; Microbial Sensitivity Tests; Naphthols; Pyrroles; Quinolines | 2015 |
Antifungal Activity of Propolis Against Yeasts Isolated From Blood Culture: In Vitro Evaluation.
Topics: Antifungal Agents; Blood Culture; Candida; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Propolis | 2016 |
Cross-resistance to fluconazole induced by exposure to the agricultural azole tetraconazole: an environmental resistance school?
Topics: Animals; Anti-Allergic Agents; Antifungal Agents; ATP-Binding Cassette Transporters; Candida; Chlorobenzenes; Drug Resistance, Microbial; Ergosterol; Fluconazole; Fungicides, Industrial; Gene Expression Regulation, Fungal; Humans; Itraconazole; Malathion; Microbial Sensitivity Tests; Promethazine; Rhodamines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2016 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole | 2016 |
Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
Topics: Amphotericin B; Animals; Antifungal Agents; Birds; Brazil; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disease Reservoirs; Environmental Microbiology; Feces; Fluconazole; Humans; Itraconazole; Ketoconazole; Molecular Typing; Mycological Typing Techniques; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Trees | 2016 |
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Triazoles; Turkey; Voriconazole | 2016 |
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States | 2016 |
[25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans].
Topics: Antifungal Agents; Candida albicans; Candidiasis; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Introns; Itraconazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Vagina | 2016 |
Evaluation of antifungal combination against Cryptococcus spp.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Typing; Naphthalenes; Polymorphism, Restriction Fragment Length; Terbinafine; Voriconazole | 2016 |
Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Phenotype; Sequence Analysis, DNA; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2016 |
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme.
Topics: Antifungal Agents; Clotrimazole; Cryptococcus; Enzyme Activation; Ergosterol; Fluconazole; Humans; Itraconazole; Ketoconazole; Lanosterol; Pyridines; Sterol 14-Demethylase; Tetrazoles; Voriconazole | 2016 |
Epidemiology, species distribution, antifungal susceptibility, and ERG11 mutations of Candida species isolated from pregnant Chinese Han women.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fluconazole; Genes, Fungal; Humans; Itraconazole; Mutation, Missense; Open Reading Frames; Pregnancy; Pregnancy Complications, Infectious; Vaginitis | 2016 |
Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; China; Clotrimazole; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests | 2016 |
Management of chronic vulvovaginal candidiasis: a long term retrospective study.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Female; Fluconazole; Humans; Itraconazole; Maintenance Chemotherapy; Middle Aged; Remission Induction; Retrospective Studies; Time Factors; Young Adult | 2017 |
Probiotic yeast Saccharomyces boulardii (nom. nud.) modulates adhesive properties of Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Cell Adhesion; Fluconazole; Gentian Violet; Humans; Hydrogen-Ion Concentration; Itraconazole; Lacticaseibacillus casei; Lacticaseibacillus rhamnosus; Microbial Interactions; Saccharomyces boulardii; Staining and Labeling; Temperature | 2016 |
In vitro evaluation of antifungal susceptibility and keratinase, elastase, lipase and DNase activities of different dermatophyte species isolated from clinical specimens in Iran.
Topics: Antifungal Agents; Arthrodermataceae; Deoxyribonucleases; Dermatomycoses; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Iran; Itraconazole; Lipase; Microbial Sensitivity Tests; Microsporum; Pancreatic Elastase; Peptide Hydrolases; Trichophyton | 2016 |
Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa.
Topics: Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Cytochrome P450 Family 51; Drug Evaluation, Preclinical; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Kinetics; Lipids; Malassezia; Spectrophotometry; Sterol 14-Demethylase; Sterols; Voriconazole | 2016 |
Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; HEK293 Cells; Hemolysis; Heterocyclic Compounds, 2-Ring; Humans; Itraconazole; Mice; Microbial Sensitivity Tests; Reactive Oxygen Species; Structure-Activity Relationship; Thiazoles; Triazoles; Voriconazole | 2016 |
Cross-reactivity between voriconazole, fluconazole and itraconazole.
Topics: Adult; Antifungal Agents; Cross Reactions; Drug Hypersensitivity; Fluconazole; Humans; Itraconazole; Male; Voriconazole | 2016 |
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
Topics: Adult; Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Itraconazole; Spain; Triazoles; Voriconazole | 2017 |
Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents?
Topics: Antifungal Agents; Candida; Candida albicans; Clotrimazole; Female; Fluconazole; Humans; Itraconazole; Oils, Volatile | 2016 |
Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies.
Topics: Agar; Amphotericin B; Antifungal Agents; Culture Media; Fluconazole; Itraconazole; Malassezia; Miconazole; Microbial Sensitivity Tests; Voriconazole | 2017 |
A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Microbiological Techniques; Molecular Diagnostic Techniques; Naphthalenes; Penile Diseases; Recurrence; Terbinafine; Treatment Outcome | 2017 |
Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adolescent; Adult; Aged; Allografts; Antifungal Agents; Blood Donors; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Premedication; Salvage Therapy; Survival Analysis; Triazoles; Young Adult | 2016 |
Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey.
Topics: Adult; Age Factors; Aged; Antifungal Agents; Arthrodermataceae; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fluconazole; Glycated Hemoglobin; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Prevalence; Sex Factors; Terbinafine; Tinea Pedis; Toes; Trichophyton; Turkey | 2017 |
Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
Topics: Amino Acid Substitution; Antifungal Agents; ATP-Binding Cassette Transporters; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Gene Expression Profiling; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Mutation, Missense; Real-Time Polymerase Chain Reaction; Sequence Analysis, DNA; Voriconazole | 2017 |
A rapid UPLC-MS/MS assay for the simultaneous measurement of fluconazole, voriconazole, posaconazole, itraconazole, and hydroxyitraconazole concentrations in serum.
Topics: Antifungal Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Fluconazole; Humans; Itraconazole; Limit of Detection; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors; Triazoles; Voriconazole | 2017 |
The First Isolation of Aspergillus allahabadii from a Cormorant with Pulmonary Aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Bird Diseases; Birds; Child; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Pulmonary Aspergillosis; Voriconazole | 2016 |
Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; RNA, Messenger; Sequence Analysis, DNA; Voriconazole | 2017 |
A newly identified amino acid substitution T123I in the 14α-demethylase (Erg11p) of Candida albicans confers azole resistance.
Topics: Amino Acid Substitution; Antifungal Agents; Binding Sites; Candida albicans; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Isoleucine; Itraconazole; Microbial Sensitivity Tests; Models, Molecular; Open Reading Frames; Phosphorylation; Protein Binding; Protein Conformation, alpha-Helical; Protein Interaction Domains and Motifs; Saccharomyces cerevisiae; Threonine; Voriconazole | 2017 |
Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Biofilms; Candida; Caspofungin; Conjunctiva; Echinocandins; Eye Infections, Fungal; Fluconazole; Horse Diseases; Horses; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests | 2017 |
The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51.
Topics: Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyridines; Sterol 14-Demethylase; Substrate Specificity; Tetrazoles; Trichophyton; Voriconazole | 2017 |
[A case of coccidioidomycosis in Turkey imported from the United States of America].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antifungal Agents; Arizona; Coccidioides; Coccidioidomycosis; Fluconazole; Humans; Itraconazole; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pleura; Recurrence; Spores, Fungal; Travel; Turkey | 2017 |
Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Fusariosis; Fusarium; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Naphthalenes; Onychomycosis; Terbinafine; Voriconazole | 2017 |
Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum.
Topics: Acetonitriles; Adult; Antifungal Agents; Calibration; Chromatography, Liquid; Drug Monitoring; Female; Fluconazole; Humans; Indicators and Reagents; Isotope Labeling; Itraconazole; Nitriles; Plasma; Pyridines; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2017 |
In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Topics: Adult; Amphotericin B; Antifungal Agents; Burkina Faso; Candida albicans; Candidiasis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged | 2017 |
Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain.
Topics: Adult; Aged; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Humans; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Myelodysplastic Syndromes; Solutions; Spain; Tablets; Triazoles | 2017 |
Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Resistance, Fungal; Echinocandins; Fluconazole; Hydrolysis; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Virulence | 2017 |
The identification of Meyerozyma guilliermondii from blood cultures and surveillance samples in a university hospital in Northeast Turkey: A ten-year survey.
Topics: Antifungal Agents; Blood Culture; Candida; Candidiasis; Drug Resistance, Fungal; Epidemiological Monitoring; Fluconazole; Hospitalization; Hospitals, University; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pichia; Surveys and Questionnaires; Time Factors; Turkey; Voriconazole | 2017 |
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software.
Topics: Ciprofloxacin; Clarithromycin; Computer Simulation; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Fluconazole; Humans; Itraconazole; Ketoconazole; Models, Biological; Paroxetine; Quinidine; Rifampin; Software | 2018 |
Identification of novel natural inhibitors of Opisthorchis felineus cytochrome P450 using structure-based screening and molecular dynamic simulation.
Topics: Animals; Anthelmintics; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Evaluation, Preclinical; Fluconazole; Humans; Itraconazole; Molecular Docking Simulation; Molecular Dynamics Simulation; Opisthorchiasis; Opisthorchis; Structure-Activity Relationship | 2018 |
Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.
Topics: Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Denmark; Drug Resistance, Multiple, Fungal; Echinocandins; Epidemiological Monitoring; Female; Fluconazole; Fungemia; Humans; Incidence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Sex Factors | 2018 |
Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Cryptococcus gattii; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Triazoles | 2018 |
Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor.
Topics: Antifungal Agents; Arthrodermataceae; Crop Protection; Drug Discovery; Fluconazole; Fungicides, Industrial; Humans; Itraconazole; Malassezia; Microbial Sensitivity Tests; Tinea Pedis; Tinea Versicolor; Trichophyton | 2018 |
Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study.
Topics: Antifungal Agents; Aspergillus; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Fungi; Fusarium; Humans; India; Itraconazole; Microbial Sensitivity Tests; Natamycin; Voriconazole | 2018 |
Activity of Diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside, its Hydrochloride, and N,N-dialkyl Derivatives Against Non-albicans Candida Isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Clotrimazole; Diosgenin; Erythrocytes; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Saponins | 2018 |
The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Infant, Newborn; Infant, Premature; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Voriconazole | 2018 |
Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance.
Topics: Allylamine; Antifungal Agents; Arthrodermataceae; Ciclopirox; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Morpholines; Squalene Monooxygenase; Terbinafine; Trichophyton; Voriconazole | 2018 |
A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
Topics: Amphotericin B; Antifungal Agents; Brazil; Caspofungin; Echinocandins; Fluconazole; Histoplasma; Histoplasmosis; HIV; HIV Infections; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole | 2018 |
Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
Topics: Acetaminophen; Analgesics; Antifungal Agents; Aspirin; Candida; Candida albicans; Candida glabrata; Candidiasis; Dipyrone; Drug Resistance, Fungal; Fluconazole; Humans; Ibuprofen; Itraconazole; Meloxicam; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Genetic diversity and antifungal susceptibility of Candida albicans isolated from Iranian patients.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Cluster Analysis; Drug Resistance, Fungal; Fluconazole; Genetic Variation; Genotype; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Microbial Viability; Microsatellite Repeats | 2019 |
Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) on Candida Species Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Chronic Disease; Dose-Response Relationship, Drug; Female; Fluconazole; Humans; Itraconazole; Middle Aged; Phenylethyl Alcohol; Vulvovaginitis | 2018 |
Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; China; Cost-Benefit Analysis; Female; Fluconazole; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2018 |
Antifungal activity of essential oils against azole-resistant and azole-susceptible vaginal Candida glabrata strains.
Topics: Antifungal Agents; Azoles; Candida glabrata; Cells, Cultured; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Oils, Volatile; Vagina | 2018 |
Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
Topics: Animals; Antifungal Agents; Bacterial Adhesion; Biofilms; Caenorhabditis elegans; Cat Diseases; Cats; Dermatomycoses; Dog Diseases; Dogs; Epithelial Cells; Fluconazole; Foxes; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Virulence | 2018 |
Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Female; Fluconazole; Fungi; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Mycoses | 2018 |
In vitro combination of antifungal agents against Malassezia pachydermatis.
Topics: Antifungal Agents; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Itraconazole; Malassezia; Miconazole; Microbial Sensitivity Tests | 2019 |
Lyophilized tablets for focal delivery of fluconazole and itraconazole through vaginal mucosa, rational design and in vitro evaluation.
Topics: Antifungal Agents; Drug Design; Drug Liberation; Female; Fluconazole; Freeze Drying; Humans; Itraconazole; Liposomes; Mucous Membrane; Tablets; Vagina; Vitamin E | 2018 |
Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Female; Fluconazole; HIV Infections; Humans; Incidence; Iran; Itraconazole; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Prevalence; Young Adult | 2018 |
Oral colonization by Candida species in HIV-positive patients: association and antifungal susceptibility study.
Topics: Adult; Antifungal Agents; Brazil; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Young Adult | 2018 |
Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candida glabrata; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Itraconazole; Lanosterol; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles; Voriconazole | 2018 |
Crystal Structures of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery.
Topics: Antifungal Agents; Azoles; Candida albicans; Candida glabrata; Catalytic Domain; Fluconazole; Fungal Proteins; Humans; Itraconazole; Lanosterol; Microbial Sensitivity Tests; Protein Binding; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles | 2018 |
Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China.
Topics: Antifungal Agents; Candida; Candidiasis; China; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Infant; Infection Control; Intensive Care, Neonatal; Itraconazole; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Treatment Outcome | 2018 |
Fluorescent Tracking of the Endoplasmic Reticulum in Live Pathogenic Fungal Cells.
Topics: Antifungal Agents; Candida albicans; Candida glabrata; Endoplasmic Reticulum; Fluconazole; Fluorescent Dyes; Fungal Proteins; Itraconazole; Microscopy, Fluorescence; Oxidoreductases; Sterol 14-Demethylase | 2018 |
[Factors related to oral candidiasis in HIV children and adolescents, species characterization and antifungal susceptibility].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; HIV Infections; Humans; Infant; Itraconazole; Male; Mexico; Mouth Mucosa; Prospective Studies; Risk Factors; Viral Load; Young Adult | 2018 |
Eumycetoma pedis in an Albanian farmer.
Topics: Antifungal Agents; Diagnosis, Differential; Farmers; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Madurella; Male; Middle Aged; Mycetoma | 2018 |
Antifungal susceptibility of yeasts isolated from anthropogenic watershed.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fresh Water; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reference Values; Sequence Analysis, DNA; Voriconazole; Yeasts | 2019 |
Predicting the Effects of Different Triazole Antifungal Agents on the Pharmacokinetics of Tamoxifen.
Topics: Antifungal Agents; Bone Density Conservation Agents; Drug Interactions; Female; Fluconazole; Forecasting; Humans; Itraconazole; Middle Aged; Models, Biological; Tamoxifen; Triazoles; Voriconazole | 2019 |
The Evolution of Azole Resistance in
Topics: Amino Acid Sequence; Antifungal Agents; Azoles; Candida albicans; Fluconazole; Fungal Proteins; Itraconazole; Mutation; Protein Binding; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
Epidemiology and susceptibility profile to classic antifungals and over-the-counter products of Malassezia clinical isolates from a Portuguese University Hospital: a prospective study.
Topics: Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Itraconazole; Malassezia; Microbial Sensitivity Tests; Nonprescription Drugs; Portugal; Prospective Studies; Skin; Voriconazole | 2019 |
Diversity of phenotypically non-dermatophyte, non-Aspergillus filamentous fungi causing nail infections: importance of accurate identification and antifungal susceptibility testing.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Biodiversity; Child; Child, Preschool; Female; Fluconazole; Fungi; Hong Kong; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nail Diseases; Onychomycosis; Phenotype; Phylogeny; Terbinafine; Young Adult | 2019 |
Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.
Topics: Animals; Antifungal Agents; Antihypertensive Agents; Bosentan; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Male; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole | 2020 |
Epidemiology and antifungal susceptibility testing of non-albicansCandida species colonizing mucosae of HIV-infected patients in Yaoundé (Cameroon).
Topics: Adolescent; Adult; Aged; Antifungal Agents; Cameroon; Candida; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Female; Fluconazole; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Young Adult | 2019 |
Evaluation of Candida colonization and use of the Candida Colonization Index in a paediatric Intensive Care Unit: a prospective observational study.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Child; Child, Preschool; Disease Susceptibility; Feasibility Studies; Female; Fluconazole; Humans; Infant; Intensive Care Units, Pediatric; Itraconazole; Male; Microbial Sensitivity Tests; Organ Specificity; Prospective Studies; Sensitivity and Specificity; Voriconazole | 2019 |
Candida species isolated from pigeon (Columbia livia) droppings may express virulence factors and resistance to azoles.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Brazil; Candida; Columbidae; Cryptococcosis; Drug Resistance, Fungal; Feces; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Virulence Factors | 2019 |
Evaluation of the Antifungal Activity of
Topics: Animals; Antifungal Agents; Arthrodermataceae; Azoles; Candida; Cryptococcus; Drug Combinations; Drug Synergism; Fluconazole; Guidelines as Topic; Humans; Itraconazole; Ketoconazole; Mentha piperita; Microbial Sensitivity Tests; Monoterpenes; Oils, Volatile | 2019 |
In vitro synergy of azole antifungals and methotrexate against Candida albicans.
Topics: Candida albicans; Cell Membrane; Cell Wall; Dose-Response Relationship, Drug; Drug Synergism; Fluconazole; Gastrula; In Vitro Techniques; Itraconazole; Methotrexate; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Voriconazole | 2019 |
Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Disk Diffusion Antimicrobial Tests; Econazole; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Pemphigus; Triazoles | 2019 |
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
Clinical significance of nosocomial
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Cross Infection; Cryptococcosis; Cryptococcus; Female; Fluconazole; Humans; Itraconazole; Male; Mexico; Middle Aged; Retrospective Studies | 2019 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
Agricultural systems as potential sources of emerging human mycoses caused by Trichoderma: a successful, common phylotype of Trichoderma longibrachiatum in the frontline.
Topics: Agriculture; Antifungal Agents; Environmental Exposure; Environmental Microbiology; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Mycoses; Phylogeny; Triazoles; Trichoderma | 2019 |
The Influence of Different Triazole Antifungal Agents on the Pharmacokinetics of Cyclophosphamide.
Topics: Antifungal Agents; Cyclophosphamide; Drug Interactions; Fluconazole; Humans; Itraconazole; Ketoconazole; Models, Biological | 2020 |
Synergistic Effects of Efflux Pump Modulators on the Azole Antifungal Susceptibility of Microsporum canis.
Topics: Anti-Dyskinesia Agents; Antifungal Agents; Azoles; Dermatomycoses; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Haloperidol; Histamine H1 Antagonists; Humans; Itraconazole; Microbial Sensitivity Tests; Microsporum; Promethazine; Voriconazole | 2020 |
Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; Follow-Up Studies; Humans; Incidence; Infant, Newborn; Itraconazole; Lebanon; Microbial Sensitivity Tests; Pregnancy; Prevalence; Vaginal Discharge; Voriconazole | 2020 |
Azole resistance in Candida from animals calls for the One Health approach to tackle the emergence of antimicrobial resistance.
Topics: Animals; Antifungal Agents; Candida albicans; Candida parapsilosis; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Male; Voriconazole | 2020 |
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; United Kingdom; Voriconazole | 2020 |
Synergistic effects of ketamine and azole derivatives on
Topics: Animals; Antifungal Agents; Biofilms; Candida; Candida albicans; Cell Survival; DNA Damage; DNA Fragmentation; DNA, Fungal; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Itraconazole; Ketamine; L Cells; Membrane Potential, Mitochondrial; Mice; Microbial Sensitivity Tests; Microbial Viability; Phosphatidylserines; Reactive Oxygen Species | 2020 |
Disseminated cutaneous cryptococcosis in an immunocompetent elderly long-term pigeon fancier.
Topics: Administration, Cutaneous; Aged; Animals; Antifungal Agents; Columbidae; Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Skin; Treatment Outcome | 2020 |
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole | 2020 |
Inhibitory effects of voriconazole, itraconazole and fluconazole on the pharmacokinetic profiles of ivosidenib in rats by UHPLC-MS/MS.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Chromatography, High Pressure Liquid; Drug Interactions; Fluconazole; Glycine; Itraconazole; Male; Pyridines; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Voriconazole | 2020 |
Comparative evaluation of E-test and CLSI methods for Itraconazole, Fluconazole and Ketoconazole susceptibilities of Microsporum canis strains.
Topics: Animals; Antifungal Agents; Cats; Dogs; Fluconazole; Indicator Dilution Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microsporum | 2020 |
Modulation of ERG Genes Expression in Clinical Isolates of Candida tropicalis Susceptible and Resistant to Fluconazole and Itraconazole.
Topics: Antifungal Agents; Brazil; Candida tropicalis; Drug Resistance, Fungal; Fluconazole; Gene Expression Regulation, Fungal; Genes, Fungal; Itraconazole; Microbial Sensitivity Tests | 2020 |
An LC-MS/MS Bioanalytical Assay for the Determination of Gilteritinib in Rat Plasma and Application to a Drug-Drug Interaction Study.
Topics: Administration, Oral; Aniline Compounds; Animals; Chromatography, High Pressure Liquid; Drug Interactions; Fluconazole; Itraconazole; Male; Pyrazines; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2020 |
In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
Topics: Amphotericin B; Antifungal Agents; China; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycelium; Phylogeny; Saccharomyces cerevisiae; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 2021 |
The H741D mutation in Tac1p contributes to the upregulation of CDR1 and CDR2 expression in Candida albicans.
Topics: Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Itraconazole; Membrane Transport Proteins; Mutation; Transcription Factors | 2020 |
A call for antifungal stewardship.
Topics: Antifungal Agents; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Pharmaceutical Preparations; Terbinafine; Tinea | 2020 |
The science and rationale of arriving at the correct drug and dosimetry of griseofulvin, fluconazole, terbinafine and itraconazole in superficial dermatophyte infections: an important step before a pragmatic trial.
Topics: Antifungal Agents; Arthrodermataceae; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Pharmaceutical Preparations; Terbinafine | 2021 |
Physiologically based pharmacokinetic modeling and simulation to predict drug-drug interactions of ivosidenib with CYP3A perpetrators in patients with acute myeloid leukemia.
Topics: Administration, Oral; Antineoplastic Agents; Area Under Curve; Computer Simulation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Fluconazole; Glycine; Healthy Volunteers; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Male; Microsomes, Liver; Models, Biological; Pyridines; Rifampin | 2020 |
Coccidioidomycosis in a reference center in Northeast Brazil: clinical/epidemiological profile and most common radiological findings.
Topics: Adult; Brazil; Coccidioides; Coccidioidomycosis; Fluconazole; Humans; Itraconazole | 2020 |
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Rhodotorula; Species Specificity; Triazoles; Voriconazole | 2020 |
High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antitubercular Agents; Candida; Candidiasis; Child; Drug Interactions; Drug Resistance, Multiple, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Rifampin; Species Specificity; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
The synergistic antifungal activity of resveratrol with azoles against Candida albicans.
Topics: Antifungal Agents; Azoles; Candida albicans; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Resveratrol | 2021 |
Transcriptomic studies on Purpureocillium lilacinum reveal molecular mechanisms of response to fluconazole and itraconazole.
Topics: Antifungal Agents; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Hypocreales; Itraconazole; Microbial Sensitivity Tests; Mycoses; Transcriptome | 2021 |
Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression.
Topics: Antifungal Agents; Azoles; Candida tropicalis; China; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Itraconazole; Voriconazole | 2021 |
Treatment of patients experiencing dupilumab facial redness with itraconazole and fluconazole: A single-institutional, retrospective medical record review.
Topics: Antibodies, Monoclonal, Humanized; Antifungal Agents; Erythema; Fluconazole; Humans; Itraconazole; Medical Records; Retrospective Studies | 2022 |
Generalized Bullous Fixed Drug Eruption to Fluconazole with Positive Patch Testing and Confirmed Tolerance to Itraconazole.
Topics: Aged; Antifungal Agents; Candidiasis, Oral; Drug Eruptions; Drug Tolerance; Fluconazole; Humans; Itraconazole; Male; Patch Tests | 2021 |
Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Genetic Loci; Genetic Variation; Genotype; Imidazoles; Iran; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Voriconazole | 2021 |
Isolation of antifungal-resistant yeasts from bulk milk in Japan.
Topics: Animals; Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Itraconazole; Japan; Microbial Sensitivity Tests; Milk; Yeasts | 2021 |
Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
Topics: Adult; Amphotericin B; Antifungal Agents; Biofilms; Biomass; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Middle Aged; Polymorphism, Restriction Fragment Length; Vagina; Virulence; Voriconazole; Young Adult | 2021 |
Physiologically Based Pharmacokinetic Modeling for Selumetinib to Evaluate Drug-Drug Interactions and Pediatric Dose Regimens.
Topics: Adolescent; Age Factors; Area Under Curve; Benzimidazoles; Body Surface Area; Child; Child, Preschool; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme Inhibitors; Drug Dosage Calculations; Drug Interactions; Fluconazole; Humans; Itraconazole; Metabolic Clearance Rate; Mitogen-Activated Protein Kinase Kinases; Protein Kinase Inhibitors; Rifampin | 2021 |
Trends in Systemic Antifungal Use in Australia, 2005-2016: a Time-Series Analysis.
Topics: Antifungal Agents; Australia; Fluconazole; Itraconazole | 2022 |
Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp.
Topics: Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Plant Extracts; Propolis; Stomatitis, Denture | 2021 |
ZnO, TiO2 and Ag nanoparticles impact against some species of pathogenic bacteria and yeast.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Brucella abortus; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Metal Nanoparticles; Microbial Sensitivity Tests; Particle Size; Salmonella typhimurium; Silver; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Titanium; Zinc Oxide | 2021 |
Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.
Topics: Antifungal Agents; Carcinoma, Non-Small-Cell Lung; Crizotinib; Fluconazole; Humans; Itraconazole; Lung Neoplasms; Triazoles; Voriconazole | 2022 |
Prevalence and susceptibility profiles of oral yeast species isolated from a healthy adult Thai cohort.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida tropicalis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Prevalence; Thailand; Voriconazole | 2022 |
Nannizzia incurvata in Hue city - Viet Nam: Molecular identification and antifungal susceptibility testing.
Topics: Antifungal Agents; Arthrodermataceae; DNA, Ribosomal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Lipase; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Phylogeny; Terbinafine; Tinea; Vietnam; Voriconazole | 2022 |
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Risk Factors; Voriconazole | 2022 |
Malassezia species: the need to establish epidemiological cutoff values.
Topics: Amphotericin B; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Voriconazole | 2022 |
Efficacy of Lamiaceae essential oils with selected azoles against Candida albicans clinical isolates.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Fluconazole; Itraconazole; Lamiaceae; Microbial Sensitivity Tests; Oils, Volatile | 2022 |
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; COVID-19; Female; Fluconazole; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; SARS-CoV-2; Voriconazole | 2023 |
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility.
Topics: Amphotericin B; Animals; Antifungal Agents; Calmodulin; Cat Diseases; Cats; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Phylogeny; Sporothrix; Sporotrichosis; Thailand; Tubulin | 2022 |
Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2022 |
PULMONARY AND COELOMIC MYCOSES DUE TO
Topics: Alligators and Crocodiles; Animals; Beauveria; Fluconazole; Itraconazole; Metarhizium; Mycoses; Pest Control, Biological; Terbinafine; Turtles; Voriconazole | 2022 |
In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Caspofungin; Female; Fluconazole; Humans; Itraconazole; Voriconazole | 2023 |
Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
Topics: Adult; Amphotericin B; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Humans; Itraconazole; Middle Aged; Natamycin; Prospective Studies; Tertiary Care Centers; Voriconazole; Young Adult | 2022 |
Malassezia spp. and Candida spp. from patients with psoriasis exhibit reduced susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Candida; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Malassezia; Microbial Sensitivity Tests; Psoriasis; Saccharomyces cerevisiae; Terbinafine | 2023 |
Gradient concentration strip-specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes.
Topics: Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Retrospective Studies; Saccharomyces cerevisiae | 2023 |
Verifying in vitro-determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically-based pharmacokinetic modeling.
Topics: Adult; Cannabidiol; Child; Child, Preschool; Drug Interactions; Fluconazole; Humans; Itraconazole; Rifampin | 2023 |
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Mycoses; Voriconazole | 2023 |
Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
Topics: Antifungal Agents; Arthrodermataceae; Caspofungin; Fluconazole; Griseofulvin; Hospitals, University; Humans; Iran; Itraconazole; Terbinafine; Triazoles | 2023 |
Inadequate diagnostic testing and systemic antifungal prescribing for tinea capitis in an observational cohort study of 3.9 million children, United States.
Topics: Antifungal Agents; Child; Cohort Studies; Fluconazole; Humans; Itraconazole; Terbinafine; Tinea Capitis; United States | 2023 |
Aspects related to biofilm production and antifungal susceptibility of clinically relevant yeasts of the genus Trichosporon.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Caspofungin; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Trichosporon; Trichosporonosis | 2023 |
Real world co-prescribing contraindicated drugs with fluconazole and itraconazole.
Topics: Cross-Sectional Studies; Drug Interactions; Fluconazole; Humans; Itraconazole; Retrospective Studies; Solifenacin Succinate | 2023 |
Impact of Concomitant Use of Azoles on Bortezomib-related Adverse Drug Reactions Using JADER.
Topics: Azoles; Bortezomib; Drug-Related Side Effects and Adverse Reactions; Fluconazole; Humans; Itraconazole; Neutropenia; Pharmaceutical Preparations | 2023 |
Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry azole susceptibility assessment in Candida and Aspergillus species.
Topics: Antifungal Agents; Aspergillus; Azoles; Candida; Fluconazole; Itraconazole; Lasers; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Voriconazole | 2023 |
Azole and 5-nitroimidazole based nanoformulations are potential antiamoebic drug candidates against brain-eating amoebae.
Topics: Amebicides; Amoeba; Antiprotozoal Agents; Azoles; Brain; Fluconazole; Humans; Itraconazole; Metronidazole; Naegleria fowleri | 2023 |
Atazanavir Resensitizes Candida auris to Azoles.
Topics: Animals; Antifungal Agents; Atazanavir Sulfate; Azoles; Candida; Candida auris; Drug Resistance, Fungal; Fluconazole; Itraconazole; Mice; Microbial Sensitivity Tests | 2023 |
Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis, Vulvovaginal; Farnesol; Female; Fluconazole; Humans; Itraconazole | 2023 |
Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Virulence; Voriconazole | 2023 |
A 3-year study of
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Neoplasms | 2023 |
The Argentinian landscape of mycological diagnostic capacity and treatment accessibility.
Topics: Animals; Antifungal Agents; Argentina; Fluconazole; Invasive Fungal Infections; Itraconazole | 2023 |
Efficacy of manuka honey with conventional antifungals on
Topics: Animals; Antifungal Agents; Azoles; Cat Diseases; Cats; Clotrimazole; Dog Diseases; Dogs; Fluconazole; Honey; Itraconazole; Miconazole | 2023 |
In vitro combination of antifungal drugs with tacrolimus (FK506) holds promise against clinical Candida species, including Candida auris.
Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candida auris; Candida glabrata; Candida parapsilosis; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Tacrolimus | 2023 |
Saquinavir potentiates itraconazole's antifungal activity against multidrug-resistant Candida auris in vitro andin vivo.
Topics: Animals; Antifungal Agents; Azoles; Candida; Candida auris; Fluconazole; Itraconazole; Mice; Microbial Sensitivity Tests; Saquinavir | 2023 |
In vitro sensitivity of Malassezia furfur isolates from HIV-positive and negative patients to antifungal agents
Topics: Amphotericin B; Animals; Antifungal Agents; Dermatitis, Seborrheic; Fluconazole; HIV Infections; Humans; Itraconazole; Malassezia; Saccharomyces cerevisiae; Voriconazole | 2023 |
Synthesis and antifungal activity of new azole derivatives containing an N-acylmorpholine ring.
Topics: Animals; Antifungal Agents; Azoles; Candidiasis; Female; Male; Mice; Microbial Sensitivity Tests; Rats; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship | 1995 |
New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Pyrimidinones; Rats; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Thiophenes; Triazoles | 1998 |
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles | 1998 |
Novel antifungals based on 4-substituted imidazole: a combinatorial chemistry approach to lead discovery and optimization.
Topics: Antifungal Agents; Candida; Combinatorial Chemistry Techniques; Drug Design; Ergosterol; Fungi; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2000 |
Interaction of common azole antifungals with P glycoprotein.
Topics: 3T3 Cells; Adenosine Triphosphate; Animals; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Cell Line; Hydrolysis; Mice | 2002 |
Synthesis of Sordaricin analogues as potent antifungal agents against Candida albicans.
Topics: Animals; Antifungal Agents; Bacterial Infections; Bridged-Ring Compounds; Candida albicans; Diterpenes; Mice; Microbial Sensitivity Tests | 2002 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Distamycin analogues with enhanced lipophilicity: synthesis and antimicrobial activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Cell Line; Cricetinae; Distamycins; DNA; Electrophoresis, Capillary; Humans; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Structure-Activity Relationship | 2004 |
Synthesis of some diguanidino 1-methyl-2,5-diaryl-1H-pyrroles as antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Drug Resistance, Microbial; Fluconazole; Guanidine; Microbial Sensitivity Tests; Pyrroles; Structure-Activity Relationship | 2005 |
Antifungal agents. 11. N-substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: synthesis, anti-Candida activity, and QSAR studies.
Topics: Antifungal Agents; Candida albicans; Imidazoles; Microbial Sensitivity Tests; Models, Molecular; Pyrroles; Quantitative Structure-Activity Relationship | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking.
Topics: Antifungal Agents; Azoles; Binding Sites; Databases, Factual; Fungi; Hydrogen Bonding; In Vitro Techniques; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship | 2006 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols | 2007 |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Topics: Antifungal Agents; Area Under Curve; Candida; Fungemia; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2007 |
A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mutation; Oxidative Phosphorylation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase (CYP51).
Topics: Antifungal Agents; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Triazoles | 2007 |
Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Chemistry, Pharmaceutical; Drug Design; Drug Resistance, Fungal; Fluconazole; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Models, Chemical; Time Factors; Triazoles | 2007 |
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; Environmental Microbiology; Fungicides, Industrial; Germany; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Oropharynx; Vitis | 2007 |
Synthesis and antifungal activities of novel 2-aminotetralin derivatives.
Topics: Administration, Intravaginal; Animals; Antifungal Agents; Binding Sites; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fluconazole; Microbial Sensitivity Tests; Models, Molecular; Oxidoreductases; Protein Binding; Rats; Sterol 14-Demethylase; Structure-Activity Relationship; Tetrahydronaphthalenes; Vaginal Diseases | 2007 |
Voriconazole inhibits melanization in Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Cell Line; Cryptococcus neoformans; Fluconazole; Gene Expression Regulation, Fungal; Laccase; Macrophages; Melanins; Mice; Microbial Sensitivity Tests; Phagocytosis; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods.
Topics: Azoles; Candida albicans; Colony Count, Microbial; Colorimetry; Culture Media; Drug Interactions; Drug Resistance, Fungal; Drug Synergism; Humans; Immunosuppressive Agents; Microbial Sensitivity Tests; Models, Biological; Spectrophotometry; Tacrolimus | 2008 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis; Catheterization, Central Venous; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungemia; Fungi; Humans; Microbial Sensitivity Tests | 2008 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts | 2008 |
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Drug Design; Microbial Sensitivity Tests; Models, Molecular; Propanols; Structure-Activity Relationship | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole; Yeasts | 2008 |
1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
Topics: Antifungal Agents; Arthrodermataceae; Candida albicans; Cell Line, Tumor; Cell Survival; Computer Simulation; Humans; Imidazoles; Models, Molecular; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2008 |
CYP56 (Dit2p) in Candida albicans: characterization and investigation of its role in growth and antifungal drug susceptibility.
Topics: Base Sequence; Candida albicans; Cell Wall; Cytochrome P-450 Enzyme System; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Gene Deletion; Gene Expression; Genes, Fungal; Mutation; Phenotype; Recombinant Proteins; Tyrosine | 2008 |
Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus.
Topics: Antifungal Agents; Azoles; Base Sequence; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Genes, Fungal; Humans; Molecular Sequence Data; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Species Specificity; Sterol 14-Demethylase | 2008 |
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
Identification, characterization, and azole-binding properties of Mycobacterium smegmatis CYP164A2, a homolog of ML2088, the sole cytochrome P450 gene of Mycobacterium leprae.
Topics: Amino Acid Motifs; Amino Acid Sequence; Azoles; Base Sequence; Cloning, Molecular; Conserved Sequence; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Genes, Bacterial; Hydrogen-Ion Concentration; Molecular Sequence Data; Molecular Structure; Molecular Weight; Mycobacterium leprae; Mycobacterium smegmatis; Osmolar Concentration; Recombinant Proteins; Sequence Homology, Amino Acid; Sodium Chloride | 2009 |
Synthesis and structure-activity relationships of 2-phenyl-1-[(pyridinyl- and piperidinylmethyl)amino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Microbial Sensitivity Tests; Models, Molecular; Propanols; Structure-Activity Relationship | 2009 |
Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Enzyme Inhibitors; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2009 |
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Immunohistochemistry; Injections, Intraperitoneal; Lipopeptides; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2009 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain | 2009 |
Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols.
Topics: Antifungal Agents; Catalytic Domain; Chemistry, Pharmaceutical; Computer Simulation; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Models, Chemical; Propanols; Protein Binding; Triazoles | 2009 |
Amide analogs of antifungal dioxane-triazole derivatives: synthesis and in vitro activities.
Topics: Amides; Antifungal Agents; Benzamides; Candida; Dioxanes; Microbial Sensitivity Tests; Triazoles | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
New azoles with potent antifungal activity: design, synthesis and molecular docking.
Topics: Antifungal Agents; Azoles; Candida albicans; Catalytic Domain; Cytochrome P-450 Enzyme System; Drug Design; Fungal Proteins; Fungi; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Protein Binding; Structure-Activity Relationship | 2009 |
Synthesis of new linear guanidines and macrocyclic amidinourea derivatives endowed with high antifungal activity against Candida spp. and Aspergillus spp.
Topics: Antifungal Agents; Aspergillus; Candida; Drug Design; Guanidine; Humans; Macrocyclic Compounds; Microbial Sensitivity Tests; Urea | 2009 |
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia | 2009 |
Design of new antifungal agents: synthesis and evaluation of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.
Topics: Antifungal Agents; Binding Sites; Candida albicans; Computer Simulation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Design; Fungal Proteins; Propanols; Structure-Activity Relationship; Triazoles | 2009 |
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles | 2009 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
Topics: Animals; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Disease Models, Animal; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genes, Fungal; Genetic Engineering; Humans; In Vitro Techniques; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation | 2010 |
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
Topics: Animals; Antifungal Agents; Base Sequence; Calcineurin; Candida glabrata; Candidiasis; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Female; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation; Opportunistic Infections; Transcription Factors; Virulence | 2010 |
Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives.
Topics: Antifungal Agents; Azoles; Binding Sites; Catalytic Domain; Computer Simulation; Cytochrome P-450 Enzyme System; Drug Design; Microbial Sensitivity Tests; Oximes; Sterol 14-Demethylase; Structure-Activity Relationship | 2010 |
In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyridinium Compounds; Yeasts | 2010 |
A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Drug Resistance, Fungal; Fungal Proteins; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction | 2010 |
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Search for antifungal compounds from the wood of durable tropical trees.
Topics: Acetals; Alkenes; Alkynes; Animals; Antifungal Agents; Basidiomycota; French Guiana; Lauraceae; Mice; Microbial Sensitivity Tests; Molecular Structure; NIH 3T3 Cells; Plant Stems; Polyporaceae; Trees; Wood | 2010 |
Synthesis and antifungal activity of some substituted phenothiazines and related compounds.
Topics: Antifungal Agents; Drug Discovery; Fungi; Microbial Sensitivity Tests; Phenothiazines; Structure-Activity Relationship | 2011 |
New azoles with antifungal activity: Design, synthesis, and molecular docking.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Azoles; Fungi; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycoses; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship | 2011 |
Design, synthesis and antifungal evaluation of 1-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-1H-1,2,4-triazol-5(4H)-one.
Topics: Antifungal Agents; Candida albicans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2011 |
Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.
Topics: Antifungal Agents; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole | 2011 |
Design, synthesis and molecular docking studies of novel triazole as antifungal agent.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Propanols; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole | 2011 |
Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Binding Sites; Catalytic Domain; Computer Simulation; Hydrogen Bonding; Microbial Sensitivity Tests; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2011 |
Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans.
Topics: Antifungal Agents; Candida albicans; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Liver; Models, Molecular; Nitriles; Protein Conformation; Saccharomyces cerevisiae; Sterol 14-Demethylase; User-Computer Interface | 2012 |
Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
Topics: Amino Alcohols; Antitubercular Agents; Cell Line; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Optical Rotation; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism | 2012 |
New triazole derivatives as antifungal agents: synthesis via click reaction, in vitro evaluation and molecular docking studies.
Topics: Antifungal Agents; Catalysis; Catalytic Domain; Click Chemistry; Computer Simulation; Copper; Fungi; Humans; Microbial Sensitivity Tests; Triazoles | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Design, synthesis and structure-activity relationships of new triazole derivatives containing N-substituted phenoxypropylamino side chains.
Topics: Antifungal Agents; Chemistry Techniques, Synthetic; Drug Design; Fungi; Microbial Sensitivity Tests; Models, Molecular; Nitrogen; Propylamines; Protein Conformation; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2012 |
Synthesis and biological evaluation of vinyl ether-containing azole derivatives as inhibitors of Trichophyton rubrum.
Topics: Antifungal Agents; Azoles; Molecular Structure; Structure-Activity Relationship; Trichophyton; Vinyl Compounds | 2012 |
Synthesis and anti-Candida activity of novel 2-hydrazino-1,3-thiazole derivatives.
Topics: Animals; Antifungal Agents; Candida; Candida albicans; Cell Survival; Drug Resistance, Fungal; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Structure-Activity Relationship; Thiazoles | 2013 |
Antifungal agents from Pseudallescheria boydii SNB-CN73 isolated from a Nasutitermes sp. termite.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Drug Screening Assays, Antitumor; Epinephrine; Escherichia coli; Fatty Alcohols; Humans; Isoptera; KB Cells; Miconazole; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pseudallescheria; Trichophyton | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Designing and synthesis of novel antimicrobial heterocyclic analogs of fatty acids.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Candida; Cyclization; Dose-Response Relationship, Drug; Drug Design; Fatty Acids; Heterocyclic Compounds; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Software; Structure-Activity Relationship | 2013 |
Synthesis and evaluation of novel azoles as potent antifungal agents.
Topics: Antifungal Agents; Azoles; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2014 |
Antifungal ether diglycosides from Matayba guianensis Aublet.
Topics: Antifungal Agents; Candida; Glycosides; Humans; Leukocytes, Mononuclear; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Conformation; Plant Bark; Plant Roots; Sapindaceae | 2014 |
Synthesis, antifungal activities and molecular docking studies of novel 2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl dithiocarbamates.
Topics: Aspergillus fumigatus; Candida; Carbamates; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Docking Simulation | 2014 |
Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility.
Topics: Animals; Antifungal Agents; Area Under Curve; Candida; Drug Design; Drug Evaluation, Preclinical; Half-Life; Heterocyclic Compounds; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Docking Simulation; Rats; Solubility; Structure-Activity Relationship; Triazoles; Water | 2014 |
Imidazolylchromanones containing non-benzylic oxime ethers: synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii.
Topics: Amino Acid Sequence; Antifungal Agents; Azoles; Chromans; Cryptococcus gattii; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Sequence Homology, Amino Acid; Sterol 14-Demethylase | 2014 |
Polyhydroxy cyclohexanols from a Dendrodochium sp. fungus associated with the sea cucumber Holothuria nobilis Selenka.
Topics: Animals; Antifungal Agents; Cryptococcus neoformans; Cyclohexanols; Holothuria; Humans; Microbial Sensitivity Tests; Molecular Structure; Oceans and Seas; Trichophyton | 2014 |
Discovery of a novel broad-spectrum antifungal agent derived from albaconazole.
Topics: | 2013 |
Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains.
Topics: Antifungal Agents; Candida albicans; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Piperidines; Structure-Activity Relationship; Triazoles | 2014 |
Design and optimization of highly-selective fungal CYP51 inhibitors.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Conformation; Sterol 14-Demethylase; Structure-Activity Relationship | 2014 |
Antibacterial ilicicolinic acids C and D and ilicicolinal from Neonectria discophora SNB-CN63 isolated from a termite nest.
Topics: Animals; Anti-Bacterial Agents; Benzoates; Benzofurans; Drug Screening Assays, Antitumor; Female; French Guiana; Humans; Hypocreales; Isoptera; KB Cells; Molecular Structure | 2015 |
Synthesis and biological evaluation of 1,3-diaryl pyrazole derivatives as potential antibacterial and anti-inflammatory agents.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candida albicans; Drug Resistance, Multiple, Bacterial; Furans; Gram-Negative Bacteria; Gram-Positive Cocci; Ibuprofen; Indomethacin; Mice; Pyrazoles | 2015 |
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Cell Line; Cell Survival; Drug Design; Drug Resistance, Microbial; Fungi; Hemolysis; Humans; Kanamycin; Mice; Mycoses; Surface-Active Agents | 2015 |
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
Topics: Antifungal Agents; Benzimidazoles; Carbon-13 Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Reactive Oxygen Species; Yeasts | 2016 |
Design, synthesis, and structure-activity relationship studies of benzothiazole derivatives as antifungal agents.
Topics: Antifungal Agents; Benzothiazoles; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Drug Design; Microbial Sensitivity Tests; Molecular Docking Simulation; Saccharomyces cerevisiae; Sterol 14-Demethylase; Structure-Activity Relationship | 2016 |
Discovery of biphenyl imidazole derivatives as potent antifungal agents: Design, synthesis, and structure-activity relationship studies.
Topics: Antifungal Agents; Biphenyl Compounds; Candida albicans; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Discovery; Imidazoles; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2017 |
Novel alkylated azoles as potent antifungals.
Topics: Alkylation; Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Cell Line; Ergosterol; Fungi; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Mycoses | 2017 |
Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Design; Heterocyclic Compounds; Hydrocarbons, Aromatic; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors.
Topics: Alkaloids; Antifungal Agents; Biofilms; Drug Resistance, Fungal; Fungi; Heterocyclic Compounds, 4 or More Rings; Microbial Sensitivity Tests; Naphthyridines | 2018 |
New 1,5 and 2,5-disubstituted tetrazoles-dependent activity towards surface barrier of Candida albicans.
Topics: Antifungal Agents; Caco-2 Cells; Candida albicans; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2018 |
Synthesis, molecular modeling studies and evaluation of antifungal activity of a novel series of thiazole derivatives.
Topics: Antifungal Agents; Candida; Candidiasis; Cryptococcosis; Cryptococcus; HEK293 Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Paracoccidioides; Paracoccidioidomycosis; Structure-Activity Relationship; Thiazoles | 2018 |
Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51.
Topics: Antifungal Agents; Aspergillus fumigatus; Binding Sites; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Drug Design; Drug Resistance, Fungal; Drug Stability; Fluconazole; Fungal Proteins; Gas Chromatography-Mass Spectrometry; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Isoforms; Sterol 14-Demethylase; Sterols; Structure-Activity Relationship; Triazoles | 2018 |
Synthesis of novel dihydrotriazine derivatives bearing 1,3-diaryl pyrazole moieties as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Binding Sites; Cell Line; Cell Survival; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Structure, Tertiary; Pyrazoles; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines | 2019 |
Design, synthesis, and structure-activity relationship studies of l-amino alcohol derivatives as broad-spectrum antifungal agents.
Topics: A549 Cells; Amino Alcohols; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Catalytic Domain; Cryptococcus neoformans; Drug Design; Drug Stability; Ergosterol; Humans; Microbial Sensitivity Tests; Protein Binding; Stereoisomerism; Sterol 14-Demethylase; Structure-Activity Relationship | 2019 |
Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles.
Topics: Antifungal Agents; Azoles; Candida; Cell Survival; Coumarins; Dose-Response Relationship, Drug; HEK293 Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Optical Imaging; Structure-Activity Relationship | 2019 |
Design, synthesis and evaluation of biphenyl imidazole analogues as potent antifungal agents.
Topics: Antifungal Agents; Aspergillus fumigatus; Binding Sites; Biphenyl Compounds; Candida albicans; Catalytic Domain; Cell Line, Tumor; Cell Survival; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Isoforms; Structure-Activity Relationship | 2019 |
Oxadiazolylthiazoles as novel and selective antifungal agents.
Topics: Antifungal Agents; Aspergillus; Biofilms; Caco-2 Cells; Candida; Cryptococcus; Humans; Microbial Sensitivity Tests; Oxadiazoles; Stereoisomerism; Thiazoles | 2020 |
New azole antifungals with a fused triazinone scaffold.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazines | 2020 |
Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis.
Topics: 14-alpha Demethylase Inhibitors; Animals; Azoles; Candida albicans; Candidiasis; Cytochrome P450 Family 51; Drug Discovery; Drug Resistance, Fungal; Female; Histone Deacetylase Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred ICR; Sterol 14-Demethylase; Treatment Outcome | 2020 |
Integrating the Impact of Lipophilicity on Potency and Pharmacokinetic Parameters Enables the Use of Diverse Chemical Space during Small Molecule Drug Optimization.
Topics: Area Under Curve; Blood Proteins; Drug Design; Half-Life; Humans; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Protein Binding; ROC Curve; Small Molecule Libraries | 2020 |
Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
Topics: Animals; Bacteria; Drug Screening Assays, Antitumor; Epidermophyton; HeLa Cells; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Nitroso Compounds; Pyrazoles; Rats, Sprague-Dawley; Structure-Activity Relationship; Trichophyton | 2020 |
Lanosterol 14α-demethylase (CYP51)/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Candida tropicalis; Candidiasis, Cutaneous; Cryptococcosis; Cryptococcus neoformans; Cytochrome P450 Family 51; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Histone Deacetylase Inhibitors; Histone Deacetylases; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
A new sulfated triterpene glycoside from the sea cucumber Colochirus quadrangularis, and evaluation of its antifungal, antitumor and immunomodulatory activities.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Glycosides; Humans; Immunomodulation; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Saponins; Sea Cucumbers; Triterpenes | 2021 |
Improving the metabolic stability of antifungal compounds based on a scaffold hopping strategy: Design, synthesis, and structure-activity relationship studies of dihydrooxazole derivatives.
Topics: Antifungal Agents; Drug Design; Humans; Molecular Structure; Structure-Activity Relationship | 2021 |
Design, synthesis and evaluation of novel 5-phenylthiophene derivatives as potent fungicidal of Candida albicans and antifungal reagents of fluconazole-resistant fungi.
Topics: Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Fungal; Fluconazole; Fungicides, Industrial; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiophenes | 2021 |
Broadening antifungal spectrum and improving metabolic stablity based on a scaffold strategy: Design, synthesis, and evaluation of novel 4-phenyl-4,5-dihydrooxazole derivatives as potent fungistatic and fungicidal reagents.
Topics: Antifungal Agents; Candida albicans; Candida tropicalis; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Fungal; Fungicides, Industrial; Microbial Sensitivity Tests; Molecular Structure; Oxazoles; Structure-Activity Relationship | 2022 |
Design, synthesis, and biological activity evaluation of 2-(benzo[b]thiophen-2-yl)-4-phenyl-4,5-dihydrooxazole derivatives as broad-spectrum antifungal agents.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Design; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Oxazoles; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiophenes | 2022 |
Relaxed Substrate Requirements of Sterol 14α-Demethylase from
Topics: 14-alpha Demethylase Inhibitors; Ligands; Naegleria fowleri; Sterol 14-Demethylase; Substrate Specificity | 2021 |
Design, synthesis, and evaluation of novel 3-thiophene derivatives as potent fungistatic and fungicidal reagents based on a conformational restriction strategy.
Topics: Animals; Antifungal Agents; Azoles; Humans; Indicators and Reagents; Mammals; Microbial Sensitivity Tests; Thiophenes | 2022 |
Development of Lipo-γ-AA Peptides as Potent Antifungal Agents.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Mice; Microbial Sensitivity Tests; Peptides | 2022 |